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G E N E R A L  I N T R O D U C T I O N1
A B S T R AC T
In this thesis we explore the pathophysiological and preclinical concepts underlying the effects 
of supraphysiological oxygenation (part 1), assess the clinical effects of hyperoxia in critical care 
(part 2) and investigate preventive strategies in oxygen management by promoting conservative 
oxygenation in the intensive care unit (part 3).
Thesis
The Effects of Oxygen in Critical Illness
Part 2
Clinical Effects and 
Associated Outcomes
Part 3














General Discussion and Summary
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S U B J E C T  A N D  S U S P E C T:  OX YG E N
Owing to its indispensable nature, oxygen may the most appealing element in life and among 
the most important components for therapy in critical care. It is the basis for aerobic cell 
metabolism and a prerequisite for life by fueling the mitochondria and supplying energy to the body. 
Supplemental oxygen is routinely administered in emergency situations and has life-saving potential 
in critically ill patients. Therefore it is a cornerstone in the treatment of patients in the intensive care 
unit. However, Swiss-born Renaissance physician and father of toxicology, Paracelcus noted: “Alle 
Dinge sind Gift, und nichts ist ohne Gift. Allein die Dosis macht, daß ein Ding kein Gift ist”. In free 
interpretation: the dose makes the poison. This accounts for many aspects in medicine, but it may 
also be well applicable to the essential oxygen molecule. Following the independent discovery of 
oxygen by the chemists Scheele, Priestley and Lavoisier between 1772 and 1775, Joseph Priestley was 
the first to suggest that dephlogisticated air (oxygen) may also have adverse effects.
As a deficiency in the amount of oxygen in the tissues (hypoxia) is a feared complication for 
all patients, oxygen therapy is universally applied when impaired oxygen delivery to vital organs 
is suspected or anticipated. Under these circumstances, hypoxia is aggressively prevented by 
clinicians, but oxygen may also exert harmful effects, when it is administered in supraphysiological 
doses (hyperoxia). 
Hyperoxia can be defined as a state where oxygen administration exceeds the concentrations 
in ambient air (21%) or where the achieved oxygen levels of arterial blood are higher than in 
spontaneously breathing healthy subjects at sea level (supraphysiological). In order to prevent 
or counteract hazardous hypoxic episodes, oxygen is usually administered using nasal cannulas, 
face masks or mechanical ventilators under the paradigm “the more, the merrier”. The effects 
of supplemental oxygen are monitored by measuring the oxygen saturation in circulating red 
blood cells using red and infrared light (pulse oximetry). In general, this is a very useful method to 
roughly estimate the current oxygenation status of the patient, but its interpretation is limited in 
several situations and clinicians do not fully rely on this measurement. Importantly, pulse oximetry 
is characterized by a ceiling effect in which complete saturation (100%) of the oxygen carrying 
molecule (hemoglobin) is indicated but a further increase in the partial pressure of oxygen in 
the arterial blood (PaO
2
) is still possible. In addition, saturation levels below 70% are determined 
by extrapolation as pulse oximeters are not calibrated for extremely low saturations. Actual 
oxygenation is therefore more accurately assessed by arterial blood gas (ABG) measurements 
for which intermittent sampling and analysis by clinical laboratories or point-of-care devices is 
required. Such repeated measurements are time consuming, whereas pulse oximetry is a non-
invasive method allowing for continuous monitoring at the bedside. Both techniques are used 
concurrently in the intensive care unit (ICU) in order to provide a continuous estimation of 
the arterial oxygenation. When supranormal oxygen levels are achieved, the pulse oximeter usually 
indicates 100% oxyhemoglobin saturation, but the severity and exact degree of hyperoxia can 
only be assessed with delay by determining the actual partial pressure of arterial oxygen using 
ABG analysis. Hence, because an excess of oxygen is difficult to monitor on a continuous basis and 
oxygen is generally administered in a liberal manner, arterial hyperoxia is frequently encountered in 














F R I E N D  A N D  F O E
A high fraction of inspired oxygen (FiO
2
) is highly effective in promoting the oxygen content of 
arterial blood during specific emergency settings. In case of injured lungs or when the oxygen 
uptake or carrying capacity is impaired, high FiO
2
 levels may be necessary to preserve adequate 
oxygenation. However, hyperoxia may contribute to pulmonary inflammation, edema and tissue 
injury (biotrauma) in concurrence with the potential side effects of positive airway pressures 
(barotrauma) and volumes (volutrauma) applied by mechanical ventilation, also known as ventilator-
induced lung injury (4, 5). When the lungs are relatively healthy, supplemental oxygen typically 
leads to increased and supranormal PaO
2
 levels. Arterial hyperoxia induces vasoconstriction in most 
vascular beds which can be beneficial during vasodilatory shock but may also impose risk when 
organ perfusion is impaired. Furthermore, arterial hyperoxia has been associated with poor clinical 
outcomes in several cohort studies. A causal relationship has been questioned, but hyperoxia does 
have a strong potential to induce hemodynamic changes, lung injury and oxygen toxicity (6-12). 
Oxygen toxicity by free radicals is a well-established condition since the pioneering efforts of 
Lorrain Smith and Paul Bert in its discovery in the late 19th century (13). The description historically 
includes deleterious effects on the central nervous system and pulmonary intoxication. Oxygen free 
radicals are commonly referred to as reactive oxygen species (ROS) and are versatile molecules with 
an important role in cell signaling and homeostasis. ROS are formed during aerobic metabolism but 
physiological levels may be exceeded during environmental stress or when supplemental oxygen 
is administered. Critical illness may be viewed as an important environmental stressor and a typical 
setting for inadequate levels of ROS. When antioxidant systems are insufficient, supplemental 
oxygen can cause accumulation of oxygen radicals and may initiate or perpetuate oxygen 
toxicity. These potential side-effects of supplemental oxygen are pertinent to divers (14), pilots 
and premature infants (15, 16) but are of special concern in mechanically ventilated and oxygen 
supported critically ill patients (17).
T R I A L  A N D  E R R O R
The effects of oxygen have been comprehensively studied in experimental animal models but data 
from clinical trials in the intensive care unit are scarce. Compelling evidence on the time- and dose-
response relationship between arterial hyperoxia, physiological parameters and clinical outcomes 
of critically ill subgroups is lacking. Strikingly, oxygenation guidelines are available for only a limited 
number of subgroups, and these are not easily extrapolated to universal recommendations. This 
may lead to a suboptimal treatment policy in the intensive care unit as long as safe target ranges are 
not exactly known. Consequently, clinicians find themselves in a quandary during oxygen therapy 
when pursuing physiological PaO
2
 ranges and achieve adequate oxygenation in their patients.
E V I D E N C E  A N D  S E T T L E M E N T
In this thesis, we aimed to expand on the available evidence and fill in crucial knowledge gaps 














Considering the beneficial but also harmful effects, oxygen can be regarded as a molecule 
yielding two competing harms, as a double-edged sword, a Janus face, and a representation of Dr. 
Jekyll and Mr. Hyde. Therefore, an essential research question regarding oxygen therapy emerges: 
the more oxygen the better or can there be too much of a good thing and may less be more? 
In this matter, conservative oxygen therapy has been proposed as a therapeutic strategy in 
which both hypoxia and hyperoxia are actively and concomitantly prevented. In contrast to liberal 
oxygen administration the rationale is to prevent harm by iatrogenic hyperoxia, while preserving 
adequate tissue oxygenation. However, the feasibility and effectiveness of such strategies have not 
been studied and the effects on clinical outcomes remain to be determined. 
Hence, the aims of this thesis were to
1. assess preclinical effects and summarize the pathophysiological characteristics of hyperoxia;
2. review previous clinical findings and evaluate the epidemiology of hyperoxia in critical care;
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O U T L I N E  O F  T H E  T H E S I S
The general purpose of this thesis is to investigate the pathophysiology and epidemiology of 
hyperoxia in critical illness and explore strategies for prevention of oxygen toxicity in the intensive 
care unit. 
 – In Chapter 2, we give an introduction to the pathophysiological concepts of oxygen toxicity and 
review the literature for recent experimental, translational and clinical data, and further discuss 
the implications for therapy.
 – In Chapter 3, we investigate the time- and dose response effects of supplemental oxygen in an 
experimental mouse model using hyperoxic mechanical ventilation.
 – In Chapter 4, we explore the acute hemodynamic and microcirculatory changes during 
increased oxygen supply in mechanically ventilated patients in the intensive care unit after 
coronary artery bypass grafting surgery 
 – In Chapter 5, we describe the independent and combined effects of the partial pressures of 
both arterial carbon dioxide and arterial oxygen in a multicenter cohort of patients admitted to 
Dutch intensive care units after cardiac arrest.
 – In Chapter 6, we systematically review the literature for cohort studies comparing arterial 
hyperoxia to normoxia in critically ill adults and performed a meta-analysis and meta-regression 
of the results.
 – In Chapter 7, we evaluate previously used and newly constructed metrics of arterial hyperoxia 
and systematically assess their association with clinical outcomes in different subgroups in 
the intensive care unit.
 – In Chapter 8, we identify the common beliefs and self-reported attitudes of critical care 
physicians and nurses on oxygenation targets and compared this with actual treatment of 
patients in three tertiary care intensive care units in the Netherlands.
 – In Chapter 9, we study the feasibility, effectiveness and clinical outcomes of a two-step 
implementation of conservative oxygenation targets in the same three intensive care units.
 – In Chapter 10, we discuss the benefits and possible harms of oxygen therapy during critical 
illness, review the current evidence and summarize the findings of the present thesis.
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A B S T R AC T
Oxygen administration is uniformly used in emergency and intensive care medicine and has 
life-saving potential in critical conditions. However, excessive oxygenation also has deleterious 
properties in various pathophysiological processes and consequently both clinical and translational 
studies investigating hyperoxia during critical illness have gained increasing interest. Reactive 
oxygen species (ROS) are notorious by-products of hyperoxia and play a pivotal role in cell 
signaling pathways. The effects are diverse but when the homeostatic balance is disturbed, 
ROS typically conserve a vicious cycle of tissue injury, characterized by cell damage, cell death 
and inflammation. The most prominent symptoms in the abundantly exposed lungs include 
tracheobronchitis, pulmonary edema, and respiratory failure. In addition, absorption atelectasis 
results as a physiological phenomenon with increasing levels of inspiratory oxygen. Hyperoxia-
induced vasoconstriction can be beneficial during vasodilatory shock but hemodynamic changes 
may also impose risk when organ perfusion is impaired. In this context, oxygen may be recognized 
as a multifaceted agent, a modifiable risk factor and a feasible target for intervention. Although 
most clinical outcomes are still under extensive investigation, careful titration of oxygen supply is 




























I N T R O D U C T I O N
Oxygen is a vital element in human survival and plays a major role in a diverse range of biological 
and physiological processes. In medical practice, it is among the most universally used agents 
for the treatment of critically ill patients (1) and part of the routine treatment in acute shock 
and emergency medicine (2). In order to ensure sufficient oxygenation, oxygen therapy during 
mechanical ventilation, anesthesia and resuscitation usually exceeds physiological levels. However, 
Renaissance physician Paracelsus noted: “nothing is without poison – the poison is in the dose”. 
This accounts for many aspects in medicine, but it may also be well applicable to the oxygen 
molecule (3). The concept of oxygen toxicity has been described in the late 19th century following 
the pioneering efforts of Lorrain Smith and Paul Bert, but it was not until a century later that 
the effects of hyperoxia were increasingly studied. Although several lines of evidence indicate 
that hyperoxia may be harmful, robust interventional studies are still limited. In order to develop 
adequate recommendations for optimal oxygen levels it is important to extend our current 
understandings of hyperoxia-induced injury. The aim of this review is to provide a comprehensive 
overview of the effects of hyperoxia from the bench and the bedside. The first part will focus on 
established insights and recent experimental and translational advances; the latter part addresses 
pathophysiological concepts, clinical studies and implications for therapy.
Pathogenesis from the benchside
Reactive oxygen species
Reactive oxygen species (ROS) are versatile molecules that can be essential in the regulation of 
intracellular signaling pathways and in host defense (4). However, ROS have also repeatedly been 
postulated to be of major significance in tissue damage, organ dysfunction and clinical disease. 
When referring to oxygen toxicity, it is frequently assumed that it is not oxygen itself that exerts 
toxic effects but merely the ROS that are generated as an undesirable byproduct of adenosine 
triphosphate synthesis during aerobic cellular metabolism. The implications for the lungs are 
probably the most prominent as lung tissue is continuously and abundantly exposed to oxygen 
and its byproducts. In physiological circumstances, ROS are formed in the electron transport 
chain during proton transport across the inner mitochondrial membrane. Mitochondrial oxidative 
phosphorylation is the most important source of oxygen species, but ROS may also be generated 
in response to exogenous stimuli, such as microbes, cytokines and xenobiotics (5). Antioxidant 
tasks are accomplished by enzymes as catalases, glutathione peroxidases, thioredoxins and 
peroxyredoxins. These enzymes use electron donors in order to avoid the intermediate formation 
of the hydroxyl radical (OH∙), which is a strongly reactive oxidant. In this process superoxide 
dismutase (SOD) is an important antioxidant enzyme as it efficiently reduces the concentration 
of the superoxide anion (O
2







). In general, ROS generation from mitochondria increases with oxygen tension and 
is dependent on the clinical balance between the underlying condition and oxygen supply (6). 
In response to bacterial invasion neutrophils can also produce large amounts of ROS that may 




























principally well protected against oxygen toxicity by adequate intra- and extracellular antioxidant 
activity. Beside this physiological activity, additional antioxidants can be recruited in the epithelial 
lining fluid (7). However, when the production of ROS exceeds the limits of counteraction by 
antioxidant responses, ROS concentrations reach inadequate levels and a cellular state of oxidative 
stress manifests. Oxidative stress refers to the imbalance caused by increased ROS formation or 
deficient oxidant suppressors (8). When antioxidant systems are insufficient during critical illness 
and mechanical ventilation, supplemental oxygen can cause accumulation of oxygen radicals and 
may initiate or perpetuate oxygen toxicity. Moreover, ROS control can be markedly influenced by 
ageing, genetic factors and pharmacochemical agents (6). 
Cell death
When the delicate homeostatic balance is disturbed, oxidative stress leads to damage of nucleic acids, 
proteins and lipids, resulting in cell death by both apoptotic and necrotic pathways (9). Necrosis is 
characterized by incomplete apoptosis and supported by integrity loss of the cell membrane and 
cytoplasmic swelling. Programmed cell death by apoptosis can be achieved through extrinsic or 
intrinsic pathways, concomitantly. The extrinsic pathway is triggered by extracellular signals that 
stimulate intracellular apoptotic cascades after binding the cell membrane. The intrinsic apoptotic 
pathway is initiated by increased mitochondrial ROS formation. Subsequently, the opening of 
transition pores is facilitated making the outer mitochondrial membrane more permeable for pro-
apoptotic components. These components can then pass to the cytoplasm and induce a state of 
intracellular stress. When this occurs in both endothelial and epithelial cells, lytic damage and cell 
death contribute to interstitial pulmonary edema and impaired gas exchange by means of alveolar 
collapse and disintegration of the alveolar-capillary barrier.
Cell damage and inflammatory pathways
In addition to direct cell death by necrosis or apoptosis, cellular disruption caused by hyperoxia 
and ROS has been shown to release endogenous damage-associated molecular pattern molecules 
(DAMPs) that alert the innate immune system (10-12). DAMPs, or alarmins, are cell fragments 
released during cellular dysfunction and sterile injury and act as pleiotropic modulators of 
inflammation. During oxidative stress, mitochondrial damage is a pivotal cause of extracellular 
hazardous content including both free radicals and DAMPs. As they resemble bacterial DNA, 
circulating mitochondrial DAMPs are efficiently recognized by pattern recognition receptors and 
activate polymorphonuclear neutrophils (PMNs). Subsequently, PMNs release interleukins and 
contribute to a sterile inflammatory reaction and, ultimately, neutrophil-mediated organ injury. In 
response to hyperoxia-mediated ROS production, resident lung cells initiate the release of various 
cytokines. Chemotactic factors orchestrate the inflammatory response by attracting inflammatory 
cells to the pulmonary compartment. Recruited neutrophils and monocytes are in turn significant 
sources of additional ROS, conserving a vicious cycle leading to further tissue damage (Fig. 1). 
Under enduring conditions of injury to pulmonary epithelium and increasing alveolar 
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Figure 1. Vicious cycle of hyperoxia induced cell injury. 




, hydrogen peroxide; 
IFN, interferon gamma; IL, interleukin; MAPK, mitogen-activated protein kinase; NADPH, nicotinamide 
adenine dinucleotide phosphate; NF-κB, nuclear factor kappa B; NLR, nodlike receptor; Nrf2, nuclear factor-2 




 ∙−, superoxide; OH∙, hydroxyl radical; ONOO−, peroxynitrite; PMN, 
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a systemic inflammatory response, in which cytokines are efficiently activated and phagocytosis 
by alveolar macrophages is hampered (13). Cytokine concentrations decrease after long-term 
exposure, suggesting that a fast upregulation of inflammatory action is followed by a gradual 
impairment of the innate immune system (14). Besides mitochondrial damage, the inflammatory 
actions of oxygen are importantly modulated by the hypoxia-inducible transcription factor 
(HIF) (15, 16). HIF-1α is thought to be upregulated during relative changes in oxygenation and 
accordingly responds to normoxia as a relative hypoxic state directly after hyperoxia. Through this 
mechanism, intermittent hyperoxia may trigger a paradoxical phenomenon in which the genetic 
expression of inflammatory mediators and erythropoietin (EPO) is stimulated in the absence of true 
tissue hypoxia (17).
Animal studies
Principal insights in hyperoxia-induced mechanisms have been obtained from experimental 
models. The first animal studies documented structural morphologic and biochemical changes 
in the lungs of a wide variety of animal species that were exposed to hyperoxia (18). Pioneering 
studies using conscious dogs postulated that normobaric hyperoxia decreased metabolic rate and 
altered hemodynamics (19, 20). These findings were subsequently reproduced in primates in whom 
progressive pulmonary injury, interstitial edema and inflammatory activation were observed (21). 
In later experiments, biochemical effects of ROS and interventional targets on the molecular level 
were more intensively studied in spontaneously breathing animals in hyperoxic environments and 
showed both detrimental and protective potential (22-26). Recent experiments were performed in 
mechanically ventilated rodents, rabbits and pigs mimicking the clinical environment of critically 
ill patients (27-31). In this context, the interaction between injurious ventilation and concurrent 
hyperoxia was shown to transcend lung injury by alveolar distention alone (22, 32-35). However, 
studies in mechanically ventilated animals are usually restricted to short exposure periods (32, 
34-38), even though hyperoxia may induce time-dependent inflammation (23). In order to improve 
our understanding of the impact of long-term exposure to both mechanical ventilation and 
hyperoxia, future studies involving mechanical ventilation of longer duration and with clinically 
relevant settings are essential for a robust representation of the ICU environment.
Pathogenesis from the bedside
Hyperoxia induced tissue injury 
Under normobaric circumstances, the side-effects of oxygen are initially restricted to the lungs. 
However, when hyperoxia manifests for prolonged periods or under hyperbaric conditions, other 
organs are concurrently at risk as more oxygen is dissolved in plasma (6). The amount of dissolved 
oxygen will readily increase at partial pressures of arterial oxygen (PaO
2
) exceeding 100 mmHg. 
Oxyhemoglobin saturation is nearly complete when PaO
2
 approaches this level and the carrying 




The harmful effects depend on underlying conditions, duration and degree of the hyperoxic 




























may vary between subgroups (39). Most pathophysiological changes originate rapidly and are 
rather universal effects, but the effects of hyperoxia are assumed to be time- and dose-dependent 
(40). In general, excessive oxygen supply causes absorption atelectasis by displacement of alveolar 
nitrogen. The progressive washout of nitrogen coincides with the abundant presence of oxygen in 
the alveoli which, driven by a steep pressure gradient, rapidly diffuses into the mixed venous blood. 
As a result, the alveolar volume is markedly reduced and leads to increased ventilation/perfusion 
mismatch by (partial) alveolar collapse and impaired gas exchange, which can be attenuated 
by applying positive end-expiratory pressure (PEEP) (41). Impaired mucociliary clearance by 
hyperoxia further contributes to obstructive atelectasis and altered surfactant metabolism 
facilitates adhesive atelectasis through alveolar instability and collapse. Several lines of evidence 
indicate further effects of breathing high oxygen levels in animals and healthy subjects (1, 42), but 
evidence of pulmonary toxicity in a clinical scenario is limited (43). The pathological features of 
this condition are commonly referred to as the Lorrain Smith effect (44) and are characterized by 
tracheobronchitis, which can be accompanied by pleuritic pain, bronchial irritation, cough and sore 
throat. Symptoms may spread from the upper airways into the lungs where diffuse alveolar damage 
manifests and contributes to edema, vascular leakage, arteriolar thickening, pulmonary fibrosis and 
emphysema, reflected by progressive paradoxical hypoxia, dyspnea and tachypnea. Additionally, 
prolonged hyperoxic exposure alters the microbial flora in the upper airways and further increases 
the risk of secondary infections and lethality. Notably, these pulmonary effects are often in addition 
to the primary (e.g. pneumonia) and secondary lung injury (e.g. ventilator-induced lung injury), 
which are accompanied by inflammatory responses. 
The central nervous system is typically the first to reveal symptoms from excessive ROS 
formation. The spectrum of neurological symptoms is referred to as the Paul Bert effect and ranges 
from nausea, dizziness and headache to vision disturbances (retinal damage), neuropathies, 
paralysis and convulsions (1). 
Vascular effects of hyperoxia have been well documented and may have both harmful and 
beneficial effects. Arterial hyperoxia increases the systemic vascular resistance and induces 
vasoconstriction, which may impair organ perfusion, especially in the cerebral and coronary 
region (45-47). Accompanying cardiovascular alterations result from even short term exposure 
and include a decrease in heart rate, stroke volume and cardiac output (48). However, hyperoxia 
is not a universal vasoconstrictor in all vascular regions and blood flow may be redistributed to 
the hepatosplanchnic circulation in septic shock (1, 49). Alternatively, the administration of oxygen 
promotes hemodynamic stabilization during vasodilatory shock, decreases intracranial pressure by 
cerebral vasoconstriction and preserves tissue oxygenation during hemodilution (2, 50). 
Clinical studies
Critical care
Recent studies assessing the clinical effects of arterial hyperoxia or normobaric supplemental 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































As highlighted in recent meta-analyses (88, 89), the effects on major clinical end points 
are conflicting and may be partially explained by heterogeneous methodology and subgroup 
differences in critically ill patients. Pooled effect estimates favoring normoxia are quite consistent 
but the harmful effects were previously shown to be impacted by the definition of hyperoxia and 
may be more pertinent to specific subgroups and at specific moments of admission. 
It is well-established that the use of higher FiO
2
 can lead to progressive hypercapnia during 
a state of chronic compensated respiratory acidosis and serious adverse outcomes have been 
shown in acute exacerbations of chronic obstructive pulmonary disease (COPD) or asthma (54-56). 
Likewise, high fractions of oxygen in the inspired air and arterial blood have been associated with 
increased mortality in mechanically ventilated patients (52).
Owing to a striking lack of robust clinical trials, a causal relationship is still uncertain and both 
the magnitude and direction of the associations depend on the adjustment for illness severity 
scores, FiO
2
 and other confounders (51, 52). Future randomized controlled studies are urgently 
needed to definitively elucidate the causal effects of oxygenation targets and derangements on 
clinical outcomes of critically ill patients.
Excessive oxygenation may be most intensively studied after resuscitation from cardiac arrest 
as both the vascular alterations and the ischemia and reperfusion injury are hypothesized to be 
hazardous (90). In a dose-dependent manner, hyperoxia has been linked to worse outcome in 
these patients. (58, 60-62). The adverse association was not systematically reproduced, possibly 
due to heterogeneity in study methods (57, 59, 64, 66, 67, 91). The only randomized controlled trial in 
the postresuscitation period found that 30% oxygen ventilation was not worse in comparison with 
100% oxygen, but the study was underpowered to detect significant differences (63). In view of all 
recent data, supplemental oxygen administration during resuscitation still appears desirable, while 
hyperoxia should be avoided in the post-resuscitation phase and saturation should be targeted 
at 94–96% (90, 92).
A large number of both experimental and clinical studies have primed pediatricians with great 
awareness of the risks of hyperoxia. For neonatal resuscitation, the routine use of 100% oxygen 
has been abandoned after numerous associations with myocardial, neurologic and kidney injury, 
retinopathy, inflammation and increased mortality (93, 94). However, strict adherence to lower 
target ranges of oxygen saturation among preterm infants did not significantly reduce disability or 
deaths (95). Results from a prospective large-scale meta-analysis investigating the most appropriate 
level of oxygenation for extremely preterm neonates suggested that functional oxyhemoglobin 
saturation (SpO
2
) should be targeted at 90-95% in the postnatal period (96).
Hyperoxia-induced vasoconstriction poses a major concern in the management of acute 
coronary syndromes and guidelines increasingly suggest a restriction of supplementary oxygen to 
only those at increased risk for hypoxia (97). Indeed, oxygen therapy has not been shown to be 
beneficial after acute myocardial infarction and may even be harmful causing a marked reduction 
in coronary blood flow and myocardial oxygen consumption (98, 99). The vasoconstriction caused 
by hyperoxia may be of special concern in the acute setting before reperfusion. The AVOID trial 
aimed to definitively qualify the role of supplemental oxygen in acute myocardial infarction (70) 




























infarct size at six months (100). In contrast, a smaller trial observed a beneficial effect of 30-40% 
oxygen inhalation over controls both during occlusion and reperfusion (72). Hemodynamic effects 
may also be pertinent to patients with acute ischemic stroke, who do not appear to benefit from 
increased survival after prolonged treatment with oxygen (82, 84). 
Despite the theoretical benefit of decreasing intracranial pressure through cerebral 
vasoconstriction, hyperoxia has repeatedly been associated with delayed cerebral ischemia 
and increased cerebral excitotoxicity after cerebrovascular incidents (77, 80, 81). Interestingly, 
the synergistic combination of hyperbaric and normobaric hyperoxia was recently found to have 
potential therapeutic efficacy in severe traumatic brain injury (101). However, observational data in 
patients with traumatic brain injury, ischemic stroke, subarachnoid or intracerebral hemorrhage, 
remain equivocal (74-76, 78, 79, 86). 
Perioperative care
Liberal oxygen supply is usually accepted in perioperative care, in order to avoid potentially life-
threatening consequences of hypoxia during surgery. Further effects of perioperative hyperoxia 
have been comprehensively summarized in meta-analyses, enrolling over 7,000 patients, and 
generally showed a reduced risk of surgical site infections and postoperative nausea, without 
luxation of postoperative atelectasis (102, 103). However, risks may outweigh benefits in specific 
age groups (39) and different subsets. This was recently highlighted in patients undergoing cancer 
surgery where 80% oxygen supply in the perioperative setting showed a significantly increased 
long-term all-cause mortality compared with those randomized to 30% (104).
Implications for therapy
Several therapeutic options that limit the harmful effects of hyperoxia can be contemplated, but 
prevention of excessive oxygenation is likely to be the most effective strategy. A rational approach 
may be a more conservative administration strategy in which oxygen is titrated to a lower tolerable 
level in order to prevent iatrogenic harm while preserving adequate tissue oxygenation. Recently, 
a pilot interventional study showed that conservative oxygen therapy in mechanically ventilated 
patients in the intensive care unit (ICU) can be feasible and free of adverse outcomes, while 
decreasing excess oxygen exposure (53). Importantly, when the risks for severe tissue hypoxia are 
pronounced, ample oxygen supply remains vital and should be started immediately to increase 
oxygen delivery and preserve tissue oxygenation. Also, oxygen may aid hemodynamic stabilization, 
decrease intracranial pressure and can be used to stimulate erythropoietin and increase 
hemoglobin, when using intermittent hyperoxia as a paradoxical trigger for HIF expression.
Experimental interventions to decrease harm from hyperoxia are targeted at numerous steps in 
the pathway of ROS-induced damage. The primary source for intervention in the oxidative cycle is 
inhibition of oxidant generation, either quantitatively or qualitatively. Bleomycin and amiodarone 
are well-known originators of drug-induced pulmonary disease and should be avoided to 
minimize preventable ROS formation (105, 106). Limiting the exposure to other exogenous stimuli 




























but this strategy proves cumbersome in actual practice. Although the clinical applicability has 
been questioned due to little or no preventative or therapeutic effect, the supply of antioxidant 
enzymes may be a potentially feasible approach to facilitate the conversion, avoid the intermediate 
formation, and reduce the concentration of strongly reactive oxidants. However, some of these 
antioxidants may actually have pro-oxidant properties depending on their concentration and 
interaction with other molecules. The neutralizing effect of antioxidants may also not be sufficient 
to secure metabolic stability, even when secondary inflammation is mitigated. Finally, oxidant 
scavenging can shift the balance towards harm when the role of oxidants in cell signaling pathways 
is suppressed (107).
As an alternative, pathways of cell integrity, cell death, and inflammation may be targeted to 
reduce further damage and enhance the defense against oxygen radicals. Experimental research 
suggests protective effects through modulation of protein kinases (108, 109) and transcription 
factors (110-113). Moreover, numerous preclinical studies have demonstrated that manipulation of 
chemokines, cytokines (13, 114), growth factors (115), receptors (116-118) and DAMPs (11, 12, 119) may 
limit hyperoxia induced injury, but these targets all remain to be evaluated at the bedside.
C O N C L U S I O N
Although oxygen remains of life-saving importance in critical care, accumulating evidence 
has demonstrated the prominent role of hyperoxia and the consequent formation of reactive 
oxygen species in the pathogenesis of several life-threatening diseases. The toxic effects of 
supraphysiological oxygen concentrations are driven by cell damage, cell death and inflammation. 
These aspects are of special concern in the pulmonary compartment, where absorption atelectasis 
impairs respiratory function at high inspiratory oxygen levels. The cerebral and coronary circulations 
are at specific risk when vascular alterations manifest. Long-term exposure to hyperoxia impairs 
the innate immune response and increases susceptibility to infectious complications and tissue injury. 
Given that critically ill patients are prone for inflammation, cardiovascular instability and depleted 
antioxidant mechanisms, the most rational practice may be to supply oxygen conservatively and 
titrate the therapy carefully to the patient’s needs. However, our understanding of oxygen toxicity 
is limited in humans and conflicting findings hamper the constitution of compelling guidelines. 
Further research is warranted to study hyperoxia induced effects in clinical practice, to elucidate 
time- and dose-response relationships, and to provide evidence-based oxygenation targets and 
interventions through robust clinical trials.
AC K N O W L E D G E M E N T S
For the preparation of the illustration, creative support by Iris Levert is gratefully acknowledged.
L I S T  O F  A B B R E V I AT I O N S
DAMP, damage-associated molecular pattern molecule; FiO
2
, fraction of inspired oxygen; HIF, 
hypoxia-inducible factor; ICU, intensive care unit; PaO
2
, partial pressure of arterial oxygen; PMN, 




























R E F E R E N C E S
1. Bitterman H. Bench-to-bedside review: oxygen as a drug. Crit Care. 2009;13(1):205.
2. Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369(18):1726-34.
3. Altemeier WA, Sinclair SE. Hyperoxia in the intensive care unit: why more is not always better. Curr Opin 
Crit Care. 2007;13(1):73-8.
4. Magder S. Reactive oxygen species: toxic molecules or spark of life? Crit Care. 2006;10(1):208.
5. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular 
signaling. Cell Signal. 2012;24(5):981-90.
6. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(Pt 2):335-44.
7. Comhair SA, Erzurum SC. Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung 
Cell Mol Physiol. 2002;283(2):L246-55.
8. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist’s guide to reactive oxygen 
species. Nat Rev Immunol. 2013;13(5):349-61.
9. Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet PF. Oxygen toxicity in mouse lung: pathways to 
cell death. Am J Respir Cell Mol Biol. 1998;19(4):573-81.
10. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause 
inflammatory responses to injury. Nature. 2010;464(7285):104-7.
11. Kuipers MT, van der Poll T, Schultz MJ, Wieland CW. Bench-to-bedside review: Damage-associated 
molecular patterns in the onset of ventilator-induced lung injury. Crit Care. 2011;15(6):235.
12. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, et al. Alarmins: awaiting a clinical 
response. J Clin Invest. 2012;122(8):2711-9.
13. Bhandari V, Elias JA. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. 
Free Radic Biol Med. 2006;41(1):4-18.
14. Baleeiro CE, Wilcoxen SE, Morris SB, Standiford TJ, Paine R, 3rd. Sublethal hyperoxia impairs pulmonary 
innate immunity. J Immunol. 2003;171(2):955-63.
15. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, et al. Emerging role of damage-associated 
molecular patterns derived from mitochondria in inflammation. Trends Immunol. 2011;32(4):157-64.
16. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364(7):656-65.
17. Rocco M, D’Itri L, De Bels D, Corazza F, Balestra C. The “normobaric oxygen paradox”: a new tool for 
the anesthetist? Minerva Anestesiol. 2014;80(3):366-72.
18. Crapo JD. Morphological-Changes in Pulmonary Oxygen-Toxicity. Ann Rev Physiol. 1986;48:721-31.
19. Lodato RF. Effects of normobaric hyperoxia on hemodynamics and O2 utilization in conscious dogs. Adv 
Exp Med Biol. 1990;277:807-15.
20. Lodato RF. Decreased O2 consumption and cardiac output during normobaric hyperoxia in conscious 
dogs. J Appl Physiol (1985). 1989;67(4):1551-9.
21. Fracica PJ, Knapp MJ, Piantadosi CA, Takeda K, Fulkerson WJ, Coleman RE, et al. Responses of baboons 
to prolonged hyperoxia: physiology and qualitative pathology. J Appl Physiol (1985). 1991;71(6):2352-62.
22. Bailey TC, Martin EL, Zhao L, Veldhuizen RA. High oxygen concentrations predispose mouse lungs to 
the deleterious effects of high stretch ventilation. J Appl Physiol (1985). 2003;94(3):975-82.
23. Nagato AC, Bezerra FS, Lanzetti M, Lopes AA, Silva MA, Porto LC, et al. Time course of inflammation, 




























24. Nagato A, Silva FL, Silva AR, Bezerra FS, Oliveira ML, Bello-Klein A, et al. Hyperoxia-induced lung injury is 
dose dependent in Wistar rats. Exp Lung Res. 2009;35(8):713-28.
25. Hou L, Xie K, Qin M, Peng D, Ma S, Shang L, et al. Effects of reactive oxygen species scavenger on the protective 
action of 100% oxygen treatment against sterile inflammation in mice. Shock. 2010;33(6):646-54.
26. Waisman D, Brod V, Rahat MA, Amit-Cohen BC, Lahat N, Rimar D, et al. Dose-related effects of hyperoxia 
on the lung inflammatory response in septic rats. Shock. 2012;37(1):95-102.
27. Kikuchi Y, Tateda K, Fuse ET, Matsumoto T, Gotoh N, Fukushima J, et al. Hyperoxia exaggerates bacterial 
dissemination and lethality in Pseudomonas aeruginosa pneumonia. Pulm Pharmacol Ther. 2009;22(4):333-9.
28. Rodriguez-Gonzalez R, Martin-Barrasa JL, Ramos-Nuez A, Canas-Pedrosa AM, Martinez-Saavedra MT, 
Garcia-Bello MA, et al. Multiple system organ response induced by hyperoxia in a clinically relevant 
animal model of sepsis. Shock. 2014;42(2):148-53.
29. Tateda K, Deng JC, Moore TA, Newstead MW, Paine R, 3rd, Kobayashi N, et al. Hyperoxia mediates 
acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J 
Immunol. 2003;170(8):4209-16.
30. Barth E, Bassi G, Maybauer DM, Simon F, Groger M, Oter S, et al. Effects of ventilation with 100% oxygen 
during early hyperdynamic porcine fecal peritonitis. Crit Care Med. 2008;36(2):495-503.
31. Sukhotnik I, Krausz MM, Brod V, Balan M, Turkieh A, Siplovich L, et al. Divergent effects of oxygen therapy 
in four models of uncontrolled hemorrhagic shock. Shock. 2002;18(3):277-84.
32. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA. Hyperoxia increases ventilator-induced lung injury via mitogen-
activated protein kinases: a prospective, controlled animal experiment. Crit Care. 2007;11(1):R25.
33. Makena PS, Luellen CL, Balazs L, Ghosh MC, Parthasarathi K, Waters CM, et al. Preexposure to hyperoxia 
causes increased lung injury and epithelial apoptosis in mice ventilated with high tidal volumes. Am J 
Physiol Lung Cell Mol Physiol. 2010;299(5):L711-9.
34. Quinn DA, Moufarrej RK, Volokhov A, Hales CA. Interactions of lung stretch, hyperoxia, and MIP-2 
production in ventilator-induced lung injury. J Appl Physiol (1985). 2002;93(2):517-25.
35. Liu YY, Liao SK, Huang CC, Tsai YH, Quinn DA, Li LF. Role for nuclear factor-kappaB in augmented lung injury 
because of interaction between hyperoxia and high stretch ventilation. Transl Res. 2009;154(5):228-40.
36. Cannizzaro V, Berry LJ, Zosky GR, Turner DJ, Hantos Z, Sly PD. Impact of supplemental oxygen in 
mechanically ventilated adult and infant mice. Respir Physiol Neurobiol. 2009;165(1):61-6.
37. Andrade PV, Dos Santos JM, Silva HC, Wilbert DD, Cavassani SS, Oliveira-Junior IS. Influence of Hyperoxia 
and Mechanical Ventilation in Lung Inflammation and Diaphragm Function in Aged Versus Adult Rats. 
Inflammation. 2014;37(2):486-94.
38. Cavassani SS, Junqueira VB, Moraes JB, Luzo KK, Silva CM, Barros M, et al. Short courses of mechanical 
ventilation with high-O2 levels in elderly rat lungs. Acta Cir Bras. 2011;26(2):107-13.
39. Habre W, Petak F. Perioperative use of oxygen: variabilities across age. Br J Anaesth. 2014;113 Suppl 2:ii26-36.
40. Asfar P, Singer M, Radermacher P. Understanding the benefits and harms of oxygen therapy. Intensive 
Care Med. 2015;41(6):1118-21.
41. Aboab J, Jonson B, Kouatchet A, Taille S, Niklason L, Brochard L. Effect of inspired oxygen fraction on 
alveolar derecruitment in acute respiratory distress syndrome. Intensive Care Med. 2006;32(12):1979-86.
42. Capellier G, Panwar R. Is it time for permissive hypoxaemia in the intensive care unit? Crit Care 
Resusc. 2011;13(3):139-41.
43. Kapanci Y, Tosco R, Eggermann J, Gould VE. Oxygen pneumonitis in man., Light- and electron-




























44. Smith JL. The pathological effects due to increase of oxygen tension in the air breathed. J 
Physiol. 1899;24(1):19-35.
45. Bak Z, Sjoberg F, Rousseau A, Steinvall I, Janerot-Sjoberg B. Human cardiovascular dose-response to 
supplemental oxygen. Acta Physiol (Oxf). 2007;191(1):15-24.
46. Floyd TF, Clark JM, Gelfand R, Detre JA, Ratcliffe S, Guvakov D, et al. Independent cerebral vasoconstrictive 
effects of hyperoxia and accompanying arterial hypocapnia at 1 ATA. J Appl Physiol (1985). 2003;95(6):2453-61.
47. Iscoe S, Beasley R, Fisher JA. Supplementary oxygen for nonhypoxemic patients: O2 much of a good 
thing? Crit Care. 2011;15(3):305.
48. Waring WS, Thomson AJ, Adwani SH, Rosseel AJ, Potter JF, Webb DJ, et al. Cardiovascular effects of acute 
oxygen administration in healthy adults. J Cardiovasc Pharmacol. 2003;42(2):245-50.
49. Calzia E, Asfar P, Hauser B, Matejovic M, Ballestra C, Radermacher P, et al. Hyperoxia may be beneficial. 
Crit Care Med. 2010;38(10 Suppl):S559-68.
50. Kemming GI, Meisner FG, Kleen M, Meier JM, Tillmanns J, Hutter JW, et al. Hyperoxic ventilation at 
the critical haematocrit. Resuscitation. 2003;56(3):289-97.
51. Eastwood G, Bellomo R, Bailey M, Taori G, Pilcher D, Young P, et al. Arterial oxygen tension and mortality 
in mechanically ventilated patients. Intensive Care Med. 2012;38(1):91-8.
52. de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, et al. Association between 
administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive 
care unit patients. Crit Care. 2008;12(6):R156.
53. Suzuki S, Eastwood GM, Glassford NJ, Peck L, Young H, Garcia-Alvarez M, et al. Conservative oxygen therapy 
in mechanically ventilated patients: a pilot before-and-after trial. Crit Care Med. 2014;42(6):1414-22.
54. Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in 
chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ. 
2010;341:c5462.
55. Cameron L, Pilcher J, Weatherall M, Beasley R, Perrin K. The risk of serious adverse outcomes associated 
with hypoxaemia and hyperoxaemia in acute exacerbations of COPD. Postgrad Med J. 2012;88(1046):684-9.
56. Perrin K, Wijesinghe M, Healy B, Wadsworth K, Bowditch R, Bibby S, et al. Randomised controlled 
trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. 
Thorax. 2011;66(11):937-41.
57. Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, et al. Arterial hyperoxia and in-hospital 
mortality after resuscitation from cardiac arrest. Crit Care. 2011;15(2):R90.
58. Elmer J, Scutella M, Pullalarevu R, Wang B, Vaghasia N, Trzeciak S, et al. The association between hyperoxia and 
patient outcomes after cardiac arrest: analysis of a high-resolution database. Intensive Care Med. 2015;41(1):49-57.
59. Ihle JF, Bernard S, Bailey MJ, Pilcher DV, Smith K, Scheinkestel CD. Hyperoxia in the intensive care unit and 
outcome after out-of-hospital ventricular fibrillation cardiac arrest. Crit Care Resusc. 2013;15(3):186-90.
60. Janz DR, Hollenbeck RD, Pollock JS, McPherson JA, Rice TW. Hyperoxia is associated with increased 
mortality in patients treated with mild therapeutic hypothermia after sudden cardiac arrest. Crit Care 
Med. 2012;40(12):3135-9.
61. Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, et al. Association Between 
Arterial Hyperoxia Following Resuscitation From Cardiac Arrest and In-Hospital Mortality. 
JAMA. 2010;303(21):2165-71.
62. Kilgannon JH, Jones AE, Parrillo JE, Dellinger RP, Milcarek B, Hunter K, et al. Relationship between supranormal 




























63. Kuisma M, Boyd J, Voipio V, Alaspaa A, Roine RO, Rosenberg P. Comparison of 30 and the 100% inspired 
oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study. 
Resuscitation. 2006;69(2):199-206.
64. Lee BK, Jeung KW, Lee HY, Lee SJ, Jung YH, Lee WK, et al. Association between mean arterial blood gas tension 
and outcome in cardiac arrest patients treated with therapeutic hypothermia. Am J Emerg Med. 2014;32(1):55-60.
65. Nelskyla A, Parr MJ, Skrifvars MB. Prevalence and factors correlating with hyperoxia exposure following 
cardiac arrest--an observational single centre study. Scand J Trauma Resusc Emerg Med. 2013;21(1):35.
66. Spindelboeck W, Schindler O, Moser A, Hausler F, Wallner S, Strasser C, et al. Increasing arterial oxygen 
partial pressure during cardiopulmonary resuscitation is associated with improved rates of hospital 
admission. Resuscitation. 2013;84(6):770-5.
67. Vaahersalo J, Bendel S, Reinikainen M, Kurola J, Tiainen M, Raj R, et al. Arterial blood gas tensions after 
resuscitation from out-of-hospital cardiac arrest: associations with long-term neurologic outcome. Crit 
Care Med. 2014;42(6):1463-70.
68. Minana G, Nunez J, Banuls P, Sanchis J, Nunez E, Robles R, et al. Prognostic implications of arterial blood 
gases in acute decompensated heart failure. Eur J Intern Med. 2011;22(5):489-94.
69. Ranchord AM, Argyle R, Beynon R, Perrin K, Sharma V, Weatherall M, et al. High-concentration versus 
titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. Am 
Heart J. 2012;163(2):168-75.
70. Stub D, Smith K, Bernard S, Bray JE, Stephenson M, Cameron P, et al. A randomized controlled trial of 
oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID 
Study). Am Heart J. 2012;163(3):339-45 e1.
71. Sutton AD, Bailey M, Bellomo R, Eastwood GM, Pilcher DV. The association between early arterial 
oxygenation in the ICU and mortality following cardiac surgery. Anaesth Intensive Care. 2014;42(6):730-5.
72. Ukholkina GB, Kostyanov IY, Kuchkina NV, Grendo EP, Gofman YB. Effect of oxygenotherapy used in 
combination with reperfusion in patients with acute myocardial infarction. Kardiologiya. 2005;45(5):59.
73. Zughaft D, Bhiladvala P, Van Dijkman A, Harnek J, Madsen Hardig B, Bjork J, et al. The analgesic effect of 
oxygen during percutaneous coronary intervention (the OXYPAIN Trial). Acute Card Care. 2013;15(3):63-8.
74. Asher SR, Curry P, Sharma D, Wang J, O’Keefe GE, Daniel-Johnson J, et al. Survival advantage and PaO2 
threshold in severe traumatic brain injury. J Neurosurg Anesthesiol. 2013;25(2):168-73.
75. Brenner M, Stein D, Hu P, Kufera J, Wooford M, Scalea T. Association between early hyperoxia and worse 
outcomes after traumatic brain injury. Arch Surg. 2012;147(11):1042-6.
76. Davis DP, Meade W, Sise MJ, Kennedy F, Simon F, Tominaga G, et al. Both hypoxemia and extreme hyperoxemia 
may be detrimental in patients with severe traumatic brain injury. J Neurotrauma. 2009;26(12):2217-23.
77. Quintard H, Patet C, Suys T, Marques-Vidal P, Oddo M. Normobaric Hyperoxia is Associated with 
Increased Cerebral Excitotoxicity After Severe Traumatic Brain Injury. Neurocrit Care. 2015;22(2):243-50.
78. Raj R, Bendel S, Reinikainen M, Kivisaari R, Siironen J, Lang M, et al. Hyperoxemia and long-term outcome 
after traumatic brain injury. Crit Care. 2013;17(4):R177.
79. Rincon F, Kang J, Vibbert M, Urtecho J, Athar MK, Jallo J. Significance of arterial hyperoxia and 
relationship with case fatality in traumatic brain injury: a multicentre cohort study. J Neurol Neurosurg 
Psychiatry. 2014;85(7):799-805.
80. Jeon SB, Choi HA, Badjatia N, Schmidt JM, Lantigua H, Claassen J, et al. Hyperoxia may be related to 





























81. Rincon F, Kang J, Maltenfort M, Vibbert M, Urtecho J, Athar MK, et al. Association between hyperoxia and 
mortality after stroke: a multicenter cohort study. Crit Care Med. 2014;42(2):387-96.
82. Ali K, Warusevitane A, Lally F, Sim J, Sills S, Pountain S, et al. The stroke oxygen pilot study: a randomized 
controlled trial of the effects of routine oxygen supplementation early after acute stroke--effect on key 
outcomes at six months. PLoS One. 2014;8(6):e59274.
83. Roffe C, Ali K, Warusevitane A, Sills S, Pountain S, Allen M, et al. The SOS pilot study: a RCT of routine 
oxygen supplementation early after acute stroke--effect on recovery of neurological function at one 
week. PLoS One. 2011;6(5):e19113.
84. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-
randomized controlled trial. Stroke. 1999;30(10):2033-7.
85. Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, et al. A pilot study of normobaric 
oxygen therapy in acute ischemic stroke. Stroke. 2005;36(4):797-802.
86. Young P, Beasley R, Bailey M, Bellomo R, Eastwood GM, Nichol A, et al. The association between early arterial 
oxygenation and mortality in ventilated patients with acute ischaemic stroke. Crit Care Resusc. 2012;14(1):14-9.
87. Stolmeijer R, ter Maaten JC, Zijlstra JG, Ligtenberg JJ. Oxygen therapy for sepsis patients in the emergency 
department: a little less? Eur J Emerg Med. 2014;21(3):233-5.
88. Helmerhorst HJ, Roos-Blom MJ, van Westerloo DJ, de Jonge E. Association Between Arterial Hyperoxia 
and Outcome in Subsets of Critical Illness: A Systematic Review, Meta-Analysis, and Meta-Regression of 
Cohort Studies. Crit Care Med. 2015;43(7):1508-19.
89. Damiani E, Adrario E, Girardis M, Romano R, Pelaia P, Singer M, et al. Arterial hyperoxia and mortality in 
critically ill patients: a systematic review and meta-analysis. Crit Care. 2014;18(6):711.
90. Dell’Anna A, Lamanna I, Vincent JL, Taccone F. How much oxygen in adult cardiac arrest? Crit 
Care. 2014;18(5):555.
91. Wang CH, Chang WT, Huang CH, Tsai MS, Yu PH, Wang AY, et al. The effect of hyperoxia on survival 
following adult cardiac arrest: a systematic review and meta-analysis of observational studies. 
Resuscitation. 2014;85(9):1142-8.
92. Eastwood GM, Young PJ, Bellomo R. The impact of oxygen and carbon dioxide management on outcome 
after cardiac arrest. Curr Opin Crit Care. 2014;20(3):266-72.
93. Tan A, Schulze A, O’Donnell CP, Davis PG. Air versus oxygen for resuscitation of infants at birth. Cochrane 
Database Syst Rev. 2005(2):CD002273.
94. Saugstad OD, Ramji S, Vento M. Oxygen for newborn resuscitation: how much is enough? 
Pediatrics. 2006;118(2):789-92.
95. Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, et al. Effects of targeting higher vs 
lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized 
clinical trial. JAMA. 2013;309(20):2111-20.
96. Saugstad OD, Aune D. Optimal oxygenation of extremely low birth weight infants: a meta-analysis and 
systematic review of the oxygen saturation target studies. Neonatology. 2014;105(1):55-63.
97. Shuvy M, Atar D, Gabriel Steg P, Halvorsen S, Jolly S, Yusuf S, et al. Oxygen therapy in acute coronary 
syndrome: are the benefits worth the risk? Eur Heart J. 2013;34(22):1630-5.
98. Farquhar H, Weatherall M, Wijesinghe M, Perrin K, Ranchord A, Simmonds M, et al. Systematic review of 
studies of the effect of hyperoxia on coronary blood flow. Am Heart J. 2009;158(3):371-7.
99. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. Routine use of oxygen in 




























100. Stub D. AVOID Study: Air Versus Oxygen In ST-elevation MyocarDial Infarction Scientific Sessions 
American Heart Association2014 [Available from: http://my.americanheart.org/idc/groups/ahamah-
public/@wcm/@sop/@scon/documents/downloadable/ucm_469664.pdf]
101. Rockswold SB, Rockswold GL, Zaun DA, Liu J. A prospective, randomized Phase II clinical trial to evaluate 
the effect of combined hyperbaric and normobaric hyperoxia on cerebral metabolism, intracranial pressure, 
oxygen toxicity, and clinical outcome in severe traumatic brain injury. J Neurosurg. 2013;118(6):1317-28.
102. Hovaguimian F, Lysakowski C, Elia N, Tramer MR. Effect of intraoperative high inspired oxygen fraction 
on surgical site infection, postoperative nausea and vomiting, and pulmonary function: systematic review 
and meta-analysis of randomized controlled trials. Anesthesiology. 2013;119(2):303-16.
103. Togioka B, Galvagno S, Sumida S, Murphy J, Ouanes JP, Wu C. The role of perioperative high inspired 
oxygen therapy in reducing surgical site infection: a meta-analysis. Anesth Analg. 2012;114(2):334-42.
104. Meyhoff CS, Jorgensen LN, Wetterslev J, Christensen KB, Rasmussen LS, Group PT. Increased long-term 
mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow-up of 
a randomized clinical trial. Anesth Analg. 2012;115(4):849-54.
105. Cooper JA, Jr., Zitnik RJ, Matthay RA. Mechanisms of drug-induced pulmonary disease. Annu Rev 
Med. 1988;39:395-404.
106. Kallet RH, Matthay MA. Hyperoxic acute lung injury. Respir Care. 2013;58(1):123-41.
107. Halliwell B. The antioxidant paradox. Lancet. 2000;355(9210):1179-80.
108. Zhang X, Shan P, Sasidhar M, Chupp GL, Flavell RA, Choi AM, et al. Reactive oxygen species and 
extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase mediate hyperoxia-induced 
cell death in lung epithelium. Am J Respir Cell Mol Biol. 2003;28(3):305-15.
109. Ahmad A, Ahmad S, Chang LY, Schaack J, White CW. Endothelial Akt activation by hyperoxia: role in cell 
survival. Free Radic Biol Med. 2006;40(7):1108-18.
110. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, et al. Role of NRF2 in protection 
against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol. 2002;26(2):175-82.
111. Franek WR, Morrow DM, Zhu H, Vancurova I, Miskolci V, Darley-Usmar K, et al. NF-kappaB protects lung 
epithelium against hyperoxia-induced nonapoptotic cell death-oncosis. Free Radic Biol Med. 2004;37(10):1670-9.
112. Lian X, Qin Y, Hossain SA, Yang L, White A, Xu H, et al. Overexpression of Stat3C in pulmonary epithelium 
protects against hyperoxic lung injury. J Immunol. 2005;174(11):7250-6.
113. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, et al. HIF-1alpha is essential for 
myeloid cell-mediated inflammation. Cell. 2003;112(5):645-57.
114. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, et al. Interleukin-6-induced protection in 
hyperoxic acute lung injury. Am J Respir Cell Mol Biol. 2000;22(5):535-42.
115. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, et al. Vascular endothelial 
growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar 
damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. 
Circulation. 2005;112(16):2477-86.
116. Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy MC, et al. CXCR2 is critical to hyperoxia-induced 
lung injury. J Immunol. 2004;172(6):3860-8.
117. Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, et al. Receptors for advanced 





























118. Gore A, Muralidhar M, Espey MG, Degenhardt K, Mantell LL. Hyperoxia sensing: from molecular 
mechanisms to significance in disease. J Immunotoxicol. 2010;7(4):239-54.
119. Patel VS, Sitapara RA, Gore A, Phan B, Sharma L, Sampat V, et al. High Mobility Group Box-1 mediates 
hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in 
mice. Am J Respir Cell Mol Biol. 2013;48(3):280-7.

3
Intensive Care Med Exp. 2017 May;5(1):27
doi: 10.1186/s40635-017-0142-5
H Y P E R OX I A  P R OVO K E S 
A  T I M E -  A N D  D O S E - D E P E N D E N T 
I N F L A M M ATO RY  R E S P O N S E  I N 
M E C H A N I C A L LY  V E N T I L AT E D 
M I C E ,  I R R E S P E C T I V E  O F 
T I DA L  VO L U M E S
Hendrik J.F. Helmerhorst, Laura R.A. Schouten, 
Gerry T.M. Wagenaar, Nicole P. Juffermans, 
Joris J.T.H. Roelofs, Marcus J. Schultz, 
Evert de Jonge, David J. van Westerloo
A B S T R AC T
Background
Mechanical ventilation and hyperoxia have the potential to independently promote lung injury and 
inflammation. Our purpose was to study both time- and dose-dependent effects of supplemental 
oxygen in an experimental model of mechanically ventilated mice.
Methods
Healthy male C57Bl/6J mice, aged 9–10 weeks, were intraperitoneally anesthetized and randomly 
assigned to the mechanically ventilated group or the control group. In total, 100 mice were 
tracheotomized and mechanically ventilated for either 8 or 12 hours after allocation to different 
settings for the applied fractions of inspired oxygen (FiO
2
, 30%, 50% or 90%) and tidal volumes 
(7.5 ml/kg or 15 ml/kg). After euthanisation arterial blood, bronchoalveolar lavage fluid (BALf) and 
tissues were collected for analyses.
Results
Mechanical ventilation significantly increased the lung injury score (P<0.05), mean protein content 
(P<0.001) and the mean number of cells (P<0.01), including neutrophils in BALf (P<0.001). In mice 
ventilated for 12 hours, a significant increase in TNF-α, IFN-γ, IL-1β, IL-10, and MCP-1 (P<0.01) was 
observed with 90% FiO
2
, whereas IL-6 showed a decreasing trend (P for trend = 0.03) across FiO
2
 
groups. KC, MIP-2, and sRAGE were similar between FiO
2
 groups. HMGB-1 was significantly higher 
in BALf of mechanically ventilated mice compared to controls and showed a gradual increase in 
expression with increasing FiO
2
. Cytokine and chemokine levels in BALf did not markedly differ 
between FiO
2
 groups after 8 hours of ventilation. Differences between the tidal volume groups were 
small and did not appear to significantly interact with the oxygen levels.
Conclusions
We demonstrated a severe vascular leakage and a pro-inflammatory pulmonary response in 
mechanically ventilated mice, which was enhanced by severe hyperoxia and longer duration of 
mechanical ventilation. Prolonged ventilation with high oxygen concentrations induced a time-
dependent immune response characterized by elevated levels of neutrophils, cytokines and 

































I N T R O D U C T I O N
Supplemental oxygen administration is essential to enhance survival in respiratory impaired 
and mechanically ventilated patients. Inspiratory fractions of oxygen (FiO
2
) typically exceed 
concentrations of atmospheric air and are frequently applied for prolonged periods during 
mechanical ventilation in patients suffering from severe respiratory distress. However, both 
mechanical ventilation and hyperoxia can promote lung injury and induce adverse effects through 
diverse mechanisms. Clinical studies have retrospectively shown associations between arterial 
hyperoxia and poor outcomes during specific cardiovascular, neurological, respiratory and 
traumatic events (1-4). Accumulating evidence indicates a U-shaped survival curve of critically 
ill and mechanically ventilated patients in relation to arterial oxygen levels in the first 24 hours 
of admission (5-8).
Impaired lung function may be caused by the adverse hemodynamic effects that are mainly 
imputed to direct vasoconstrictive actions of high oxygen concentrations, and atelectasis which 
may be aggravated by local and systemic inflammatory responses. These responses have repeatedly 
been documented in rodents following hyperoxic exposure in inhalation chambers (9-15). Although 
hyperoxia has been suggested to induce time-dependent inflammatory responses (10), studies 
in animals are usually restricted to periods of up to 6 hours of mechanical ventilation, limiting its 
clinical applicability (16-19). Furthermore, the interaction between mechanical ventilation and 
concurrent hyperoxia may transcend lung injury by alveolar distention alone (9, 17, 20-22). Given 
that oxygen therapy cannot altogether be avoided, we aimed to increase knowledge on the host 
response to different levels of oxygen. Hypothesizing that hyperoxia induces a dose-dependent 
gradual inflammatory response that may be aggravated by prolonged periods of mechanical 
ventilation, our purpose was to induce hyperoxia in mice and study both time- and dose-dependent 
inflammation effects of supplemental oxygen during prolonged ventilatory support with protective 
and injurious tidal volumes.
M E T H O D S
The Animal Care and Use Committee of the Academic Medical Center of the University of 
Amsterdam, the Netherlands approved the study protocol in accordance with applicable research 
and ethical protocols. Animal procedures were performed in consistence with Institutional 
Standards for Care and Use of Laboratory Animals.
Animals
Healthy male C57Bl/6J mice were obtained from Charles River (Maastricht, the Netherlands) 
and housed in a temperature- and light-controlled room. The animals were acclimatized at 
the animal facility for at least seven days and had free access to rodent chow and water. Animal 
welfare was warranted throughout the experiment (23). Conscious animals were injected twice for 
intraperitoneal prehydration and anesthesia induction. Thereafter, mice were regularly checked 



































At baseline, 109 mice aged 9–10 weeks (20–28 g) were intraperitoneally prehydrated with a bolus 
of 1 ml normal saline and randomly assigned to the mechanical ventilation (MV) group (n=100) or 
the control group (n=9). All mice in the MV group were randomized to subgroups (n = 8–9 per 
subgroup) by allocating different settings for the applied fractions of inspired oxygen (FiO
2
 = 30%, 
50% or 90%), tidal volumes (TV = 7.5 ml/kg or 15 ml/kg) and MV duration (8 or 12 hours). The control 
group mice were spread over multiple days along with the instrumentation of the MV groups during 
the whole experimental period.
Experimental procedures have been described in detail previously (24, 25). One hour after 
prehydration, mice assigned to the MV groups (n=8–9 per group), were anesthetized with 
a 0.15-0.21 ml intraperitoneal bolus of 126 mg/kg ketamine (Eurovet Animal Health BV, Bladel, 
the Netherlands), 0.1 mg/kg dexmedetomidine 0.5 mg/ml (Elanca Animal Health, Houten, 
the Netherlands), 0.5 mg/kg atropine sulfate (Centrafarm BV, Etten-Leur, the Netherlands) and 5 
ml/kg 0.9% saline. Maintenance anesthesia was injected hourly through an intraperitoneal catheter 
(PE 10 tubing, BD, Breda, the Netherlands) and consisted of 36 mg/kg ketamine, 0.02 mg/kg 
dexmedetomidine, 0.075 mg/kg atropine sulfate and 9.45 ml/kg 0.65% saline. A 1:5 mix of 0.65% 
saline and 8.4% sodium bicarbonate was intraperitoneally administered through the catheter every 
30 minutes in order to compensate for fluid loss and maintain physiological bicarbonate levels 
(25). Body temperature was strictly controlled between 36.5 and 37.5°C. Systolic blood pressure and 
heart rate were noninvasively measured using a murine tail pressure cuff with pulse transducer and 
monitored on a data acquisition system (LabChart, ADInstruments Ltd, Oxford, United Kingdom). 
Tidal volumes were monitored using a calibrated pneumotachometer (tracheal cannula OD=1.3 mm, 
PTM type 378/0.9, HSE-Harvard Apparatus GmbH, March-Hugstetten, Germany) and respiration 
data acquisition software (BDAS, HSE-Harvard Apparatus GmbH). 
Anesthetized mice were tracheotomized and a Y-tube connector (OD 1.0 mm, ID 0.6 mm) 
was surgically inserted in the trachea and fixed above the carina. Subsequently, animals were 
placed on a heating plate in supine position and connected to the ventilator (Babylog 8000 plus, 
Dräger Medical, Lübeck, Germany). Ventilator settings were pre-determined in pilot experiments 
and targeted at normal acid-base balance (24). Ventilators were pressure-controlled and set to 
deliver low tidal volumes (LTV, 7.5 ml/kg) or high tidal volumes (HTV, 15 ml/kg). In both ventilation 
strategies, positive end-expiratory pressure (PEEP) levels were set at 3 cmH
2
O and the inspiration 
to expiration ratio at 1:2.8. Respiratory rates were controlled at 160 (LTV) or 52 (HTV) breaths per 
minute. Recruitment maneuvers were performed every 30 (LTV) or 60 (HTV) minutes by means of 
inspiratory holds with a pressure of 20 mbar during 5 seconds. 
Immediately after randomization, ventilators were adjusted to the assigned settings by 
an independent biotechnician. Inspiratory pressures were adjusted and regulated to achieve 
appropriate TV throughout the experiment. At the end of the experiment ventilated mice 
were euthanized by withdrawing blood from the carotid artery. Researchers were blinded for 
administered FiO
2
 levels during the experimental procedures. The allocation code of randomization 


































After euthanisation arterial blood was collected in heparin-coated syringes and used for blood gas 
analysis (Rapidpoint 405, Siemens Healthcare, Tarrytown, NY, USA). Lungs were resected en bloc 
and the right lung was instilled with normal saline (3x 0.5 mL) to obtain bronchoalveolar lavage 
fluid (BALf), which was used for automated cell counting (Z2 Beckman Coulter Counter, Brea, USA). 
Differential counts were performed on Giemsa stained cytospin slides. BALf was centrifuged and 
the supernatant was stored at -80°C for assessment of protein levels and cytokines. The left lung 
was weighed and thereafter fixed in 4% formalin and embedded in paraffin. Lung sections were 
stained with hematoxylin eosin (H&E) to analyze lung histopathology. A dedicated pathologist 
determined the histopathological lung injury score on a nominal scale by the sum of the score 
for four pathologic parameters: edema, haemorrhage, interstititial cell infiltration and hyaline 
membranes as described previously (24). Relative lung weight, expressed as lung weight corrected 
for total body weight at baseline, was used as surrogate for lung tissue edema.
Cytokines (IL-1β, IL-6, IL-10, MCP-1, MIP-2, KC, TNF-α, IFN-γ) were measured in BALf by Luminex 
(Merck Millipore Chemicals BV, Amsterdam, The Netherlands). High mobility group box 1 (HMGB-1, 
IBL International BV, Amersfoort, The Netherlands) and the soluble receptor for advanced 
glycation end products (sRAGE, R&D Systems, Abingdon, UK) were determined by enzyme-linked 
immunosorbent assays (ELISA) according to the manufacturer’s protocols. Total protein levels were 
determined in serum and BALf (Oz Biosciences, Marseille, France), using bovine serum albumin 
as reference.
The right lung was used for total RNA isolation from tissue homogenates (RNA-Bee, Tel-Test 
Inc, Bio-Connect BV, Huissen, the Netherlands), first-strand cDNA synthesis (SuperScript Choice 
System, Life Technologies, Breda, the Netherlands) and real-time quantitative PCR (TNF-α, IL-6, 
MMP-12, MCP-1, TF, PAI-1), using β-actin as a housekeeping gene reference, were performed on 
a LightCycler 480 (Roche, Almere, the Netherlands) of the Leiden Genome Technology Center 
(Leiden, The Netherlands) as described previously (26). 
Statistical analysis
The partial pressure of arterial oxygen (PaO
2
) at the end of the experiment was defined as the primary 
outcome. Inflammatory markers and markers of lung injury were assessed as secondary outcomes. 
Based on previous pilot results and with a group size of 8 animals per group the Wilcoxon ranksum 
test ensures 80% power using a two sided significance level of 0.05 to detect an estimated effect 
size of 1.85 that the observed parameter differs between groups. With an anticipated dropout rate 
of one per group, nine animals were initially assigned to each group. Differences between study 
groups were tested with one-way analysis of variance or Kruskal Wallis as appropriate. Cuzick’s test 
was used to test for trends across different FiO
2
 groups. Statistical analyses were performed using R 
version 3.2.1 (R Foundation for Statistical Computing, Vienna, Austria) and STATA/SE 10.1 (StataCorp 

































R E S U LT S
All mice survived mechanical ventilation with the applied settings in a volume-targeted approach 
(Table 1). Median systolic blood pressures decreased gradually during 8 or 12 hours of mechanical 
ventilation 145 mmHg to 90 mmHg) and were slightly higher in the 90% FiO
2
 group (Table 1, 
Additional file 1 Figure S1). Heart rates and body temperatures remained stable throughout 
the experiment.
Oxygenation and ventilation
The partial pressure of oxygen in the carotid arterial blood at the end of mechanical ventilation was 
distinctly higher with increasing fractions of supplied oxygen (P<0.001, Fig. 1a). PaCO
2
 was in general 
lower for the HTV groups, but did not show a trend across FiO
2





decreased for mechanically ventilated mice in comparison to controls and was markedly higher for 
HTV groups after 12 hours of mechanical ventilation (Fig. 1c). Dynamic lung compliance decreased 
gradually over the study interval for all study groups but the decrease was nearly complete after 
three hours of mechanical ventilation and was larger for the HTV groups (Fig. 1d).
Markers of lung injury
Mechanical ventilation significantly increased the lung injury score (Fig. 2a, 1.6-fold at 8 hours, 
P<0.01; and 1.5-fold at 12 hours, P<0.05), mean protein content (Fig. 2b, 2.6-fold at 8 hours, 
P<0.001; and 2.2-fold at 12 hours, P<0.001) and the mean number of cells (Fig. 2c, 1.7-fold at 8 
hours, P<0.01; and 2.0-fold at 12 hours, P<0.001), including neutrophils in BALf (Fig. 2d, 132-fold 
at 8 hours,  P<0.001; and 180-fold at 12 hours, P<0.001), demonstrating vascular leakage and 
inflammation as a result of mechanical ventilation even at relatively low hyperoxic conditions of 
30% FiO
2
 and low tidal volumes. Increased hyperoxia up to 90% FiO
2 
did not further increase protein 
content or the total number of cells in BALf, but showed an increased trend in the percentage of 
neutrophils towards higher FiO
2
 levels (P for trend = 0.03). Histopathology showed a decrease in 
Table 1. Ventilation and hemodynamic parameters
8h 12h
30% 50% 90% 30% 50% 90%
LTV
 TV (µl) 181 (0) 182 (0) 179 (0) 176 (0) 178 (1) 176 (0)
 P
insp
 (mbar) 13 (0) 14 (0) 12 (0) 12 (0) 13 (0) 12 (0)
 SBP (mmHg) 116 (7) 128 (7) 123 (5) 103 (4) 102 (5) 112 (4)
HTV
 TV (µl) 351 (0) 379 (1) 372 (1) 366 (2) 371 (1) 360 (1)
 P
insp
 (mbar) 20 (0) 21 (0) 20 (0) 20 (0) 20 (0) 20 (0)
 SBP (mmHg) 114 (6) 136 (8) 124 (7) 104 (4) 110 (6) 113 (5)
Data are means ±SD. TV, tidal volume; P
insp


































air restraint, suggesting progressive alveolar collapse, with higher oxygen levels (Additional file 1 
Figure S2), but this was not translated in a significant difference in the lung injury score between 
the different FiO
2
 groups (Fig. 2a).
Figure 1. Arterial oxygenation and ventilation parameters. 
Data are means ±SEM. Arterial oxygenation in carotid blood (1a, upper left panel), arterial carbon dioxide in 




 ratio (1c, lower left panel) and dynamic compliance (1d, lower 
right panel). Facets within the panels represent mechanical ventilation time. Different colors represent different 
tidal volume groups and different transparency levels represent different FiO
2
 groups. 0h, no mechanical 
ventilation time (control group); 8h, 8 hours of mechanical ventilation; 12h, 12 hours of mechanical ventilation. 
LTV, low tidal volumes; HTV, high tidal volumes. Dynamic lung compliance (tidal volume size / (peak inspiratory 




 were measured once in the arterial blood gas sample 


































Cytokine and chemokine levels in BALf increased at 8 and 12 hours after mechanical ventilation, but 
did not markedly differ between FiO
2
 groups at 8 hours of ventilation (P for trend > 0.05, Additional 
file 1 Figure S3). In mice ventilated for 12 hours, a significantly increasing trend in TNF-α, IFN-γ, IL-1β, 
IL-10, and MCP-1 (Fig. 3, P for trend < 0.01) was observed with increasing FiO
2
, whereas IL-6 showed 
a decreasing trend (P for trend = 0.03). KC, MIP-2, and sRAGE were similar between FiO
2
 groups. 
HMGB-1 was significantly higher in BALf of mechanically ventilated mice compared to controls and 
Figure 2. Markers of lung injury in BALf after indicated study interval. 
Data are means ±SEM. Lung injury score (2a, upper left panel), total protein content (2b, upper right panel), 
total cell counts (2c, lower left panel) and proportion of neutrophils (2d, lower right panel) in BALf obtained 
after the study interval. Facets within the panels represent mechanical ventilation time. Different colors 
represent different tidal volume groups and different transparency levels represent different FiO
2
 groups. 
0h, no mechanical ventilation time (control group); 8h, 8 hours of mechanical ventilation; 12h, 12 hours of 

































showed a gradual increase in expression with increasing FiO
2
. Almost no differences in cytokine and 
chemokine levels in the BALf were observed between the 30% and 50% oxygen groups. 
Differences between the tidal volume groups were small (Additional file 1 Figure S4) and did 
not appear to significantly interact with the oxygen levels (P>0.50 for the interaction term for each 
inflammatory mediator, except for IL-6, P=0.03). Inflammatory markers were also measured at 12 
hours of mechanical ventilation in the serum and are shown in Additional file 1 Figure S5.
The RNA expression of selected markers showed an increased relative expression of TNF-α, IL-6, 
and MCP-1 in lung homogenate of mice that were mechanically ventilated with high tidal volumes 
compared to controls (Additional file 1 Figure S6)
D I S C U S S I O N
In this experimental study, we demonstrated a severe vascular leakage and a pro-inflammatory 
pulmonary response in mechanically ventilated mice, which was enhanced by severe hyperoxia and 
longer duration of mechanical ventilation. Prolonged ventilation with high oxygen concentrations 
induced a time-dependent immune response characterized by elevated levels of neutrophils, 
cytokines and chemokines in the pulmonary compartment.
Although most studies in mechanically ventilated animals are restricted to short exposure 
periods, recent experiments in mechanically ventilated rodents, rabbits, and pigs, mimicking 
the clinical environment of critically ill patients, showed that hyperoxia serves as an important 
cofactor in acute lung injury, bacterial dissemination, progression of multiple system organ 
dysfunction and lethality (13-15), but can also improve organ function and attenuate tissue apoptosis 
during shock (27). In our study, divergent effects were observed in the expression of selected 
inflammatory markers across the experimental groups, which may be explained by the complex 
kinetics and dynamics of the immune response due to the concurrent exposure to anesthesia, 
mechanical ventilation and hyperoxia. Interaction between pro- and anti-inflammatory cytokines 
may contribute to the differences in cytokine levels in the experimental groups. Rapid upregulation 
of TNF-α was seen even in the acute phase reaction after induction of anesthesia in control mice. 
Cytokine concentrations may decrease after long-term hyperoxic exposure and a fast upregulation 
of inflammatory action can be followed by a gradual impairment or suppression of the innate 
immune system (28), which may in turn make the lung more susceptible to injury and infection. 
Differences in cytokine levels between the FiO
2
 groups were relatively mild. We observed a strong 
inflammatory effect at very high oxygen concentrations (FiO
2
 90%) while the increase from 30% 
to 50% did not make a large difference. Indeed, 50% of inspired oxygen may not be as detrimental 
as 90% as evidenced by the clear increase in neutrophils and most cytokines during 90% oxygen 
administration, which was also described in other studies (29-32). In addition, ventilation with 
30% may actually be a model of relative tissue hypoxia in mice following progressive lung injury 
during the experiment, although this was not reflected by the PaO
2
 levels. Comparison with control 
groups suggests that mechanical ventilation itself was very harmful, possibly not allowing additional 
damage by increasing oxidative stress. Both hypoxia and hyperoxia may induce oxidative stress and 

































Furthermore, damage associated molecular pattern (DAMP) molecules play a key role 
in the inflammatory response to injury and have been suggested to modulate the effects of 
hyperoxia and oxidative stress (34, 35). In this matter, HMGB-1 has been described as the archetypal 
chemokine that is upregulated by the innate immune system in response to cell stress (36). We also 
observed increased levels of this protein in the lungs of mechanically ventilated mice, particularly 
after concurrent exposure to high FiO
2
. The overall protein content did not significantly increase 
with severe hyperoxia, but this interpretation may be limited as we did not correct the protein in 
BALf for urea (epithelial lining fluid). The expression of most cytokines in BALf was not essentially 
different than in the serum, which may be a result of extended duration of mechanical ventilation 
causing systemic inflammation. In line with previous experiments the presence of cytokines with 
short term ventilation was definitely more pronounced in the pulmonary compartment compared 
to circulating blood of rodents (25, 37).
Our study and others generated conflicting data regarding the inflammatory response after 
hyperoxic ventilation describing both pro- (15, 17, 38, 39) and anti-inflammatory (40, 41) responses. 
Kiers et al. recently demonstrated that, in the absence of systemic inflammation, short-term 
hyperoxia without mechanical ventilation does not result in increased levels of inflammatory 
cytokines, neutrophil phagocytosis nor ROS generation in both mice and healthy volunteers 
(42). In the present study, the expression of inflammatory markers was shown to be divergent 
after mechanical ventilation and with increasing FiO
2
, which is consistent with previous research 
(16). Bailey et al. concluded that prolonged mechanical ventilation of healthy rat lungs with 
a physiological strategy can contribute to the inflammatory response and cause alterations to 
pulmonary surfactant (43). Lung injury due to continuous hyperoxic exposure has also been shown 
to be dose-dependent in rats (12, 15). 
Some clinical scenarios may dictate non-protective ventilation, both with high pressures and 
high levels of inspired oxygen in patients with heavily injured lungs. However, it is not exactly 
known whether this combination works synergistically in causing lung injury. Our data do not 
imply such an ‘add-on effect’, but the discrepancy with a previous study (20) may be explained 
by the use of lower tidal volumes in our study. It is also possible that the extended duration of 
mechanical ventilation alone was enough to cause ventilator-induced lung injury (VILI) without 
an additional effect of tidal volume size. An alternative explanation may be that lower respiratory 
rates compensated for high tidal volumes, while higher respiratory rates increased the risk of lung 
Figure 3. Inflammatory mediators in BALf in controls and after 12h of mechanical ventilation. 
Cytokine and chemokine levels in BALf obtained after 12 hours of mechanical ventilation. Data 
are means ±SEM. Facets within the panels represent mechanical ventilation time. Different colors 
represent different tidal volume groups and different transparency levels represent different FiO
2
 
groups. 0h, no mechanical ventilation time (control group); 12h, 12 hours of mechanical ventilation. 
LTV, low tidal volumes; HTV, high tidal volumes. Cuzick’s P for trend in increasing oxygen levels at 
12 hours of mechanical ventilation: IL-1β, <0.001; MIP-2, 0.27; IL-6, 0.03; KC, 0.22; IL-10, 0.001; MCP-1, 
<0.001; TNF-α, 0.001; IFN-γ, 0.001; sRAGE, 0.11; HMGB-1, 0.001. * P for trend <0.05; ** P for trend 

































































injury in the lower tidal volume groups. Also, some of the deleterious properties of hyperoxia may 
be overcome by applying PEEP, as it may counteract alveolar collapse from progressive nitrogen 
washout and mitigate the effects of atelectrauma (44). 
In our study, lung injury scores did not reveal any histopathological difference between 
study groups. However, in previous work using a high tidal volume strategy with zero PEEP, total 
histopathology scores were shown to be higher compared to low tidal volumes and 3 cmH
2
O PEEP 
with a marginal additive effect of ventilation duration (24). This was in accordance with a study 
reporting that pre-exposure to hyperoxia increases the susceptibility to VILI before initiation of 
mechanical ventilation (22). Others documented that short-term exposure to levels of oxygen up 
to 100% does not increase the changes in respiratory system mechanics induced by mechanical 
ventilation (16). The progressive airway collapse and inflammation with increasing FiO
2
 may not 
have been severe enough to induce histopathological changes and affect lung function in our 
model. The striking heterogeneity that exists between experimental studies may be explained by 
differences in subjects (e.g. species, strains, genetical modification, age, sex), and exposure (e.g. 
pre-exposure, severity, duration, anesthesia, ventilation).
Although the experiments were performed according to the high standards for methodological 
quality of animal research (45), several limitations may apply to our experimental procedures. 
The lavage technique of the lungs may induce subtle differences in the dilution of returned fluid, 
although saline injection volumes were standardized. Storage of biological specimens was secured 
according to high quality protocols. Our analyses were restricted to specific features of injurious 
ventilation and hyperoxia, yet other underlying mechanisms affecting reactive oxygen species 
and mitochondrial damage have not been considered. Other covariates such as PaCO
2
 may have 
influenced the results, even though this cannot be seen separate from ventilation settings and 
was inherent to adjusting tidal volumes and FiO
2
. Furthermore, low respiratory rates, especially in 
the LTV group, are subphysiological for mice and may cause relative hypercapnia.
The experimental setting may hamper translation of study results to the clinical setting. Indeed, 
smaller species, such as mice have different lung mechanics and immune reactions than humans 
(46, 47). Healthy mice may also respond differently than critically ill patients, especially in case 
of injured lungs prior to the start of mechanical ventilation. Interestingly, moderate hyperoxia in 
mechanically ventilated patients without severe respiratory failure does not appear to increase 
systemic or pulmonary inflammation (48).
Further, the C57Bl/6J type mice that we used are the most widely used strain of mice for 
experimental research, but have been shown to carry a spontaneous mutation, which can result 
in mitochondrial redox abnormalities and may influence the functionality of the hyperoxia defense 
(49).
Strengths of this study include the prolonged duration of mechanical ventilation which may 
be representative of the intensive care unit (ICU) setting, where hyperoxia acts as a second hit on 
top of VILI. Indeed, we showed that the immune response was considerably stronger at 12 hours of 
mechanical ventilation compared to 8 hours, which may imply that models applying mechanical 
ventilation for extended duration more accurately reflect the underlying mechanisms and 

































after 12 hours of hyperoxic mechanical ventilation. As such, our results further accentuate that we 
should limit the exposure to supraphysiological oxygen levels from excessive oxygen supply when 
prolonged periods of mechanical ventilation are anticipated. 
C O N C L U S I O N
Prolonged experimental hyperoxic mechanical ventilation was associated with a significant 
inflammatory response in the lung as evidenced by an influx of neutrophils in the pulmonary 
compartment and upregulation of specific inflammatory markers, which was not directly translated 
into extensive tissue lung injury or a change in lung compliance. The present experimental data may 
aid to determine optimal ventilator strategies in mechanically ventilated patients, but the dynamics 
and kinetics of hyperoxic ventilation need further exploration in order to characterize the long 
term effects and investigate protective measures. 
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BALf, bronchoalveolar lavage fluid; DAMP, damage associated molecular pattern; ELISA, enzyme-
linked immunosorbent assays; FiO
2
, fraction of inspired oxygen; HIF, hypoxia inducible factor; 
HMGB-1, high mobility group box-1; HTV, high tidal volume; ICU, intensive care unit; IFN-γ, 
Interferon-γ; IL-1β, Interleukin-1β; IL-6, Interleukin-6; IL-10, Interleukin-10; KC, Kupffer Cell; LTV, 
low tidal volume; MCP-1, Monocyte Chemoattractant Protein-1; MIP-2, Macrophage Inflammatory 
Protein-2; MV, mechanical ventilation; PaCO
2
, partial pressure of arterial carbon dioxide; PaO
2
, 
partial pressure of arterial oxygen; PEEP, positive end-expiratory pressure; sRAGE, soluble Receptor 
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mediators in serum after 12  h of mechanical ventilation. Figure S6. Relative RNA expression of inflammatory 
markers in lung homogenate after 12  h of mice that were mechanically ventilated with high tidal volumes 
compared to controls.
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Background
Although oxygen is generally administered in a liberal manner in the perioperative setting, 
the effects of oxygen administration on dynamic cardiovascular parameters, filling status and 
cerebral perfusion have not been fully unraveled. Our aim was to study the acute hemodynamic 
and microcirculatory changes before, during and after arterial hyperoxia in mechanically ventilated 
patients after coronary artery bypass grafting (CABG) surgery. 
Methods
This was a single-center physiological study in a tertiary care ICU in the Netherlands. Twenty-two 
patients scheduled for ICU admission after elective CABG were enrolled in the study between 
September 2014 and September 2015.
In the ICU, patients were exposed to a fraction of inspired oxygen (FiO
2
) of 90% allowing a 15-
minutes wash-in period. Various hemodynamic parameters were measured using direct pressure 
signals and continuous arterial waveform analysis at three sequential time points: before, during 
and after hyperoxia.
Results
During a 15-minutes exposure to a fraction of inspired oxygen (FiO
2





and arterial oxygen saturation (SaO
2
) were significantly higher. The systemic 
resistance increased (P<0.0001), without altering the heart rate. Stroke volume variation and pulse 
pressure variation decreased slightly. The cardiac output did not significantly decrease (P=0.08). 
Mean systemic filling pressure and arterial critical closing pressure increased (P<0.01), whereas 
the percentage of perfused microcirculatory vessels decreased (P<0.01). Other microcirculatory 
parameters and cerebral blood flow velocity showed only slight changes.
Conclusions
We found that short-term hyperoxia affects hemodynamics in ICU patients after CABG. This was 
translated in several changes in central circulatory variables, but had only slight effects on cardiac 
output, cerebral blood flow and the microcirculation.
Clinical trial registration







































B AC KG R O U N D
During and after coronary artery bypass grafting (CABG), patients are supported with mechanical 
ventilation and supplemental oxygen. Despite its lifesaving characteristics and key role in 
the treatment of vasodilatory shock, oxygen therapy may harbor considerable risks given 
the relationship between prolonged hyperoxia, lung injury and adverse outcome (1-5). The effects 
of supplemental oxygen may be even more pertinent during cardiovascular events considering 
the direct effects of high arterial oxygen concentrations on the vascular tone (6, 7). Arterial 
hyperoxia has the potential to alter hemodynamics and has been associated with adverse outcomes 
and mortality after cardiac arrest, myocardial infarction, stroke, brain injury and during mechanical 
ventilation (8-14), yet not during cardiopulmonary bypass (15, 16). It is well established that high 
oxygen concentrations induce vasoconstriction and increase the resistance of the systemic 
circulation. However, the effects on vital parameters may be diverse and the venous and arterial 
aspects of the circulation have not been clearly distinguished in previous studies. Furthermore, 
the microcirculation may react differently than systemic hemodynamics (17).
Achieving hemodynamic stabilization is an important clinical prerequisite for early extubation 
and dismissal from the intensive care unit (ICU) after cardiothoracic surgery. Any intervention 
that influences hemodynamics and blood flow to the bypassed myocardial territories may impact 
functional recovery and requires optimal fine-tuning to achieve the best outcome. Although 
oxygen is generally administered in a liberal manner in the perioperative setting, the unraveling 
of the effects of oxygen administration on dynamic cardiovascular parameters, filling status and 
cerebral perfusion may provide novel insights in the pathophysiological mechanisms involved in 
hyperoxic exposure. Our aim was to study the acute hemodynamic and microcirculatory changes 
during increased oxygen supply in mechanically ventilated ICU patients after CABG surgery. 
M E T H O D S
Participants
Adult patients with symptomatic coronary artery disease without recent myocardial infarction 
scheduled for ICU admission after coronary artery bypass surgery were screened for eligibility. 
Patients with congestive heart failure, severe arrhythmias, intracardiac shunts, extensive peripheral 
arterial occlusive disease, symptomatic pulmonary disease, aortic aneurysm and/or significant 
valvular disease were not considered for inclusion. Patients with signs of severe hemodynamic 
instability (e.g., rapid changes in vascular resistance, use of inotropic agents) during ICU admission 
were excluded. Study approval was granted by the local medical ethics committee (LUMC P14.046), 
and all patients signed informed consent. The study was registered with the Netherlands Trial 
Register, number NTR5064, registration date February 2015.
Measurements
Anesthesia during surgery was maintained with propofol and sufentanil. Ventilation was adjusted 
to achieve normocapnia. FiO
2
 was 40%, and a positive end-expiratory pressure of 5 cm H
2
O 







































postoperative care. Continuous infusion of propofol and sufentanil was maintained for all patients, 
and no bolus medications (fluids, vasoactive or sedative agents) were administered.
Mean arterial blood pressure (MAP) was measured via a 20-G radial arterial catheter inserted by 
Seldinger technique. Central venous pressure (CVP) was measured with a central venous catheter 
inserted in the right internal jugular vein (MultiCath venous catheter, Vigon GmbH & Co, Aachen, 
Germany). Pressure transducers (PX600F, Edwards Lifesciences) for the arterial and central venous 
signals were referenced to the intersection of the anterior axillary line and the fifth intercostal 
space. The airway pressure was measured at the entrance of the endotracheal tube and balanced at 
zero level against ambient air. Standard electrocardiogram leads were used to monitor heart rate. 
Body temperature was measured using a rectal temperature probe.
Beat-to-beat values of cardiac output (CO), stroke volume, stroke volume variation (SVV), 
pulse pressure variation (PPV) and heart rate (HR) were obtained by Modelflow using continuous 
arterial waveform analysis as previously described (18, 19). Hemodynamics were also monitored by 
the LiDCOplus monitor (LiDCO Group Plc., London, UK).
Before starting the protocol, the mechanical ventilation in volume-controlled mode was 
switched to airway pressure release ventilation (APRV), with settings adjusted to achieve the same 
minute ventilation, which allows for external control of the ventilator (Evita 4, Dräger AG, Lübeck, 
Germany). A computer program was used to control the ventilator as described previously (20). 
During the study interval, all patients were hemodynamically stable and ventilator settings, sedation 
and vasoactive therapy remained unchanged.
At least three videos of ten sequences (40 frames each) visualizing different sites of 
the sublingual microcirculation were recorded per patient per time point by the same dedicated 
researcher using sidestream dark field (SDF) imaging with the MicroScan Video Microscope 
(MicroVision Medical BV, Amsterdam, The Netherlands). The three best quality videos from 
representative multiple site imaging were analyzed, and calculated parameters were averaged. 
Previously suggested key points for optimal image acquisition were considered, and maximal 
efforts were undertaken to avoid pressure artifacts and eliminate secretions (21). SDF imaging data 
were recorded and analyzed using real-time quality feedback on adequate focus, contrast and 
stability with GlycoCheck (GlycoCheck BV, Maastricht, The Netherlands), as described previously 
(22). The GlycoCheck software automatically calculates the perfused boundary region (PBR), 
which is a previously validated dimension of the permeable part of the endothelial glycocalyx 
that does allow red blood cell penetration (23, 24). The red blood cell (RBC) filling percentage is 
calculated an estimate for microvascular perfusion. Recorded videos were also imported for offline 
analysis in Automated Vascular Analysis (AVA) software 4.1 (MicroVision Medical BV). The software 
automatically separates outcome parameters for large (mostly venules) or small (mostly capillaries) 
vessels using a diameter cutoff value of 20 µm. Total vessel density (TVD), perfused vessel density 
(PVD), valid vessel density (VVD) and De Backer Score were calculated as measures of microvascular 
vessel density; the percentage of perfused vessels (%PV) was calculated as the number of vessels 
continuously perfused divided by the total number of vessels of the same type. The heterogeneity 
index was defined as the difference between maximal and minimal proportions of perfused vessels 







































Blood flow velocity (BFV) in the right middle cerebral artery (MCA) was measured at an insonation 
depth of 50–52 mm by transcranial Doppler (TCD) monitoring using a Pioneer TC 4040. When 
the optimal TCD signal was achieved, a 2-MHz TCD transducer probe was fixed over the temporal 
window using an adjustable headset (Marc 500, Spencer Technologies, Nicolet Biomedical).
Experimental procedure
Approximately one hour after ICU admission the experimental procedures were initiated. All 
measurements were performed with patients in supine position at three sequential time points: 
pre-intervention, during intervention and post-intervention. Before the intervention (T1), FiO
2
 
was titrated to a level targeting a partial pressure of arterial oxygen (PaO
2
) between 67.5 mmHg (9 
kPa) and 82.5 mmHg (11 kPa) and a complete set of hemodynamic measurements was performed. 
The intervention (T2) commenced by increasing the FiO
2
 to 90% and after a 15-min wash-in period, 
all hemodynamic measurements were repeated. Thereafter (T3), the FiO
2
 was decreased by 
targeting baseline PaO
2
 levels, and after 15-min wash-out period, the final control measurements 
were completed. Before, during and after the intervention, arterial blood gas samples were analyzed 
to determine arterial oxygenation.
Four 12-second inspiratory hold maneuvers were applied using ventilator plateau pressures of 
5, 15, 25 and 35 cm H
2
O as previously reported (20). Each successive inspiratory hold was performed 
when the initial hemodynamic steady state was reestablished. When the plateau pressure increases, 
CVP increases concomitantly, whereas CO and MAP decrease with a short delay, reaching a steady 
state at 7–10 s after inflation. From these steady state measurements, a venous return curve was 
constructed by fitting a linear regression line through four values of CVP and CO. The extrapolated 
value at zero flow is the mean systemic filling pressure (P
msf
). Similarly, the ventricular output curve 
was fitted through the values of MAP and CO, where the regression line crosses the zero flow 
intercept at the critical closing pressure (P
cc
) (19).
The resistance of the systemic circulation (R
sys
) was calculated as the ratio of the pressure 
difference between MAP and mean CVP, and CO. The resistance at the arterial and venous side of 
the circulation was also separately calculated as resistance for ventricular output R
vo
 = (MAP – P
cc
)/




 – CVP)/CO (26).
Statistical analysis:
As this was an exploratory physiological intervention study studying multiple hemodynamic 
parameters we did not specifically rely on sample size calculation for one single outcome. 
The intervention (T2, hyperoxia) and post-intervention measurements (T3, normoxia), were 
compared to baseline (T1, normoxia) measurements, using a paired t-tests or Wilcoxon signed rank 
test, depending on the underlying distribution. 
Multivariate linear mixed models with random effects per patient were used to compare 
the exposure (T2) with the non-exposure (T1 and T3) measurements, to account for within-subject 
correlation and were adjusted for age, temperature, the administered dose of propofol and 
norepinephrine, and the achieved levels of arterial carbon dioxide (PaCO
2







































To account for multiple testing, the indicated levels of statistical significance were lowered 
to 0.01. All statistical analyses were conducted using R version 3.2.1 (R Foundation for Statistical 
Computing, Vienna, Austria). 
R E S U LT S
Patients were screened for eligibility from September 2014 until September 2015. Four patients were 
excluded due to severe postoperative hemodynamic or respiratory instability in the ICU. Baseline 
characteristics of the twenty-two included patients are listed in Table 1. All participating patients 
were free of surgical complications, fully recovered from anesthesia within 8 h after surgery and 
were discharged from the ICU on the first postoperative day. During the experimental procedure, 
all patients received a glucose 2.5% in 0.45% saline solution at 84 ml/h, propofol (range 200-400 
mg h-1) and sufentanil (range 5-25 µg h-1). Two patients additionally received norepinephrine (0.02 
and 0.04 µg kg-1 min-1) at a constant rate in order to keep the blood pressure in a similar range 
(MAP higher than 65 mmHg) as the other included patients during the experimental procedure. 
This was accounted for in the multivariate linear mixed model, and excluding these patients did not 
materially change the magnitude or direction of our univariate findings.
Table 1. Patient characteristics
Characteristics All patients (n = 22)
Descriptive characteristics
 Age (year) 63 (59–66)
 Male/female (n) 17/5
 BMI (kg/m2) 26 (25–29)
 Body temperature (ºC) 37 (36–37)
 APACHE IV 40 (33–61)
 SAPS II 28 (24–32)
Surgical characteristics
 Perfusion time (min) 105 (91–121)









 (ml) 585 (484–650)
 PEEP (cm H
2
O) 5 (5–5)
 Respiratory rate (breaths min-1) 12 (12–14)
ICU medication
 Propofol (mg h-1) 250 (200–288)
 Sufentanil (µg h-1) 10 (6–10)
 Norepinephrine (µg kg-1 min-1) 0 (0–0), range 0–0.04
Data are medians (interquartile range), unless stated otherwise
BMI, body mass index; APACHE, Acute Physiology and Chronic Health Evaluation score; SAPS, Simplified Acute 
Physiology Score; P
insp
, inspiratory pressure; V
T







































Arterial blood gas parameters
Arterial blood gas values at the three different time points are shown in Table 2. PaO
2
 levels pre- and 
post-hyperoxia matched well with the targeted levels. Also, pre- and post-hyperoxia arterial oxygen 
saturation (SaO
2




 were significantly higher.
PaCO
2
 decreased over time, whereas hemoglobin, hematocrit, glucose and lactate levels did 
not change.
Hemodynamic parameters
Hemodynamic values at the three different time points are shown in Table 3. After starting 
the intervention with 90% oxygen supply, R
sys
 increased (P<0.0001), without altering the heart rate. 
SVV and PPV decreased slightly. CO did not significantly decrease (P=0.08).
During the hyperoxia period P
msf





 increased, whereas the slope of the left ventricular output curve (Slope
voc





 increased because of the higher MAP and P
msf
 at constant CO. R
vo
 did not change 
because MAP and P
cc
 increased similarly. 
We did not find any reduction in cerebral blood flow and only slight shifts in microcirculatory 
scores were noted. The percentage of perfused vessels decreased during hyperoxia (P=0.01). No 
changes in vascular density were detected for either large or small vessels.
The results were virtually unchanged when multivariate mixed models were used (Table 3).
D I S C U S S I O N
In this single-center physiological intervention study, we found that a 15-min exposure to hyperoxia 
affects hemodynamics in ICU patients after CABG. This was translated in several changes in central 






 (%) 25 (21–30) 90 (90–90) 21 (21–25)
Arterial blood gas analysesa
 SaO
2
 (%) 94.9 (1.9) 99.0 (0.3)*** 95.7 (1.8)
 PaO
2
 (mmHg) 83.5 (12.2) 390.2 (93.2)*** 87.8 (21.5)
 PaCO
2
 (mmHg) 39.8 (8.1) 36.0 (7.9)** 34.5 (8.7)***
 Hb (mmol L-1) 7.2 (0.8) 7.4 (0.7) 7.4 (0.8)
 Ht (L L-1) 0.34 (0.04) 0.35 (0.03) 0.35 (0.04)
 Glucose (mmol L-1) 7.5 (1.6) 7.4 (1.7) 7.7 (1.8)
 Lactate (mmol L-1) 1.25 (0.38) 1.20 (0.40) 1.25 (0.34)
FiO2,fraction of inspired oxygen; SaO
2
, arterial oxygen saturation; PaO
2
, partial pressure of arterial oxygen; PaCO
2
, 
partial pressure of arterial carbon dioxide; Hb, hemoglobin; Ht, hematocrit. 
Data are means (SD). For FiO
2
, medians (interquartile range) are provided.
* P<0.01, ** P<0.001, ***P<0.0001 for paired comparison between indicated outcome and baseline (T1)







































Figure 1. Venous return and ventricular output curves by arterial oxygenation status. 
Relationship between cardiac output (CO) and central venous pressure (CVP) in a venous return curve and 
between CO and mean arterial blood pressure (MAP) in a ventricular output curve for the averaged patient 
(Table 3). At zero blood flow mean systemic filling pressure (P
msf
) and critical closing pressure (P
cc
) are indicated. 
Venous return curves and ventricular output curves for arterial normoxia (solid line) and hyperoxia (dashed 
line) are given
circulatory variables and in the percentage of perfused microcirculatory vessels, but showed no 
alterations in cardiac output and cerebral blood flow.
The circulation of blood can be described by either the CO or the venous return. As only blood 
returning to the heart can be pumped out in the systemic circulation, venous return should always 
equal CO. Major determinants of CO are preload, contractility and afterload. During hyperoxia, 
left ventricular afterload clearly increased. The absence of a measurable decrease in CO may be 
explained by a concomitant increase in preload. Indeed, we found higher CVP during hyperoxia. 
The alternative explanation, i.e., increased contractility, is unlikely as we found no increase in 
the slope of the cardiac output curve during hyperoxia.
The circulation can also be described by the venous return to the heart, which is driven by P
msf
 
– CVP. During hyperoxia P
msf
 increased more than CVP. However, this did not lead to an increase of 
venous return due to the simultaneous increase in venous resistance.
Vasoconstriction may be the key driver of most if not all effects of hyperoxia on hemodynamics. 
Not only does it increase blood pressure, afterload and venous resistance, it also leads to a shift 
of blood from unstressed to stressed volume, as indicated by increases in P
msf
 and CVP. We also 
observed an increase in P
cc
 by hyperoxia. P
cc
 is a theoretical pressure defined by dynamic pressure 
flow-relations and represents the arterial pressure, below which conceptually no flow will be 
possible. It is a combined estimate representing all vascular circuits. Theoretically, P
cc



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































of arterial wall tension and the pressure surrounding the blood vessel. P
cc
 may differ importantly 
between different vessels, and measured P
cc
 is an average value for the complete vasculature. An 
increase in P
cc
 may be especially relevant in certain disease states such as increased intracranial 
pressure and abdominal compartment syndrome with high pressures surrounding the vessels. In 
both situations, P
cc
 is markedly elevated. For example, intracerebral blood flow will decrease to zero 
when arterial blood pressure is lower than the critical closing pressure of the brain and beyond 
the limits of cerebral autoregulation. In such states, vasoconstriction, by either vasoactive drugs 
or hyperoxia, may have either beneficial effects by increasing blood pressure or harmful effects by 
increasing arterial wall tone and thereby P
cc.
In our study, we could not show a reduction in perfusion of the brain by hyperoxia. Similarly, 
in a previous report perfusion changes at all oxygen levels were relatively small (27, 28). It should 
be noted that all these studies were performed in situations with normal intracranial pressure. In 
situations with intracranial hypertension, such as in traumatic brain injury, we cannot rule out that 
a further increase of P
cc





can lead to a lower perfusion and possible ischemia of the brain.
Comparing our findings with earlier studies on the effects of hyperoxia on hemodynamics, 
the cardiac output fall was less than in healthy volunteers (29) and the decrease in the percentage 
of perfused vessels of the microcirculation was also in a different order of magnitude than 
previously observed (30). Recognizing the perfused boundary region of microcirculatory vessels 
as a surrogate measure for the dimension of the glycocalyx, we could not detect any hyperoxia-
induced alterations. Considering the effects on the venous system, more pronounced effects are 
to be expected in the smaller vessels compared to larger vessels. As a limited number of arterioles 
are present in the sublingual mucosa, where capillaries and venules are more abundant, only slight 
changes were anticipated in the analyzed microcirculation when high oxygen levels are applied.
Study differences may be largely explained by the use of anesthesia and mechanical ventilation 
as both affect hemodynamics and anesthesia also induces a considerable decrease in stressed 
volume. Furthermore, even in the presence of healthy lungs, both mechanical ventilation and 
bypass surgery may inflict an inflammatory response which can modify the effects of hyperoxic 
ventilation on the circulation in comparison with healthy subjects. Remaining differences may be 
clarified by the short exposure time in our procedures, although no further increase in PaO
2
 was to 
be expected from a longer exposure and therefore a steady state in hemodynamics was assumed.
The increase in stressed volume and P
msf
 by hyperoxia mimics the effects of administering a fluid 
bolus, yet without increasing the R
vr
. It is well known that the effects of extra fluids on CO are most 
pronounced in situations with underfilling of the vasculature explaining the relative conservation 
of cardiac output during hyperoxia in our postoperative, sedated patients, compared to healthy 
subjects. The effects of hyperoxia closely resemble the effects of norepinephrine and are in 
contrast to the effects of propofol (31, 32). We earlier showed that intravenous administration of 






. Interestingly, CO increased in some but not 
all patients after norepinephrine (32). An increase in CO was associated with a higher SVV. Thus, it 
appears likely that the effects of a shift from unstressed to stressed volume by vasoconstriction, 
with an increase in P
msf







































volume. Hence, the effects of hyperoxia on CO are determined by the balance between volume 
recruitment (P
msf
) and change in R
vr
 and baseline heart function, as observed before (32). Although 
our results clearly indicate that hyperoxia increases venous resistance by venous vasoconstriction 
and that left ventricular output resistance (R
vo
) did not change, we must realize that our description 
of the circulation is not complete. We cannot describe the part between the site where P
cc
 exists 
and the site where P
msf
 exists. Therefore, there is a missing part of the circulatory circuit, i.e., 
the distal arterial compartment, where control of the peripheral circulation is performed by 
the pre-capillary sphincters.
A recent study with an alternative cardiac output monitor of the arterial pressure wave showed 
a poor correlation with the thermodilution obtained CO values while changing norepinephrine 
doses (33). However, measurements carried out by our group suggest that the Modelflow technique 
is capable of measuring the effects induced by vasoconstriction in an accurate manner (32), 
suggesting that vasoactive agents may not importantly affect the precision of your technology. This 
was also underlined by the CO values measured by the LiDCOplus monitor that showed a similar 
pattern compared to the Modelflow technique in our study. Furthermore, the determination of P
msf
 
is not dependent on the accuracy of the Modelflow technique. Indeed, extrapolation of the venous 
return curve to flow zero is independent of absolute cardiac output. The ability to follow changes 
in cardiac output within a patient has been clearly demonstrated before (18). We also showed that 
beat-to-beat changes in Modelflow cardiac output follows cardiac output by beat-to-beat analysis 
of electromagnetic probe flow signals (19).
Acknowledging that our findings are to be reproduced in a larger cohort and different clinical 
settings, the following study aspects should be considered. First, the small sample size and 
the specific subgroup of patients do not warrant a broad generalizability for the observed effects. 
Hemodynamics in the current patient group may be affected by the effects of the recent bypass 
and the potential mediators of ischemia reperfusion and inflammation. Other subsets of critically 
ill patients may respond differently than patients in our cohort who were in a relatively stable 
condition before starting study procedures. Two patients received small doses of norepinephrine 
during the experiment to keep the blood pressure in the same order of magnitude as the other 
included patients but showed stable hemodynamics and the dose was not changed throughout 
the experiment. Also, excluding these patients from our analyses showed virtually no change in 
our results.
There may be a time effect in which recovery and stabilization of patients in the ICU after 
surgery may influence hemodynamics. However, assuming that the effect of hyperoxia was 
transient and respecting a 15-min time gap between the two exposures, the carryover effect 
was minimized and each case served as its own control (self-matched) (34). Adjusted changes in 
estimates were based on within-subject comparisons of exposure to hyperoxia with exposure to 
normoxia. Sampling bias was minimized by continuously measuring central circulatory variables, 
which provide a highly accurate representation of the parameters over the time periods. Cerebral 
blood flow, microcirculation and parameters assessed from the inspiratory hold procedures were 
measured intermittently, yet at representative sampling moments during the sequential time points 







































Since we could not detect large differences between the outcomes of univariate and 
multivariate statistical models accounting for repeated measurements, the observed effects 
may be predominantly attributed to hyperoxic ventilation, rather than to concomitant changes 
in other parameters. Other covariates that were considered, such as PaCO
2
, are therefore 
not a likely explanation for the hemodynamic changes as seen during the experiment. While 
a short period of supraphysiological arterial oxygenation may disturb the hemodynamic balance, 
the effects of long-term exposure to hyperoxia are still uncertain but may be essential regarding 
patient-centered outcomes.
C O N C L U S I O N S
Short-term hyperoxia after cardiac surgery induces significant alterations in systemic circulation 
mainly by vasoconstriction of both the venous and arterial circulation and an increase of mean 
systemic filling pressure. The increase in stressed volume and systemic filling pressure by hyperoxia 
resembles the effects of administering a fluid bolus or norepinephrine. This may have clinically 
important consequences in critically ill patients when hemodynamic and microcirculatory changes 
are vital, but the effects were not clearly linked to relevant changes in cardiac output and cerebral 
blood flow.
L I S T  O F  A B B R E V I AT I O N S
APACHE, Acute Physiology and Chronic Health Evaluation score; APRV, airway pressure release 
ventilation; AVA, Automated Vascular Analysis; BFV, blood flow velocity; CABG, coronary artery 
bypass grafting; CO, cardiac output; CVP, central venous pressure; ICU, intensive care unit; FiO
2
, 
fraction of inspired oxygen; Hb, hemoglobin; Ht, hematocrit; HR, heart rate; MAP, mean arterial 
pressure; MCA, middle cerebral artery; NTR, Netherlands Trial Register; PaCO
2
, partial pressure of 
arterial carbon dioxide; PaO
2
, partial pressure of arterial oxygen; PBR, perfused boundary region; 
P
cc
, critical closing pressure; PEEP, positive end-expiratory pressure; P
insp
, inspiratory pressure; P
msf
 
, mean systemic filling pressure; PPV, pulse pressure variation; PV, perfused vessels; PVD, perfused 
vessel density; RBC, red blood cell; R
sys
, resistance of the systemic circulation; R
vo
, resistance 
for ventricular output; R
vr




, arterial oxygen saturation; SAPS, 
Simplified Acute Physiology Score; SDF, sidestream dark field; Slope
voc
, slope of ventricular output 
curve; Slope
vrc
, slope of venous return curve; SVV, stroke volume variation; TCD, transcranial 
Doppler; TVD, total vessel density; V
T
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Introduction
Arterial concentrations of carbon dioxide (PaCO
2
) and oxygen (PaO
2
) during admission to 
the intensive care unit (ICU) may substantially affect organ perfusion and outcome after cardiac 
arrest. Our aim was to investigate the independent and synergistic effects of both parameters on 
hospital mortality.
Methods
This was a cohort study using data from mechanically ventilated cardiac arrest patients in the Dutch 





from arterial blood gas analyses corresponding to the worst oxygenation in the first 24 h of ICU stay 
were retrieved for analyses. Logistic regression analyses were performed to assess the relationship 
between hospital mortality and both categorized groups and a spline-based transformation of 






In total, 5,258 cardiac arrest patients admitted to 82 ICUs in the Netherlands were included. In 
the first 24 h of ICU admission, hypocapnia was encountered in 22%, and hypercapnia in 35% of 





 had an independent U-shaped relationship with hospital mortality and after 
adjustment for confounders, hypocapnia and  hypoxia were significant predictors of hospital 





 was not observed (P = 0.75).
Conclusions
The effects of aberrant arterial carbon dioxide and arterial oxygen concentrations were 







































I N T R O D U C T I O N
Even after successful resuscitation and return of spontaneous circulation (ROSC), cardiac arrest 
carries a poor prognosis with limited options for treatment (1, 2). In addition to controlling 
temperature after cardiac arrest, optimizing ventilation and oxygenation may improve outcome (3). 
International consensus currently recommends careful monitoring of post-resuscitation ventilation 
for neurological and cardiovascular outcome (4). Indeed, targeting safe levels of carbon dioxide 
and oxygen in arterial blood may limit global ischemic damage and enhance oxygenation and blood 
flow. Aberrant arterial levels have repeatedly been shown to be associated with worse outcome 
after cardiac arrest, but the effects may depend on degree and duration of the (concurrent) 
exposure (5-14). Recently, a large cohort study was performed in 125 intensive care units (ICUs) 
in Australia and New Zealand, which showed that abnormal concentrations of arterial carbon 
dioxide (PaCO
2
) were common after cardiac arrest (15). Compared with normocapnia, hypocapnia 
was independently associated with worse clinical outcomes, whereas hypercapnia was associated 
with a greater likelihood of good outcome. The results were reproduced in a smaller cohort (16) 
and are supported by pediatric (17) and experimental research (18-20). However, ventilation and 
oxygenation are closely related and effects of PaCO
2
 may not be independent from arterial oxygen 
levels (PaO
2
). In this study, we aimed to investigate the separate and combined effects of both 
parameters in a multicenter cohort of patients admitted to Dutch ICUs after cardiac arrest.
M E T H O D S
Data collection
Analyses were performed on patient data retrieved from 82 ICUs of teaching and non-teaching 
hospitals participating in the Dutch National Intensive Care Evaluation (NICE) registry between 
2007 and 2012. The NICE registry is a high quality ICU database, which is subject to multiple quality 
checks and local audits in accordance with applicable research and ethical protocols (21). In brief, 
the registry contains all clinical data required to calculate mortality risk predictions according to, 
among others, the Acute Physiology and Chronic Health Evaluation (APACHE) IV for all consecutive 
ICU patients. The registry does not contain variables determining the cause and circumstances of 
the cardiac arrest and resuscitation. For the analyses, data obtained from routine care and without 
patient identifying information was used and consent was therefore not needed according to 
the Dutch Personal Data Protection Act.
In 2012, approximately 90% of all Dutch ICUs recorded the data for their patients in the registry. In 
accordance with the previously conducted study by Schneider et al. (15), all adult patients admitted 
after out-of-hospital cardiac arrest were included. Abstracted data included demographics, 
comorbidities, arterial blood gas parameters, diagnostic and physiologic information, admission 
source and illness severity score by means of the APACHE IV.
Data extraction
Adult patients admitted to the ICU after out-of-hospital cardiac arrest and cardiopulmonary 







































were included. We excluded readmissions, trauma patients, nonventilated patients and records not 
meeting APACHE IV criteria.
As part of the NICE data collection, arterial blood gas (ABG) parameters that were associated 




 ratio in the first 24h after admission were automatically extracted and 





 to fixed normal values (40 mmHg and 80 mmHg, respectively) in 
order to prevent overadjustment of these variables in the multivariate models.
Statistical analysis
Univariate and multivariate logistic generalized estimating equation (GEE) regression models, which 
account for potential correlation of outcome within ICUs, were used to examine the relationship 









 with mortality were plotted in order to inspect the dose-response curve. 





 as a restricted cubic spline and separately in categorized groups (22). PaCO
2
 was 
categorized in three groups, using conventional thresholds (normocapnia: 35-45 mmHg). PaO
2
 
was categorized according to thresholds from previous studies (normoxia: 60-300 mmHg) (5, 7-9, 
23, 24). The individual, joint and interaction effects of two-sided derangements were separately 
investigated, as suggested for cohort studies (25). For a further understanding of the dose-
response relationship in multivariate models, PaO
2
 categories were also reanalysed with alternative 
thresholds derived from observation percentiles or previously used targets (5, 7, 8, 26). Variables 
extracted from the first 24 hours of admission were considered for the multivariate etiological 
model based on clinical relevance and in accordance with a previously used model (15). Considered 
covariates were introduced separately to the univariate models in order to estimate the unadjusted 
effect and included age, gender, AP4-adj, year of admission, admission source, therapeutic 
hypothermia and lowest glucose as a possible proxy-marker of less attentive care (24). Covariates 
were subsequently identified as confounders for the outcome using the 10% change-in-estimate 





. Collinearity among the covariates was inspected by estimating Pearson or 
Spearman correlation coefficients as appropriate. Routine temperature correction of arterial blood 
gas results is uncommon in Dutch ICUs and was performed according to the participating site’s 
practice. To account for multiple testing, the statistical significance level for the P-value was set 
at 0.01.
All analyses were conducted using SPSS version 21 (IBM Corp, Armonk, NY, USA) and R version 
3.0.1 (R Foundation for Statistical Computing, Vienna, Austria).
R E S U LT S
Data from 6,496 out-of-hospital cardiac arrest patients and 82 hospitals were extracted from 
the NICE registry and screened for enrollment (Supplemental figure 1). The main reasons for 
exclusion were no mechanical ventilation (n=196), missing valid ABG data (n=379) and not fulfilling 







































Descriptive characteristics of the 5,258 included patients are summarized in Table 1. The median 
age was 66 (IQR 56-76) and patients were predominantly male (69.6%). Median PaCO
2
 was 42 mmHg 
(IQR 36-49) and median PaO
2
 was 92 mmHg (IQR 75-124). Of all patients, 21.6% were classified as 
hypocapnic, 43.5% as normocapnic and 34.9% as hypercapnic. Patients were further classified as 
hypoxic (8%), normoxic (89.3%) or hyperoxic (2.7%). The majority of patients (87.4%) were admitted 
to the ICU from the emergency room of the same hospital. The unadjusted mean APACHE IV score 
was 117.3, with the normocapnia and the normoxia groups showing the lowest mean (P<0.001). 
Groups were relatively balanced in terms of admission source, comorbidities, temperature, glucose 
and non-respiratory markers.
Unadjusted outcome
Table 2 shows the unadjusted mortality rates. Overall, 2,491 (47.4%) patients died in the ICU and 
2,833 (53.9%) died in the hospital. Hospital mortality was highest in the hypocapnia group (58.4%), 
compared with the hypercapnia (56.8%) and normocapnia (49.3%) group (P<0.001). Compared 
with the hyperoxia (57.6%) and normoxia (52.9%) groups, hospital mortality was higher (P<0.001) in 
the hypoxia group (63.6%).
In the univariate logistic regression model, PaCO
2
 was significantly associated with mortality 
(P<0.001). This model was improved when PaO
2
 was added (P<0.001). No interaction effect (arterial 
oxygen by arterial carbon dioxide concentration) on mortality was found (P=0.25). PaO
2
 was also 






 showed a curvilinear U-shaped relationship with mortality in adjusted analyses 
(Fig. 1 and 2). 
Odds ratios from multivariate analyses are listed in Table 3. After adjustment for age, lowest 
glucose, AP4-adj and PaO
2
 (splines), hypocapnia showed a significant association with hospital 





the results were virtually unchanged (data not shown).
Adjusted for age, lowest glucose, AP4-adj and PaCO
2
 (splines), hypoxia but not hyperoxia was 
found to be associated with hospital mortality in comparison to normoxia (P<0.01). When this model 
was reanalyzed without adjustment for PaCO
2 
the results were not materially different (data not 
shown). When the model was reanalyzed with hyperoxia (>300 mmHg) as reference category, no 
effects on mortality were observed for various oxygenation ranges.
The individual and joint effect estimates for derangements (normal range vs. outside normal 





independently associated with hospital mortality (P<0.01). The estimate for the interaction term 
(presence of PaCO
2 
derangement by presence of PaO
2
 derangement) was not significant on 







































Figure 1. Adjusted probability of in-hospital death by arterial carbon dioxide levels. 
Loess smoothing curve predicted from logistic regression model adjusted for spline functions of age, lowest 
glucose, AP4-adj and PaO
2
. Grey zones represent 95% confidence intervals
Figure 2. Adjusted probability of in-hospital death by arterial oxygen levels. 
Loess smoothing curve predicted from logistic regression model adjusted for spline functions of age, lowest 
glucose, AP4-adj and PaCO
2




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































D I S C U S S I O N
In accordance with previous studies, we found that early exposure to both hypo- and hypercapnia 
is common in ICU patients resuscitated from cardiac arrest (15, 16). In contrast, hypoxia and severe 





a U-shaped relationship with outcome and after adjustment for known confounders, hypocapnia 
and hypoxia were significantly associated with hospital mortality. Hyperoxia was not independently 
associated with higher mortality in comparison with various ranges for normoxia. However, this 
study may lack power to detect significant associations for severe arterial oxygen derangements 
considering the low prevalence in the present cohort.
Our adjusted mortality plots and the categorized results stress the importance of aberrant 
arterial levels after cardiac arrest, but rigid cut-offs for optimal ranges remain to be determined and 
Table 3. Adjusted associations between subgroups and hospital mortality




 Hypocapnia vs. normocapnia 1.39 (1.18–1.63)a <0.001
 Hypercapnia vs. normocapnia 1.10 (0.95–1.27)a 0.20




 Hypoxia vs. normoxia 1.34 (1.08–1.66)b <0.01
 Hyperoxia vs. normoxia 1.13 (0.81–1.57)b 0.46




 55-80 vs. >300 mmHg 1.06 (0.76–1.50)b 0.72
 80-102 vs. >300 mmHg 0.90 (0.64–1.27)b 0.55
 102-300 vs. >300 mmHg 0.79 (0.56–1.11)b 0.17
Hypocapnia = PaCO
2
 <35 mmHg; normocapnia = PaCO
2





 <60 mmHg; normoxia = PaO
2
 60-300 mmHg; hyperoxia = PaO
2
 >300 mmHg 
a Multivariable analysis adjusted for age, lowest glucose, AP4-adj and PaO
2
 (splines)
b Multivariable analysis adjusted for age, lowest glucose, AP4-adj and PaCO
2
 (splines)
c Stratification based on thresholds from ARDSnet oxygenation target (55-80 mmHg), upper threshold of median 
cohort quintile (102 mmHg), and threshold from previous studies (300 mmHg)
Table 4. Associations between derangements and hospital mortality
Variable
Unadjusted odds ratio 
(95% CI)
Adjusted odds ratio 
(95% CI) P value
PaCO
2
 derangement vs. normocapnia 1.38 (1.24–1.54) 1.21 (1.07–1.36)a 0.003
PaO
2 
derangement vs. normoxia 1.45 (1.21–1.74) 1.27 (1.05–1.54)b 0.01
Interaction term - 1.07 (0.71–1.62) 0.75
PaCO
2
 derangement = PaCO
2
 <35 or PaCO
2





 derangement = PaO
2
 <60 or PaO
2
 >300 mmHg; normoxia = PaO
2
 60-300 mmHg
a Multivariable analysis adjusted for age, lowest glucose, AP4-adj and PaO
2
 (splines)









































validated. Increasing mortality rates may be skewed towards extreme PaO
2
 levels in the early phase 
after cardiac arrest. In line, PaCO
2
 levels between 40 and 45 mmHg appear to be favorable shortly 
after ICU admission. The complex U-shape of the survival curves for both parameters may explain 
the heterogeneity in previously observed associations (14). It shows that unfavorable effects cannot 
be consistently captured when the results are stratified by groups based on arbitrary thresholds. 
Indeed, studies assessing arterial hyperoxia with lower thresholds usually failed to show significant 
effects on outcome, whereas higher risks were observed with substantially higher upper limits (5-9). 
The current findings validate the recent calls for caution with hyperoxia in cardiac arrest patients 
only to a limited extent. The prevalence in this cohort shows that hypoxia and hyperoxia are not 
a common concern shortly after cardiac arrest patients are admitted to Dutch ICUs. In the analyses 
of those conditions, the relatively small number of exposed patients increases the probability of 
type 2 errors. Associations are therefore more likely to be consistent with increasing statistical 
power in the studied subgroups. Moreover, reanalyzing the adjusted effects of oxygenation based 
on quintiles did not detect a significant association with mortality (data not shown). Hypothesizing 
that physicians would avoid hypoxia most attentively in the most critically ill patients, hyperoxia 
could be an indirect marker of illness severity or responsive care, and could thereby reflect worse 
outcome. Accordingly, hypoxia and hypocapnia may also be markers of less attentive care or 
prehospital injury.




 suggests that it is mainly 
the effect of the individual variables that influences mortality in our model than the absolute effect 
by the interaction between the two variables. The effect of PaO
2
 on hospital mortality is therefore 
not likely to differ significantly across strata of PaCO
2
, or vice versa. Further, the effect size did not 
significantly depend on the concurrent presence of aberrant arterial carbon dioxide and arterial 
oxygen levels. Conditions, in which both parameters are concurrently and strongly modified may 





 were subtly altered when adjusted for each other and both parameters should therefore 
judiciously be considered as possible confounders.
For our analyses, we were restricted to the variables that were collected as part of the NICE 
registry. Our database does not contain prehospital variables, nor does it include all ABG samples 
per admission, but only a single measurement associated with the worst oxygenation in the first 24 
hours. Although this method has not previously been shown to be inferior, the selected data
 
may 
not be the most representative data over the total ICU stay and may therefore misclassify patients. In 
addition, selecting either the first, worst or highest value from arterial blood gas sampling emerges 
as an essential methodological issue for the intended analyses (28). The first measured sample 
may reflect pre-ICU treatment, including oxygen administration in the ambulance and emergency 
department. Early oxygen administration can influence oxidative metabolism, respiratory markers, 
vasoconstrictive status and blood flow (29-31), and may thus be an important predictor of outcome. 
In fact, both highest and lowest systolic blood pressures were significantly higher in the hyperoxia 
groups. Further, hyperoxia frequently coincides with hyperventilation and concurrent hypocapnia 
(32). Interestingly, systemic blood pressures were very similar across the PaCO
2
 subgroups in this 
cohort. PaCO
2







































and cerebral perfusion (13, 33). In view of that, the association between hypocapnia and mortality 
may be explained by cerebral vasoconstriction, whereas hypercapnia may be less harmful due to 
increased peripheral tissue oxygenation (34-38).
Although our findings are observational and do not necessarily imply causality, the present 
results are supported by previous results (5, 15). Our findings regarding hyperoxia are in line with 
several recent studies (8, 23, 39), even though conflicting results have been documented (6, 7, 
24, 40). Parts of the heterogeneity in previous findings may be attributed to the adjustment for 
PaCO
2
. Pure oxygen therapy after cardiac arrest has previously been shown to worsen neurological 
outcome in animal models (41) and exposure to hypocapnia and hypercapnia after ROSC has been 
associated with poor neurological function at hospital discharge (16). However, the effects of PaO
2
 
targets on neurological recovery of critically ill patients are still uncertain. 
In contrast to the previous study by Schneider et al. (15), both the unadjusted and adjusted 
association between mortality and hypocapnia were statistically significant. Specific study 
differences may be explained by population and methodological differences. Our multivariate 
model differed slightly and there was less dispersion of the carbon dioxide concentrations in our 
data. Other notable differences between both studies include the substantially lower median PaO
2
 
(92 vs. 106 mmHg), mean FiO
2
 (58 vs. 71%), and marginally lower mean PaCO
2
 (44 vs. 46 mmHg). 
Furthermore, the vast majority of patients in our cohort (80 vs. 40%) reached a temperature lower 





progressively decrease with decreasing body temperature and the occurrence of hypocapnia and 
hypoxia may be underestimated with uncorrected ABG levels. However, temperature correction of 
ABG measurements is ambiguous and was not routinely performed in our study, or in the study by 
Schneider et al.
In order to consistently assess the relationship between risk factors and outcome, it is 
important to re-evaluate previously established associations in different populations using robust 
methodology. The modified methodology of the present study provides further insights in 




 and accounts for clustering by hospital, 
interaction effects and model variances. Still, residual confounding by prehospital and Utstein 
variables cannot be ruled out, and derangements may not be isolated risk factors for mortality. 
C O N C L U S I O N S





 in post cardiac arrest patients. Most effects were attenuated after 
adjustment for identified confounders, but hypocapnia and hypoxia were independently associated 
with hospital mortality. The close relationship between both parameters argues for a concurrent 
assessment of the effects and further evaluation of target ranges is warranted.
C O M P E T I N G  I N T E R E S T S
Nicolette F. de Keizer and Marie-José Roos-Blom are employed by the National Intensive Care 
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A S S O C I AT I O N  B E T W E E N 
A RT E R I A L  H Y P E R OX I A  A N D 
O U TC O M E  I N  S U B S E T S 
O F  C R I T I C A L  I L L N E S S : 
A  SY S T E M AT I C  R E V I E W, 
M E TA-A N A LY S I S  A N D  M E TA-
R E G R E S S I O N  O F  C O H O RT  S T U D I E S
Hendrik J.F. Helmerhorst, Marie-José Roos-Blom, 
David J. van Westerloo, Evert de Jonge
A B S T R AC T
Objective
Oxygen is vital during critical illness but hyperoxia may harm patients. Our aim was to systematically 
evaluate the methodology and findings of cohort studies investigating the effects of hyperoxia in 
critically ill adults.
Data Source
A meta-analysis and meta-regression analysis of cohort studies published between 2008 and 2015 
was conducted. Electronic databases of MEDLINE, EMBASE and Web of Science were systematically 
searched for the keywords hyperoxia and mortality or outcome.
Study Selection
Publications assessing the effect of arterial hyperoxia on outcome in critically ill adults (≥18 years) 
admitted to critical care units were eligible. We excluded studies in patients with chronic obstructive 
pulmonary disease (COPD), extracorporeal life support or hyperbaric oxygen therapy and animal 
studies. Due to a lack of data, no studies dedicated to patients with acute lung injury, sepsis, shock 
or multiple trauma could be included.
Data Extraction
Studies were included independent of admission diagnosis and definition of hyperoxia. The primary 
outcome measure was in-hospital mortality and results were stratified for relevant subgroups 
(cardiac arrest, traumatic brain injury, stroke, post cardiac surgery and any mechanical ventilation). 
The effects of arterial oxygenation on functional outcome, long-term mortality and discharge 
parameters were studied as secondary outcomes.
Data Synthesis
Twenty-four studies were included of which five studies were only for a subset of the analyses. 
Nineteen studies were pooled for meta-analyses and showed that arterial hyperoxia during 
admission increases hospital mortality: adjusted odds ratio 1.21 [95% CI 1.08–1.37] (P=0.001). 
Functional outcome measures were diverse and generally showed a more favorable outcome for 
normoxia.
Conclusions
In various subsets of critically ill patients, arterial hyperoxia was associated with poor hospital 
outcome. Considering the substantial heterogeneity of included studies and the lack of a clinical 


































I N T R O D U C T I O N
Oxygen supply is part of the routine treatment in critically ill patients and one of the most effective 
lifesaving strategies in emergency situations. During acute conditions such as cardiac arrest, 
myocardial ischemia, traumatic brain injury and stroke, oxygen is typically administered in a liberal 
manner in the pre-hospital setting. When patients survive the initial phase of such life-threatening 
diseases, the majority is admitted to the intensive care unit (ICU), mechanically ventilated and 
supported with oxygen. During ICU stay, applied fractions of oxygen (FiO
2
) typically exceed 
accustomed concentrations of ambient air and critically ill patients often achieve supranormal 
arterial oxygen levels (PaO
2
) in the first 24 hours of admission (1, 2). In this setting, hyperoxia may 
compensate and prevent tissue hypoxia by promoting oxygen delivery to the affected organs. 
However, arterial hyperoxia has also been shown to induce vasoconstriction and reduce cardiac 
output which may impair blood flow to the organs at risk (3-5). In addition, hyperoxia facilitates 
a complex pro-inflammatory response and has been associated with cell injury by reactive oxygen 
species (ROS) (6, 7). Accordingly, oxygen therapy yields a delicate balance between benefit and 
harm, depending on dose, duration and underlying diseases.
In critically ill patients, the harmful effects are accentuated and may eventually prevail, 
considering the extended duration of supplemental oxygen and the patient’s susceptibility for 
inflammation and cardiovascular instability. In recent years, an increasing number of studies have 
investigated the association between arterial hyperoxia and (functional) outcome in these patients. 
The purpose of this review was to perform a meta-analysis and meta-regression of cohort studies 
comparing hyperoxia to normoxia in critically ill adults.
M AT E R I A L S  A N D  M E T H O D S
This study was reported in accordance with the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines for systematic reviews and meta-analyses (8). Eligibility 
criteria included observational cohort studies assessing the effect of arterial hyperoxia on outcome 
in critically ill adults (≥18 years) admitted to critical care facilities (e.g. ICU, CCU). 
Data Sources and Searches
After consultation of a librarian, the electronic databases of MEDLINE (1962-2015), EMBASE (1970-
2014) and Web of Science (1970-2014) were systematically searched by combining the key words 
and MeSH headings hyperoxia and mortality or outcome. Related synonyms, alternatives and plural 
(e.g. hyperoxaemia, arterial oxygen tension, oxygen supply, outcome, survival, fatality) were also 
considered. The main search was performed in July 2014 and updated in January 2015. In addition, 
personal records and reference lists of relevant articles were screened. The full electronic search 
string is shown in the supplemental data (Supplemental Digital Content 1).
Study Selection
Studies were independently screened based on title and abstract by two authors (HH, MR) and 


































disease (COPD) patients, patients on extracorporeal life support and patients undergoing 
surgery at the time of oxygen sampling. Data from studies with hyperbaric oxygen therapy were 
not considered.
We retrieved full text of potentially eligible articles. Data from full-text articles were preferred 
in case of duplicate reports with concurrent data in conference abstracts. Published conference 
abstracts were only included when requisite data for quality assessment of the database was 
available. No language restrictions were applied. As no formal definition for hyperoxia exists, we 
included studies independent of admission diagnosis and definition of arterial hyperoxia.
Data Extraction and Quality Assessment
Relevant data were extracted using a standardized data abstraction sheet. The primary outcome 
measure was in-hospital mortality. The effects of arterial oxygenation on functional outcomes, 
long-term mortality and discharge parameters were also noted as secondary outcomes. Predictive 
scores, including the Cerebral Performance Category (CPC), Glasgow Coma Scale (GCS) and 
the modified Rankin Scale (mRS), were used as a surrogate for functional outcome. Corresponding 
authors of included articles were contacted or data from prior analyses (9) were used in case of 
missing requisite data.
Quality scoring for observational studies is controversial and may lack validity and value (10). 
Therefore, risk of bias was estimated according to the Newcastle-Ottawa quality assessment scale 
(11), but no summary score for study quality was adopted. Furthermore, the studies substantially 
differed in methodology in terms of study population and definition of hyperoxia. Hence, results 
were stratified and if possible analyzed separately for subgroups, hyperoxia thresholds, selection of 
PaO
2
 measurement and secondary outcomes.
Data Synthesis and Analysis
Effect estimates were primarily presented as adjusted odds ratios. Unadjusted odds ratios were 
used in absence of adjusted odds ratios, and for formal meta-analysis of the data. Odds ratios with 
95% confidence intervals were pooled in a random effects model according to Mantel and Haenszel 
for crude effects and inverse variance for adjusted effects.
Heterogeneity was assessed, using the I2 statistics, Chi2 test, Tau2 and by visualization in 
a funnel plot, respectively. Small study effect was visually estimated by symmetry in funnel plots. 
The subgroup of any mechanically ventilated patients was excluded when analyzing the crude 
effects in view of the heterogeneous illness severity of this population (12, 13). In case of overlapping 
study populations (14, 15), individuals were only counted when included in a non-overlapping time 
period. As a random effects model was used and in view of the model’s reliability, pooled subgroup 
estimates were only reported in the results when five or more studies were included. In accordance, 
the I2 statistics for subgroup analyses were omitted in case of few studies in order to avoid 
overestimation of this measure. For purposes of exploring heterogeneity, adjusted odds ratios 
were also graphically presented stratified by admission diagnosis, selection of PaO
2
 measurement 
and secondary outcomes. The effects of hyperoxia by threshold were, independent of admission 


































with subgroup, threshold, and timing and selection of the PaO
2
 measurement as predictors for 
outcome. In these moderator analyses, threshold was categorized according to the primary PaO
2
 
cut-off used for defining hyperoxia. Subgroups were categorized as the subsets of critically ill 
patients. The selection of the PaO
2
 measurement was categorized as first, worst, highest or mean 
and the timing was defined as measurement within or beyond 24 hours of admission.
Analyses were conducted with RevMan 5.3 (Nordic Cochrane Centre, Cochrane Collaboration, 
Copenhagen, Denmark) and R version 3.1.2 (R Foundation for Statistical Computing, Vienna, Austria) 
using RStudio version 0.98.1028 (RStudio Inc, Boston, MA).
R E S U LT S
Search Results and Study Characteristics
Our search strategy resulted in 1609 studies considered for inclusion. After screening of titles and 
abstracts 32 full-text articles were assessed for eligibility (Fig. 1). 
In total, 24 cohort studies were included, of which five studies were included only for specific 
subset analyses or for secondary outcomes (Table 1). The included articles were published between 
2008 and 2015 and data collection was conducted between 1987 and 2012. In total, twelve articles 
included cardiac arrest patients, five included patients with traumatic brain injury (TBI), three 
included stroke patients, one included post cardiac surgery patients, and the remaining two studies 
included mechanically ventilated ICU patients, independent of admission diagnosis. The estimated 
risk of bias of included studies was moderately low. Most studies used large and high quality 
national databases and adjusted the data for severity of illness. Two studies did not adjust the data 
for potential confounders (17, 18) and two studies included cardiac arrest patients only when treated 
with therapeutic hypothermia (19, 20).
Qualitative Data Synthesis
Adjusted odds ratios for the primary outcome ranged from 0.11 to 2.00 (Supplemental Table 1, 
Supplemental Digital Content 2).
Frequent confounders included in multivariate analysis were age, sex, illness severity, and 
subgroup specific confounders such as neurological or cardiac parameters. The most commonly 
used threshold to define hyperoxia was 300 mmHg (range 85–487 mmHg), although cohort 
specific thresholds based on data distribution across percentiles were also frequently chosen. 
The selected PaO
2
 used for classification of patients were mainly based on measurements in the first 
24 hours of admission in the hospital or ICU. Some studies used longer time frames (20, 29, 34) and/
or estimated hyperoxia exposure from more than one blood gas sample (20, 21, 27, 30, 34). In most 
studies, the reference range for calculating odds ratios was chosen as self-defined normoxia range. 
In a few studies hyperoxia was compared to non-hyperoxia (17, 26).
Some studies were not pooled in the meta-analyzed models, due to missing requisite crude (12, 
13, 18, 21, 25-27) and/or adjusted data (17, 34) for the primary outcome. One study (24) was excluded 
for meta-analysis in order to prevent duplicate data synthesis as this study used a secondary analysis 



































Meta-analysis of sixteen studies covering 49,389 patients showed a crude odds ratio of 1.38 [95% 
CI 1.18–1.63] (P<0.0001) for in-hospital mortality, independent of admission diagnosis (Fig. 2). This 
corresponds with a risk ratio of 1.18 [95% CI 1.08–1.30] and a risk difference of 0.06 [95% CI -0.02–
0.13]. The overall effects were statistically significant in subgroups of cardiac arrest (P=0.001) and 
ischemic stroke (P=0.03), but not for TBI (P=0.32), subarachnoid (P=0.47), intracerebral hemorrhage 
(P=0.09) and post cardiac surgery (P=0.19). Heterogeneity among all studies was substantial 
(I2 76%), but unimportant among subgroups (I2 0%).
Meta-analysis of adjusted estimates derived from seventeen studies showed an odds ratio of 
1.21 [95% CI 1.08–1.37] (P=0.001) (Fig. 3). The tests for overall effect was only statistically significant 
for cardiac arrest patients (P=0.005). Again, heterogeneity among all studies was considerable 
(I2 80%), and moderate among subgroups (I2 41%).
Figure 1. Flow diagram of study selection for the systematic review.






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Adjusted odds ratios for mechanically ventilated patients (n=2 studies) were 1.00 [95% CI 0.94–
1.07] and 1.23 [95% CI 1.13–1.34]. In cardiac arrest patients, the adjusted odds ratios (n=6 studies) 
ranged from 0.60 to 1.80, with a pooled estimate of 1.31 [95% CI 1.09–1.57] (I2 63%). In patients with 
Figure 2. Forest plot for the crude associations between arterial hyperoxia and hospital mortality by subsets of 
critical illness. 
The pooled odds ratios were calculated using a random-effects model. Weight refers to the contribution of 


































Figure 3. Forest plot for the adjusted associations between arterial hyperoxia and hospital mortality by subsets 
of critical illness. 
The pooled odds ratios were calculated using a random-effects model. Weight refers to the contribution of 
each study to the pooled estimates. CI, confidence interval, IV, inverse variance.
TBI, adjusted odds ratios (n=5 studies) ranged from 0.11 to 2.00, with a pooled estimate of 1.26 [95% 
CI 0.85–1.88] (I2 78%). Stroke patients were combined and adjusted odds ratios (n=2 studies) were 
0.87 [95% CI 0.57–1.32] and 1.22 [95% CI 1.04–1.45]. In post cardiac surgery patients, the odds ratio 
(n=1) was 0.9 [95% CI 0.7–1.1].
The crude (Figure 4a) and adjusted (Figure 4b) effect estimates increased with increasing 
thresholds used for defining arterial hyperoxia (P=0.007 and P=0.22, respectively) and showed 






































Scatters indicate odds ratios for in-hospital mortality on a logarithmic scale, according to the hyperoxia 
threshold that was used as primary cutoff in the indicated studies. The point sizes are inversely proportional 
to the SEs of the individual studies (i.e., larger/more precise studies are shown as larger circles). The predicted 
effect sizes are modeled in a linear mixed-effects model with corresponding 95% CI boundaries and 


































Figure 5. Forest plot for the adjusted effects of arterial hyperoxia by selection of PaO
2
 measurements. 
Subgroups sorted in ascending order by timing and selection of PaO
2
 measurements. Studies sorted 
alphabetically by name of first author.
Figure 5 displays the effects stratified for selection of the PaO
2
 measurement and also showed 
significant subgroup differences (P<0.001). When modeling the crude effects, subgroup (P=0.001), 
threshold (P=0.01) and timing and selection of the PaO
2
 measurement (P=0.01 and P=0.003, 
respectively) were independent moderators of the outcome. The individual tests of moderators 
were not significant when modeling the adjusted estimates.
The symmetrical appearance of the funnel plots (Supplemental Fig. 1, Supplemental Digital 
Content 3 and Supplemental Fig. 2, Supplemental Digital Content 4) indicates that substantial 


































Figure 6. Forest plot for the adjusted effects of arterial hyperoxia by secondary outcomes. 
CPC, Cerebral Performance Category, GCS, Glasgow Coma Scale, mRS, modified Rankin Scale.
effects were almost equally published and had a similar mean publication delay (129 vs. 121 days, 
respectively, P=0.68) (supplemental data, Supplemental Digital Content 1).
Secondary outcomes were diverse and results are listed in the Supplemental Table 2 
(Supplemental Digital Content 5). Significant associations of adjusted analyses were found for 
CPC≥3 (cardiac arrest), GCS 3-8 (TBI), mRS 4-8 and delayed cerebral ischemia (stroke) (Fig. 6). 
Arterial hyperoxia was associated with hospital stay shorter than 7 days in TBI patients, although 


































a prospective cohort of cardiac arrest patients (17). ICU mortality, 6 month-mortality and failure to 
discharge home were not significantly associated with arterial hyperoxia (17, 26, 28, 32, 36).
D I S C U S S I O N
This systematic review identified nineteen observational cohort studies investigating the crude 
and/or adjusted effects of arterial hyperoxia on hospital mortality in major subgroups of critically 
ill patients. Meta-analysis of pooled data from all patients highlighted that arterial hyperoxia was 
associated with hospital mortality. After adjustment for confounders, this association was also 
established in patients admitted to critical care units following cardiac arrest, but this effect was not 
found in other subgroups. Functional outcome measures were diverse and showed a signal generally 
favoring normoxia. Other secondary outcomes were not associated with arterial hyperoxia. 
However, considerable heterogeneity and the observational character of included studies hamper 
profound conclusions and causal inferences.
The observed heterogeneity warrants cautious interpretation of pooled results. Our findings 
may be substantially influenced by the used methodology of the included studies and stress 
the importance of the used threshold, reference range, confounders, summary statistic, subgroup 
and outcome measure. The definition of hyperoxia and its reference range may be the most 
important factors determining the effect size. Indeed, increasing PaO
2
 levels were more strongly 
associated with poor outcome, but this observation may have been attenuated by detrimental 
effects of hypoxia, in cases where this subgroup was not excluded from the reference group. 
Moreover, the prevalence of hyperoxia was highly dependent on the used threshold and also 
addresses the relevance of the risks of severe hyperoxia in different cohorts. The timing and 
selection of the PaO
2
 measurement chosen to reflect arterial oxygenation emerged as another key 
determinant of the magnitude of the association. The choice of this summary statistic for defining 
hyperoxia can be essential in determining the relation between oxygenation and the outcome as 
oxygen toxicity may manifest during prolonged exposure, while direct effects may also be crucial 
in the acute and pre-hospital setting. Indeed, hyperoxia in the first arterial blood gas was more 
consistently associated with poor outcome than averaged oxygen levels, which may in fact not 
be a reliable marker of the total hyperoxic exposure during ICU stay. These findings suggest that 
oxygen may have both a time and dose dependent effect in which early (first samples) and severe 
hyperoxia are specifically hazardous. However, we cannot rule out that hyperoxia can also be 
harmful during prolonged exposure and when PaO
2
 values are moderately higher than normal. 
The study by Asher et al. (29) contradicts most other findings and is likely to be an outlier as 
a result of its small sample size which is also reflected in the funnel plots and by its weight in meta-
analyses. Further, it is the only study to use the highest PaO
2
 in the first 72 hours of admission, 
which may represent other oxygenation and ventilation strategies during this phase of admission 
than other summary statistics. Despite the addressed differences between all included studies, 
the direction of the pooled effects pertains, while the magnitude and significance level of individual 
results may be partially explained by methodological issues.
The following study strengths and limitations should be considered. First, well established 


































rhythm), TBI and stroke (e.g. Glasgow Coma Scale, Injury Severity Score), were assessed in some 
but not all included studies and may substantially determine the effect size. Moreover, authors 
should judiciously consider to recalculate illness severity scores when included as a confounder 
in multivariate analyses. These scores may contain the same PaO
2
 derived from the first 24 hours 
of admission as the PaO
2
 that is used for defining hyperoxia as outcome predictor. A recalculated 
score, omitting or standardizing oxygen components, may therefore avoid overadjustment in such 
analyses. In line, FiO
2
 levels are closely related to PaO
2
 levels, included in illness severity scores and 
may accordingly inflict multicollinearity.
Unmeasured bias may impose a further limitation inherent to analyses in observational studies. 
From the funnel plots, we cannot fully rule out that our findings are impacted by publication bias. 
On the other hand, the statistical significance level of the results did not appear to have an effect 
on publication delay and we also included data from a conference abstract study where database 
quality was previously assessed (37). Partially overlapping populations (14, 15, 26) (23, 24) in databases 
from included studies was accounted for by including only the main study in meta-analysis and by 
presenting the data as a subsample, where appropriate.
Experimental data from animal models have recently been summarized and showed an 
association between 100% oxygen therapy and worse neurological outcome following cardiac arrest 
(38). In accordance, aggregated data from observational studies focusing on cardiac arrest patients 
found a correlation between hyperoxia and hospital mortality (9). A recent meta-analysis found 
insufficient evidence regarding the safety of arterial hyperoxia, as the results may be impacted by 
methodological limitations (39). The current analyses extend these observations by including and 
aggregating all subgroups including post-operative cases, various secondary outcomes, novel data 
from recent cohort studies and by further exploring the impact of the definition of hyperoxia. Still, 
our findings may not depict a universal effect for all ICU patients and cannot be directly extrapolated 
to other subgroups.
Current guidelines aim at PaO
2
 levels around 55 to 80 mmHg, but this target range was based 
on expert-consensus more than on evidence from clinical studies (40, 41). Conflicting findings 
from previous studies further impede the constitution of compelling clinical recommendations. 
Consequently, attitudes regarding the management of oxygen administration vary considerably 
and clinicians often consider hyperoxia acceptable as long as the FiO
2
 is relatively low (1, 42). This 
may also be triggered by the double-edged nature of oxygen, which similarly urges strict prevention 
of hypoxia and its inherent hazards (12, 13). Furthermore, carbon dioxide may importantly mediate 
the effects of oxygen, although direct effects are assumed to be small (43). Hyperoxia may 
alternatively be a non-causal marker of disease severity as clinicians may intuitively treat the most 
severely ill patients with higher FiO
2
 or PEEP levels in attempts to compensate for tissue hypoxia. 
Although this is less likely as the association between hyperoxia and mortality has also been shown 
to persist after adjustment for severity scores and FiO
2
, future prospective intervention trials are 


































C O N C L U S I O N S
This systematic review has shown that, despite methodological limitations, arterial hyperoxia is 
associated with poor hospital outcome in various subsets of critically ill patients. The harmful effects 
depend on hyperoxic degree and may be more pertinent to certain subgroups at specific moments 
of admission. Taken together, the effect estimates favoring normoxia were quite consistent 
throughout our analyses, but were not universal for all subsets and secondary outcomes. In 
the absence of studies specifically addressing the effects in other important critical care subgroups, 
including acute lung injury, sepsis, shock and multiple trauma, the vast majority of the population 
in the current analysis consisted of patients with mechanical ventilation, cardiac arrest, traumatic 
brain injury and stroke. Furthermore, the impact of pursuing normoxia on the incidence of hypoxic 
episodes is unknown and the long-term effects of conservative oxygen therapy are still to be 
assessed in large cohorts. Given the lack of robust guidelines, more evidence is needed to provide 
tailored oxygen targets for critically ill patients.
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We read the article by Helmerhorst et al. (1) with interest. Hyperoxia has been studied in emergency 
situations, such as cardiac arrest (CA), myocardial ischemia, traumatic brain injury, and stroke. 
The potential harm of hyperoxia due to the oxygen free radical formation has been discussed in 
several studies. Because of the diversity of diseases and the different definitions of hyperoxia, these 
conclusions remain contradictory.
In this review, seven studies about CA have been pooled to investigate the association between 
hyperoxia and mortality. Because of the diversity of methodology, definitions of hyperoxia, 
reference range, and other confounders, the heterogeneity was significant (I2 = 66%), which 
warrants cautious interpretation of the pooled results.
In a sensitivity analysis of this pooled outcome, we found that when the study by Bellomo et 
al. (2) was excluded, the conclusion became insignificant (odds ratio, 1.38; 95% CI, 0.95–2.01; 
I2 = 70%) (Fig. 1). 
This may be explained that Bellomo et al. (2) chose the lowest PaO
2
 level or the PaO
2
 associated 
with the arterial blood gas with the highest alveolar-arterial gradient, which may lead to 
the underestimation of the proportion of hyperoxia. According to the conclusion of Kilgannon et al. 
(3), there was a dose-dependent association between mortality and PaO
2
 range, with a 24% increase 
in mortality risk for every 100 mmHg increase in PaO
2
, which means that in the study by Bellomo et 
al. (2), the mortality associated with hyperoxia may be overestimated.
Besides, in the study by Kilgannon et al. (4) based on IMPACT database, a large critical-care 
database of ICU at 120 U.S. hospitals initially developed by the Society of Critical Care Medicine, 
the first blood gas measurement in the ICU was used and found that hyperoxia (PaO
2
 of at least 300 
mmHg) was associated with increased mortality. This excluded the temporal effect of hyperoxia, 
which has been debated whether the use of blood gas value at a single time point was appropriate. 
In this sensitivity analysis, when the study by Kilgannon et al. (4) was excluded, the heterogeneity 
became insignificant, with I2 decreasing from 66% to 33%, which raised the question: Is it appropriate 
to include this study in this analysis? In the reanalysis of IMPACT database by Kilgannon et al. (3), 
they defined the exposure by the highest partial pressure of arterial oxygen over the first 24 hours 
































in the ICU, with the same inclusion and exclusion criteria of Kilgannon et al. (4). Because of different 
data acquisition time, the number of patients was slightly different. We extracted the mortality from 
Figure 1 in this article, with definition of hyperoxia as PaO
2
 of at least 300 mmHg, and reanalyzed in 
Review Manager 5.1.6. (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 
2011). The heterogeneity become insignificant (I2 = 37%) (Fig. 2), and the sensitive analysis 
was stable.
Based on current studies, hyperoxia was associated with increased mortality in CA patients; 
because of the diversity definition of hyperoxia in these studies, the pooled results should be 
interpreted with caution.
Figure 2. Reanalysis of association between hyperoxia and mortality (Kilgannon et al (4) was replaced by 
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We thank Shen and Zhang (1) for their interest and thoughtful analyses regarding our work. Their 
sensitivity analyses provide valuable insights in the relationship between arterial hyperoxia and 
hospital mortality after cardiac arrest and further emphasize the importance of the used definition 
for arterial hyperoxia. As discussed in our study (2), we strongly agree that the pooled results must 
be interpreted with caution in view of the observed heterogeneity.
The selection of a single PaO
2
 yields considerable limitations and the time point at which 
the arterial blood gas was analysed may further lead to misinterpretation of the actual exposure 
to hyperoxia during ICU admission. Indeed, we showed that both timing and selection were 
independent moderators of the outcome when modeling the crude effects (2). Sensitivity analyses 
are useful alternatives to examine the impact of individual study results and methodology. 
The abstraction of arterial hyperoxia that was used in the studies by Bellomo et al. (3) and Kilgannon 
et al. (4) may indeed not be the most representative method, but the rationale for an eventual 
exclusion of these studies in analyses should also be carefully considered. 
First, similar methods using the first, lowest or worst PaO
2
 during admission were also 
frequently used in other cohorts and have not previously been shown to be inferior. Second, 
after exclusion of the study by Bellomo et al. (3), the recalculated pooled effect estimate reflects 
statistical insignificance by the strict use of statistical thresholds, but the absolute difference 
between the original estimate and the estimate in sensitivity analyses was actually marginal (odds 
ratio difference, 0.11) and showed a slight shift in magnitude yet not in direction. The shift in effect 
size should rather be interpreted as a loss of statistical power considering the size of the excluded 
cohort. This is also supported by the adjusted analyses, which may be used to overcome several 
other study limitations. When the study by Bellomo et al. (3) was excluded in sensitivity analyses using 
adjusted effect estimates, the pooled effects remained virtually unchanged (adjusted odds ratio, 
1.32; 95% CI, 1.05–1.66 vs adjusted odds ratio, 1.31; 95% CI, 1.09–1.57). It can be debated whether this 
study essentially overestimated the mortality. The authors have comprehensively stratified the risks 
by deciles of PaO
2
, whereas we selected only the reported risk estimate according to the primarily 
used threshold of hyperoxia (i.e., 300 mmHg). Their results have previously been compared with 
the Kilgannon studies, and other methodological differences may explain heterogeneity (5). It 
is yet interesting to note that the replacement of the original Kilgannon study data (4) by their 
secondary analysis reduces the heterogeneity, which may be attributed to the use of the highest 
PaO
2
 in concordance with the study by Janz et al. (6). Nonetheless, the recalculated pooled effect 
estimates did not materially differ, which may in fact not be overly surprising because the data were 
generated from a subsample of the same cohort.
Finally, the temporal effect of hyperoxia has not been adequately accounted for in most studies 
and is typically only estimated within the first 24 hours of admission. The exact impact over the total 
ICU admission remains unknown although we have initiated comprehensive analyses comparing 
different strategies for defining hyperoxia. Preliminary results of such analyses in a Dutch 
multicenter cohort of ICU patients suggest that all strategies differ substantially, and results should 
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A B S T R AC T
Objective
Emerging evidence has shown the potential risks of arterial hyperoxia, but the lack of a clinical 
definition and methodological limitations hamper the interpretation and clinical relevance of 
previous studies. Our purpose was to evaluate previously used and newly constructed metrics of 
arterial hyperoxia and systematically assess their association with clinical outcomes in different 




Three large tertiary care ICUs in the Netherlands
Patients
A total of 14,441 eligible ICU patients
Interventions
None
Measurements and Main Results
In total, 295,079 arterial blood gas (ABG) analyses, including the partial pressure of arterial oxygen 
(PaO
2
), between July 2011 and July 2014 were extracted from the patient data management system 
database. Data from all admissions with more than one PaO
2
 measurement were supplemented 
with anonymous demographic and admission and discharge data from the Dutch National Intensive 
Care Evaluation registry. Mild hyperoxia was defined as PaO
2
 between 120 and 200 mmHg; severe 
hyperoxia as PaO
2
 >200 mmHg. Characteristics of existing and newly constructed metrics for arterial 
hyperoxia were examined and the associations with hospital mortality (primary outcome), ICU 
mortality and ventilator-free days and alive at day 28 (VFDs) were retrospectively analyzed using 
regression models in different subgroups of patients.
Severe hyperoxia was associated with higher mortality rates and fewer VFDs in comparison 
to both mild hyperoxia and normoxia for all metrics except for the worst PaO
2
. Adjusted effect 
estimates for conditional mortality were larger for severe hyperoxia than for mild hyperoxia. This 
association was found both within and beyond the first 24 hours of admission and was consistent for 
large subgroups. The largest point estimates were found for the exposure identified by the average 
PaO
2
, closely followed by the median PaO
2
 and these estimates differed substantially between 
subsets. Time spent in hyperoxia showed a linear and positive relationship with hospital mortality.
Conclusions
Our results suggest that we should limit the PaO
2
 levels of critically ill patients within a safe 
range, as we do with other physiological variables. Analytical metrics of arterial hyperoxia should 
be judiciously considered when interpreting and comparing study results and future studies are 

































I N T R O D U C T I O N
Oxygen therapy and arterial oxygenation play a vital role in the clinical course of patients in 
the intensive care unit (ICU). The effects of hypoxia are well established and are actively prevented 
in order to maintain physiological stability. In contrast, hyperoxia is frequently encountered in 
the ICU but generally accepted (1-3). In recent years, emerging evidence has shown the potential 
risks of arterial hyperoxia (4, 5), but observational studies failed to indisputably demonstrate 
its impact on clinical outcomes of critically ill patients (6-9). Most studies focus on hospital 
mortality of mechanically ventilated patients, but the lack of a clinical definition of hyperoxia and 
methodological limitations hamper the interpretation and clinical relevance of these studies (10). 
Importantly, it is unknown whether the partial pressure of arterial oxygen (PaO
2
) from a single 
arterial blood gas (ABG) measurement in the first 24 hours of admission reliably estimates the actual 
exposure to hyperoxia and associated risks during the ICU stay. Also, we do not know whether high 
arterial peak-levels of oxygen or prolonged exposure to high PaO
2
 are associated with adverse 
outcomes. Knowledge on oxygenation metrics and related summary statistics is important when 
interpreting studies on the effects of hyperoxia and for setting up future research. Oxygenation 
based metrics may be based on a certain time period (e.g. first 24 hours after ICU admission or 
complete ICU period) and on a single measurement, central tendency or cumulative exposure.
The aim of this study was to 1) comprehensively assess the metric-related association of arterial 
oxygenation with clinical outcomes in different subsets of critically ill patients and 2) systematically 
evaluate the influence of choosing a certain metric on the composition of subgroups of patients 
with arterial hyperoxia and mortality in those subgroups.
M AT E R I A L S  A N D  M E T H O D S
Data collection
Data were collected between July 2011 and July 2014. Data collection procedures have been 
described in detail previously, and reviewed and approved by the Medical Ethical Committee 
of the Leiden University Medical Center (2, 11). In brief, arterial blood gas (ABG) analyses and 
concurrent ventilator settings were extracted from the patient data management system (PDMS) 
database (MetaVision, iMDsoft, Leiden, The Netherlands) of closed format, mixed medical 
and surgical, tertiary care ICUs of three participating hospitals in the Netherlands. Data were 
supplemented with anonymous demographic data, admission and discharge data, and variables 
to quantify severity of illness from the Dutch National Intensive Care Evaluation (NICE) registry, 
a high quality database, which has been described previously (12). According to the Dutch Medical 
Research Involving Human Subjects Act, there was no need for informed patient consent, as only 
registries without patient identifying information were used. Admissions were only eligible for 
inclusion when requisite data from more than one ABG measurement was available. Patients on 
extracorporeal membrane oxygenation were excluded from the study. Conservative oxygenation 
was promoted during the study in all three units, but actual strategies were left to the discretion of 


































We calculated several previously used and newly constructed metrics for arterial hyperoxia. Existing 
metrics were derived from a systematic literature review and included the first, highest, worst, 
and average PaO
2
, typically assessed over the first 24 hours of admission (9). These metrics were 
compared to new metrics within specific time frames, namely the median, area under the curve and 
time spent in arterial hyperoxia.
As no formal definition for arterial hyperoxia exists, we stratified the analyses using previously 
used thresholds, while considering the incidence in the present cohort. Mild hyperoxia was defined 
as PaO
2
 120 – 200 mmHg (13) and severe hyperoxia as PaO
2 
> 200 mmHg (14).
Metrics of single sampling
The first PaO
2
 (FIR) was the PaO
2
 value that was measured in the first ABG registered in the PDMS 
after the patient was admitted to the ICU.
Highest PaO
2
 (MAX) was the maximum value that was registered during the first 24 hours 
(MAX
0-24




 (WOR) was defined as the PaO
2
 
derived from the ABG associated with the lowest concurrent PaO
2
 to fractions of inspired oxygen 
ratio (FiO
2
) ratio (P/F ratio) and also calculated for the first 24 hours (WOR
0-24




Metrics of central tendency
The average (AVG) and median (MED) PaO
2
 were calculated over the first 24 hours and over the total 
ICU LOS per admission.
Metrics of cumulative exposure
Per patient, the area under the curve was computed over the first 24 hours (AUC
0-24
), first 96 hours 
(AUC
0-96
) and total duration of ICU admission (AUC
ICU LOS
) using linear interpolation of the available 
PaO
2
 measurements. We calculated the median PaO
2
 over the respective time frames and inserted 
these values as PaO
2
 measurements at the starting (T=0) and end point of the curve (T=24, T=96 or 
at discharge or death, depending on considered time frame).
Smoothing curves, using natural spline interpolation (16), were fitted to compute the individual 
time spent in the range of hyperoxia in a similar manner. Patients with an interval longer than 24 
hours between two consecutive PaO
2
 measurements were excluded from these analyses (n=392), as 
the amount of estimated data from the fitted curve would otherwise excessively exceed the amount 
of real data.
Statistical Analyses
In accordance with a study examining glucose metrics in critical care (17), we analyzed 
the associations between the metrics and hospital mortality (primary outcome) by logistic 
regression with each metric categorized by severity of the hyperoxic exposure based on specified 

































normoxia (60-120 mmHg) or median quintiles. The associations between the metric and secondary 
outcomes, including ICU mortality, and ventilator-free days (VFDs) were also assessed. VFDs were 
calculated as the number of ventilator-free days and alive, 28 days after ICU admission according to 
a previously described definition (18).
Data were reanalyzed for specific subgroups categorized by use of mechanical ventilation, 
admission type and specific admission diagnoses that were studied in previous work (8, 9, 19). 
The multivariate models were adjusted for age and APACHE IV, which were found to be confounders 
in previous studies (17). The APACHE score was calculated from the data obtained within 24 hours 
of admission. ICU LOS was also included as potential confounder for the association with hospital 
mortality. In the multivariate logistic regression models, we quantify how the metrics are associated 
with the distribution between death and discharge at a specific time point, given that either of 
the two occurs (conditional hospital mortality). Adjusted associations with conditional hospital 
mortality were also depicted using loess smoothing curves.
The relationship between the individual metrics, that were not directly dependent on the ICU 
LOS, was examined using pairwise correlations and cluster analysis. The area under the receiver-
operating characteristic curve (C-statistic), the Brier score and the Nagelkerke R2 were determined 
as measures of discrimination and/or calibration for the univariate models of metrics using data 
from the first 24 hours of admission. In these models, spline based transformations of the metrics 
were used to predict hospital mortality. A recalibration of the APACHE IV score was explored by 
replacing the oxygen component by the first, mean, median, worst or highest PaO
2
 within the first 
24 hours of admission. The multivariate models were reanalyzed by additionally adjusting for 
applied FiO
2
 levels and also if the oxygen component in the APACHE score covariate was removed.
All statistical analyses were conducted using R version 3.2.1 (R Foundation for Statistical 
Computing, Vienna, Austria). To account for multiple testing, the indicated levels of statistical 
significance were lowered to 0.01.
R E S U LT S
In total, 14,441 patients were included and 295,079 ABG analyses were obtained from eligible 
admissions (Table 1). The median time to the first ABG measurement was 26 (IQR 13-69) minutes, 
the median interval between two consecutive ABG samples was 249 (IQR 147-358) minutes, and 
the median number of ABG measurements per patient was 7 (IQR 4-17).
Metric characteristics
All metrics calculated over the first 24 hours of admission were strongly related to the corresponding 
metrics calculated over the total ICU LOS (Pearson r = 0.87–0.91, Supplemental Fig. 1, Supplemental 
Digital Content 1). Also, AVG
ICU LOS
 had high correlation with MED
ICU LOS
 (r = 0.92). In contrast, very 






. Cluster analysis in 
the Supplemental Digital Content showed that the metrics could be subdivided in multiple families, 
where the highest PaO
2
 appeared to be least related to the other metrics (Supplemental Fig. 2, 

































Table 1. Descriptive characteristics
Total
Patients characteristics
No. of patients 14,441
Demographics
 Age, y 65 (55-73)
 Male, n (%) 9315 (64.5)
 BMI, kg/m2 25.8 (23.3-29.0)
 Planned admission, n (%) 7328 (50.7)
 Medical admission, n (%) 5130 (35.5)
 Planned surgery, n (%) 5038 (34.9)
 Emergency surgery, n (%) 1344 (9.3)
Clinical characteristics
 APACHE IV score 54 (41-75)
 APACHE IV predicted mortality, % 5.2 (1.4-22.9)
 SAPS II score 34 (26-45)
 SAPS II predicted mortality, % 15 (7-34)
Clinical outcomes
 Mechanical ventilation time, hrs 11 (5-40)
 ICU LOS, hrs 37 (21-85)
 ICU mortality, n (%) 1427 (9.9)
 Hospital mortality, n (%) 1989 (13.8)
Oxygenation and ventilation characteristics
No. of arterial blood gas analyses 295,079
Arterial blood gas results
 PaO
2
, mmHg 81 (70-98)
 PaCO
2
, mmHg 40 (34-46)
 pH 7.42 (7.36-7.47)
 Hb, mmol/L 6.2 (1.2)
 Lactate, mmol/L 1.5 (1.0-2.2)




, % 40 (31-50)
 PEEP, cm H
2
O 7 (5-10)








 ratio 219 (165-290)
 Oxygenation index 3.8 (2.5-6.1)
Data are means (±SD) or medians (IQR), unless stated otherwise, BMI, Body Mass Index; APACHE, Acute Physiology 
and Chronic Health Evaluation score; SAPS, Simplified Acute Physiology Score; ICU LOS, Intensive Care Unit Length 
of Stay; PaO
2
, partial pressure of arterial oxygen; PaCO
2
, partial pressure of arterial carbon dioxide; Hb, hemoglobin; 
FiO
2





 ratio multiplied by the concurrent mean airway pressure
Within 24 hours of admission, a spline based transformation of the worst PaO
2
 was the best 
discriminator for hospital mortality. When recalculating the APACHE score with different metrics 
using PaO
2

































for APACHE IV with either worst, highest, first, average or median PaO
2
 (Supplemental Table 1, 
Supplemental Digital Content 1).
Clinical outcomes
Unadjusted analyses showed higher mortality rates and fewer VFDs for severe hyperoxia in 
comparison to both mild hyperoxia and normoxia for all metrics except for the worst PaO
2
, where 
lower or equal mortality rates and more VFDs for severe hyperoxia were assessed (Supplemental 
Table 2, Supplemental Digital Content 1). 
Table 2 shows the event rates and adjusted estimates regarding patient-centered outcomes for 
each metric. 
The estimates are pooled in forest plots (Supplemental Fig. 3–4, Supplemental Digital 
Content 1) and there were notable differences in effect size depending on the used metric for 
hyperoxia. The choice of a certain metric for oxygenation had major influence on the incidence 
of arterial hyperoxia. For example, severe hyperoxia was present in 20% of patients when using 
MAX
ICU LOS
 compared to 1% of patients using AVG
ICU LOS
.
Without exception, the point estimates for conditional mortality were larger for severe 
hyperoxia than for mild hyperoxia. The highest odds ratios were found for the exposure identified 
by the average PaO
2
, closely followed by the median PaO
2
. The AUC and time in arterial hyperoxia 
showed a consistent effect favoring the middle quintiles and no time in arterial hyperoxia. Mild 
hyperoxia was mainly associated with a slight increase in VFDS, whereas severe hyperoxia was 




) showed a J-shaped relationship with 
hospital mortality (Figure 1). 
Time spent in mild hyperoxia and time spent in severe hyperoxia both showed a linear and 





) and linear (MAX
ICU LOS
) relationships were found for the other 
metrics (Supplemental Fig. 5–8, Supplemental Digital Content 1).
Subpopulations
In mechanically ventilated patients, the adjusted odds ratios for conditional hospital mortality 
were highly comparable with the estimates for the total study population (Table 3). In large patient 
groups, such as planned and medical admissions, the odds ratios differed slightly from those in 
mechanically ventilated patients. In smaller subpopulations, including patients admitted with 
cardiac arrest, stroke, and sepsis, no statistically significant risks from arterial hyperoxia could 
be identified. 
D I S C U S S I O N
In this multicenter cohort study, we found a dose-response relationship between supraphysiological 
arterial oxygen levels and hospital mortality, ICU mortality and ventilator-free days. The effect size 
was importantly influenced by the definition of arterial hyperoxia and severe hyperoxia was more 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2. Adjusted probability of in-hospital death by time in hyperoxia. 
Probability of death predicted from logistic regression model adjusted for age, APACHE IV score and ICU 
LOS. Lines represent estimated time in mild (dashed) and severe (solid) hyperoxia. Grey zones represent 95% 
confidence intervals. A linear model was presented, because the smoothing curve for both metrics showed 
a clear linear relationship between the predicted outcome and time in hyperoxia.
Figure 1. Adjusted probability of in-hospital death by mean PaO
2
. 
Loess smoothing curve predicted from logistic regression model adjusted for age, APACHE IV score and 
ICU LOS. Blue line represents oxygenation by mean PaO
2























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































metric that defines the exposure was shown to be an essential factor in determining the risk for 
the studied population.
We selected a variety of metrics that were identified by a previous systematic review of 
the literature (9). These pre-existing metrics are usually calculated over the first 24 hours of 
admission, but our findings show that exposure to arterial hyperoxia in other time frames and using 
different definitions may substantially impact on the studied outcomes. For this study a new set 
of relevant oxygenation metrics was compiled for ICU patients. This allowed for comprehensive 
insights in the epidemiology and associated outcomes across multiple abstractions of arterial 
hyperoxia. However, we cannot rule out that the observed effects in this study can be subtly altered 
when alternative metrics are used. 
By studying the continuous application-related adverse effects of hyperoxia this study addressed 
the timely clinical questions whether arterial hyperoxia is a biomarker for mortality and when 
the exposure is sufficient to cause harm (20-22). Metrics of central tendency (mean, median) were 
found to have the strongest relationship with outcome. The effects were smaller for the metrics of 
single measurements (i.e. highest, worst, first). In this context, the maximum PaO
2
 value may be an 
incidental outlier but could also be indicative of a longer lasting, gradual process of increasing PaO
2
 
levels where a maximum is ultimately achieved, thereby mimicking metrics of central tendency. 
However, the latter explanation is less likely as this metric was shown to substantially differ from 
other metrics in cluster, correlation, and regression analyses.
Metrics of cumulative oxygen exposure, including hourly exposure and AUC in the first 24 
hours, have recently been used by Elmer et al. to show associations with morbidity and mortality 
after cardiac arrest (23, 24). We additionally calculated AUC and time in arterial hyperoxia from 
admission to discharge, which may be a more accurate measure of total hyperoxia exposure even 
though exposure beyond the ICU admission, e.g. in the general wards, was not considered in this 
study. Assuming that these metrics closely reflect the actual exposure, the association between 
arterial hyperoxia and poor outcome is consistent in multivariate models which account for 
the total length of stay and illness severity. Notably, our results were essentially unchanged when 
the multivariate models were additionally adjusted for applied FiO
2
 levels and also if the oxygen 
component in the APACHE score covariate was removed in order to avoid overadjustment. Still, we 
cannot exclude that residual confounding may be present from unmeasured variables.
In contrast with a previous study in mechanically ventilated patients (13) but in concordance 
with another (15), hyperoxia identified by the worst PaO
2
 in the first 24 hours was not significantly 
associated with hospital mortality. Since the spline based transformation of this metric calculated 
over the total ICU LOS did emerge as the best discriminator for mortality, the association may be 
primarily driven by the discriminative capability of the arterial normoxia and/or hypoxia range. In 
other words, the worst PaO
2
 is an important measure over the total ICU stay, but within the first 24 
hours a hypoxic worst PaO
2
 may predict mortality more precise than a hyperoxic measurement. 
When comparing previous studies, the selected metrics should be explicitly considered, as we 
showed that this may considerably impact on the observed effect sizes. Regional differences in 
oxygen management and cohort type may further be responsible for specific study differences. For 

































ranges by different metrics should also be taken into consideration. Indeed, the probability of type 
2 errors increases with relatively low numbers of exposed patients in specific subsets. In smaller 
subsets of cardiac arrest, stroke, or sepsis patients, our risk estimates were in the same order of 
magnitude as previously found for arterial hyperoxia although subtle differences can be designated 
(7, 9, 25-27). The absence of significant effects in small subsets may be a signal of the used 
definition or may reflect indifferent outcome or a lack of statistical power. Analyses in different 
subpopulations should therefore mainly be considered exploratory and interpreted with caution. 
Also, we accounted for multiple testing by lowering the level for statistical significance.
Several limitations deserve further mention. First, methodological flaws following 
the retrospective nature of this study should be considered and causality cannot be inferred. Second, 
immortal time bias may play a role in models predicting hazard when no censored data is available. 
We therefore corrected for the total ICU LOS in multivariate analyses, modeled hospital mortality 
given either death or discharge, and only analyzed the predictive value for metrics that were not 
computed based on the total ICU LOS. The inherent limitation of non-continuous PaO
2
 sampling 
with a lack of data between successive measurements was overcome by using linear and natural 
spline interpolation between separate PaO
2
 measurements and calculate area under the curves and 
time spent in arterial hyperoxia, but it should be considered that real data of unmeasured arterial 
oxygenation and ventilatory management was not available. Further, our statistical models were 
fully calibrated on the data of the present cohort but may not universally fit other data and cannot 
be directly extrapolated to other cohorts. We used a cohort in which conservative oxygenation was 
promoted, and the exposure rates may therefore differ in comparison to other hospitals. However, 
we used a multicenter cohort and the concepts are likely to be comparable across different ICUs and 
regions. Indeed, our findings were quite consistent in the three participating centers and over time. 
The dose-response relationship was recently also illustrated in a meta-regression of cohort studies 
(9). When pooling these studies, heterogeneity of included studies was found to be substantial, 
which could be partially explained by the use of different metrics for arterial hyperoxia and different 
multivariate models.
Strengths of our study include the representation of arterial hyperoxia by several relevant and 
novel analytical metrics of PaO
2
, the large multicenter cohort and an unprecedented set of ABG 
samples, including data within and beyond the first 24 hours of admission. We placed previously 
found associations of arterial hyperoxia with hospital mortality in a broader and clinically relevant 
context of varying definitions, durations and also included secondary outcomes, such as length of 
stay, mechanical ventilation time and ventilator-free days. Our strategies to investigate the effects 
of a continuously changing parameter on patient-centered outcomes can be further applied as 
a toolbox for other clinical challenges such as glucose and carbon dioxide management.
The present findings underline the importance of preventing excessive oxygenation during 
prolonged periods and urge careful oxygen titration in critically ill and mechanically ventilated 
patients. PaO
2
 levels exceeding 200 mmHg were not only associated with ICU mortality and hospital 
mortality but may also lead to fewer ventilator-free days. Mild hyperoxia was not consistently 
shown to be harmful and may have beneficial properties when attempting to compensate and 

































of death increases linearly when the exposure time in mild hyperoxia increases strongly. Thus, on 
the short term mild hyperoxia may not directly impact on outcome, but clinicians should still be 
aware that cumulative exposure to even mild hyperoxia may be harmful. Taking this into account, 
exposure time may also be a marker of responsive care, even though the effect sizes were similar 
when adjusting for proxy markers of less responsive care (e.g. lowest glucose). It should be realized 
that hyperoxia is a label that admits to several definitions, where PaO
2
 is not a single indicator of 
blood oxygen and may embrace both care given and the consequences of that care. The curvilinear 
relationship between the metrics and outcome, suggest that both arterial hypoxia and arterial 
hyperoxia should be actively avoided, and deviations from the normal may be a result of unfavorable 
oxygen management. Given the diversity of patients, clinical scenarios and characteristics of 
oxygen, universal recommendations remain cumbersome. However, in expectation of future 
randomized controlled trials, our findings may be auxiliary to guide targeted oxygen management 
by estimating the potential risk in different clinical situations.
C O N C L U S I O N S
We found that metrics of central tendency for severe arterial hyperoxia, as well as exposure time for 
mild and severe arterial hyperoxia, were associated with unfavorable outcomes of ICU patients and 
this association was found both within and beyond the first day of admission. Our results suggest 
that the relationship was consistent for large patient groups and that previously used approaches 
may not have completely captured the actual exposure effects.
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A B S T R AC T
Background
High inspiratory oxygen concentrations are frequently administered in ventilated patients in 
the intensive care unit (ICU) but may induce lung injury and systemic toxicity. We compared beliefs 
and actual clinical practice regarding oxygen therapy in critically ill patients.
Methods
In three large teaching hospitals in the Netherlands, ICU physicians and nurses were invited to 
complete a questionnaire about oxygen therapy. Furthermore, arterial blood gas (ABG) analysis 
data and ventilator settings were retrieved to assess actual oxygen practice in the same hospitals 1 
year prior to the survey.
Results
In total, 59% of the 215 respondents believed that oxygen-induced lung injury is a concern. 
The majority of physicians and nurses stated that minimal acceptable oxygen saturation and 
partial arterial oxygen pressure (PaO
2
) ranges were 85% to 95% and 7 to 10 kPa (52.5 to 75 mmHg), 
respectively. Analysis of 107,888 ABG results with concurrent ventilator settings, derived from 5,565 
patient admissions, showed a median (interquartile range (IQR)) PaO
2
 of 11.7 kPa (9.9 to 14.3) [87.8 
mmHg], median fractions of inspired oxygen (FiO
2
) of 0.4 (0.4 to 0.5), and median positive end-
expiratory pressure (PEEP) of 5 (5 to 8) cm H
2
O. Of all PaO
2
 values, 73% were higher than the upper 
limit of the commonly self-reported acceptable range, and in 58% of these cases, neither FiO
2
 nor 
PEEP levels were lowered until the next ABG sample was taken.
Conclusions
Most ICU clinicians acknowledge the potential adverse effects of prolonged exposure to hyperoxia 
and report a low tolerance for high oxygen levels. However, in actual clinical practice, a large 






















B AC KG R O U N D
Oxygen supply during mechanical ventilation is a highly effective and uniformly used intervention to 
support oxygenation of mechanically ventilated patients in the intensive care unit (ICU). Although 
oxygen administration is a lifesaving strategy in the management of patients with respiratory 
insufficiency, the clinical implications of hyperoxia remain an important subject of debate (1). 
The controversies are triggered by a considerable number of studies showing both beneficial, 
harmful and/or insignificant effects of oxygen therapy on outcome in different subgroups (2-15). 
However, morbidity and mortality may be substantially impacted by the used threshold and depend 
on degree, duration, and susceptibility for hyperoxia. 
The emerging laboratory evidence for the double-edged nature of oxygen (lifesaving but 
also potentially harmful) is compelling (16-22), but robust clinical studies and evidence-based 
guidelines in critically ill patients are still limited (23-26). Consequently, the attitudes and beliefs in 
the management of oxygen administration vary considerably in clinical practice (27, 28). In general, 
physicians are inclined to treat hypoxemia aggressively in order to achieve satisfactory tissue 
oxygenation (23, 29, 30). However, hyperoxemia is often considered acceptable, especially when 
applied fractions of inspired oxygen (FiO
2
) are relatively low (31-33).
Given the lack of established guidelines on oxygen therapy in ICU patients, our study was 
designed to investigate the common beliefs and self-reported attitudes of ICU physicians and 
nurses on oxygenation targets and to compare this with actual treatment of ICU patients in 
the same hospitals. We hypothesized that the potential harmful effects of oxygen are well known 
and generally acknowledged, but that in real clinical practice, hyperoxia is not a major concern for 
ICU professionals. 
M E T H O D S
Questionnaire
An anonymous online survey was performed between June and August 2012 to elicit the self-reported 
behavior of ICU personnel with respect to oxygen therapy. The questionnaire was a modified and 
comprehensive version of previously used questionnaires from Canada and Australia/New Zealand 
(27, 28) and comprised multiple choice questions (see Additional file 1). The target population 
consisted of physicians and nurses, working in closed format, mixed medical and surgical, tertiary 
care ICUs of three participating hospitals, including two academic and one large teaching hospital 
in the Netherlands. Participants were invited by email to complete the online questionnaire. 
A reminder was sent once to all participants.
Patient data
Analyses were performed on data recorded between 1 April 2011 and 31 March 2012 for all patients 
admitted to the ICU departments of the same hospitals that participated in the questionnaire study. 
Anonymous encrypted data were collected from the patient data management system (PDMS) 
database (MetaVision, iMDsoft, Leiden, The Netherlands). According to the Dutch Medical Research 
Involving Human Subjects Act, there was no need for informed patient consent or approval by 





















Arterial blood gas (ABG) analyses and concurrent ventilator settings were extracted to 
retrospectively assess actual practices regarding oxygen therapy. Data from ICU admission to 
dismissal or death were included for analysis. Data with a partial arterial oxygen pressure (PaO
2
) 
of ≤4.5 kPa or 33.8 mmHg (n=209) were excluded to prevent confounding by venous blood gas 
samples. Further exclusion of samples with PaO
2
 of 4.5 to 5.0 kPa (n=146) or PaO
2
 of 5.0 to 6.0 
kPa (n=356) did not materially change our observations (data not shown). Every set of ABG data 
and ventilator settings was compared with the following set, as described previously (32). Prone 
positioning, recruitment maneuvers, and other efforts that may improve oxygenation could not be 
explored in this database. Clinicians’ responses to ABG results were explored by analyzing the FiO
2
 
and positive end-expiratory pressure (PEEP) adjustments in a subsample of mechanically ventilated 
patients when more than two ABG samples and ventilator settings were recorded. PaO
2
 values were 
categorized according to the commonly self-reported acceptable range (7 to 10 kPa or 52.5 to 75 
mmHg) extracted from the survey results (Fig. 1). This range is roughly consistent with oxygenation 
goals (7.3 to 10.7 kPa or 55 to 80 mmHg) previously suggested by the Acute Respiratory Distress 
Syndrome (ARDS) network (30, 34).
Mechanical ventilation protocol
Local guidelines, applicable during the survey and collection of ABG and ventilation data, instructed 




 levels higher than 60% should be avoided by increasing PEEP 





 or saturation were specified in the participating hospitals during this period.
Statistical analysis
All data are expressed as percentages of the total number of respondents for the particular 
questions, unless otherwise specified. Data are presented as means (±SD) or medians (interquartile 
range, IQR) depending on data distributions, unless stated otherwise. For assessing differences 
between physicians and nurses, ICU personnel were grouped according to their respective 
profession and data were analyzed using Fisher’s exact tests. ICU physicians, fellows, and residents 
were classified as physicians; ICU nurses and ICU nurses in training were classified as nurses.
Statistical analyses were conducted using STATA/SE 10.1 (StataCorp LP, College Station, TX, USA).
R E S U LT S
Data derived from questionnaire
Respondent characteristics
Approximately 500 potential participants were invited to complete the online questionnaire. Full or 
partial responses were received from 215 ICU physicians and nurses with a mean age of 40.4±10.0 
years (range 24 to 62). In total, 171 (80%) respondents fully completed all questions. The group 
of respondents consisted of 28 (13%) critical care physicians, 15 (7%) fellows, 15 (7%) residents, 






















Opinions towards oxygen toxicity 
The responses are listed in Table 1. Overall, 126 (59%) respondents considered oxygen induced 
lung injury in mechanically ventilated patients a major concern. However, the vast majority of 
respondents (81%) considered high tidal volumes and high inspiratory pressures as the greatest risk 
for lung injury in mechanically ventilated patients. No differences between physicians and nurses 
were detected.
Self-reported acceptance of hyperoxemia and hypoxemia
The percentages of respondents accepting various oxygenation ranges in a young to middle-aged 
mechanically ventilated patient with ARDS are shown in Figure 1. 
For both short and longer lasting periods, the vast majority of respondents choose 7 to 10 kPa 
(52.5 to 75 mmHg) as the lowest acceptable PaO
2
 range. Physicians were more tolerant towards 
lower PaO
2
 limits for short duration than nurses (P<0.001). 
Table 1. Questionnaire responses regarding risks assessment and management in oxygen therapy 
Question
Responses
 (% of total)
Physicians vs.
 nurses
Is oxygen induced lung injury a concern when placing a patient on mechanical 
ventilation?
 YES, a major concern 
  due to the high incidence of injury 
  due to the severity of injury 
  due to the high incidence and severity of injury 
 YES, but not a major concern 








In your opinion, which one of the following two situations poses a greater threat 




 High tidal volumes and high ventilator pressures 





In situations when maximal SaO
2
 achievable is low (±85%) or when FiO
2
 
requirements are high, do you assess indices of tissue oxygenation? 
 NO 
 YES, lactate 
 YES, microcirculation with OPS/SDF imaging











NS, Not significant; FiO
2
, Fractions of inspired Oxygen; OPS, Orthogonal Polarization Spectral; SDF, Sidestream Dark 
Field; SaO
2
, Arterial Oxygen Saturation; SvO
2





















Presented with a patient whose arterial oxygen saturation (SaO
2
) levels are low (<85%) or FiO
2
 
requirements are high, indices of tissue oxygenation were frequently assessed (Table 1). Differences 
between physicians and nurses approached statistical significance (P=0.05), with physicians favoring 
lactate assessment, and nurses being less likely to demand some assessment of tissue oxygenation. 
Nurses in training more often favored lactate assessment than senior ICU nurses (P=0.01).
Adjustment of FiO
2
 in specific clinical cases
The proportions of ICU clinicians adjusting FiO
2
 levels in specified clinical cases are listed in 
Table 2. Observed differences by profession were mainly restricted to questions regarding patients 
with untreatable anemia, where physicians generally favored higher FiO
2
 levels than nurses. Only 
minor differences within the clustered categories of physicians (comparison between physicians, 
fellows, residents) and nurses (ICU nurses, nurses in training) were observed.
Data derived from ABG measurements and ventilator settings
Descriptive data
A total of 107,888 ABG results with concurrent ventilator settings, covering 5,565 patient admissions, 
were retrieved and included for analysis over a 1-year period prior to the survey in three hospitals. 
Median interval between two consecutive ABG samples was 214 min (IQR 130 to 331), and the median 
number of ABG samples per patient was 7 (IQR 4 to 19). Mean PaO
2
 was 12.9 kPa (SD 5.1) or 96.8 
mmHg and median PaO
2
 was 11.7 kPa (IQR 9.9 to 14.3) or 87.8 mmHg. Overall, in 25.3% of ABG 
results, PaO
2
 was in the self-reported range (7 to 10 kPa), 1.2% was lower and 73.4% was higher than 
the predefined range.
Figure 1. Self-reported tolerance limits for short-term (15 min, open bars) and longer term (24 to 48 h, closed 
bars) oxygenation. 
Bars represent percentage of respondents (n=200). The presented case is a young to middle-aged ARDS patient 
in the ICU requiring mechanical ventilation. Ventilator settings (e.g., PEEP, airway pressures, I:E ratio, flow ratio) 




 ratio and hemodynamic indices. Lung injury due to high FiO
2
 and/














































































































































































































































































































































































































































































































































































































































































































































































































































































































Mechanical ventilation settings showed a mean PEEP of 6.1 cm H
2
O (SD 4.3), and median PEEP 
was 5 (IQR 5 to 8). Mean FiO
2
 was 0.45 (SD 0.14), and median FiO
2
 was 0.40 (IQR 0.40 to 0.50). Only 
small differences were observed between the three participating hospitals.
Recorded FiO
2
 adjustments following ABG analysis
After exclusion of spontaneously breathing and non-invasively ventilated patients, 62,875 ABG 
records derived from 4,264 mechanically ventilated patients were included for analysis of FiO
2
 
adjustments in response to ABG samples. 
Analyzing every first registered ABG sample in the ICU, 62,222 PaO
2
 measurements covering 
3,791 patients were retrospectively categorized in predefined ranges and were followed by 
a recorded FiO
2
 adjustment. The subsequently registered PaO
2
 measurement was compared with 
the first registered PaO
2
 (Table 3). 
Table 4 shows that quantity, direction, and magnitude of ventilator adjustments in response to 
high arterial oxygen levels are considerably influenced by the level of FiO
2
. In 58.3% of cases with 
PaO
2
 higher than the upper level of the commonly self-reported acceptable oxygenation (10 kPa 
or 75 mmHg), neither FiO
2
 nor PEEP levels had been lowered when the next ABG sample was taken. 
Table 3. FiO
2





















<7 kPa (1.2) Higher (34.7) 96.6% (+5.3) 0.4% 3.0% (-0.5)
 Unchanged (46.9) 87.4% (+5.6) 3.2% 9.4% (-0.6)
Lower (18.4) 95.1% (+7.9) 2.4% 2.5% (-0.9)
7–10 kPa (25.3) Higher (27.9) 76.3% (+3.1) 2.7% 21.0% (-0.9)
Unchanged (56.0) 66.3% (+2.0) 4.3% 29.4% (-0.8)
Lower (16.1) 61.3% (+2.6) 3.6% 35.1% (-1.0)
>10 kPa (73.4) Higher (10.8) 48.6% (+4.6) 2.1% 49.3% (-3.1)
Unchanged (62.0) 44.7% (+2.1) 3.1% 52.2% (-2.3)
Lower (27.2) 23.5% (+2.4) 1.7% 74.8% (-4.6)
Total (100) – 46.3% (+2.6) 2.7% 51.0% (-2.9)
Data presented as percentages of total and irrespective of adjustment of other ventilator settings (e.g. PEEP, I:E 
ratio). Delta, mean difference between two successive ABG samples; PaO
2
, any recorderd PaO
2
 stratified by self-


















, lower than previous level. A total of 62,222 PaO
2
 measurements from 3,791 patients (57.7% 
of all 107,888 ABG samples) in the database is followed by an adjustment of ventilator settings, and 98.2% of PO
2
 
measurements is followed by a successive PO
2





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































D I S C U S S I O N
In accordance with accumulating laboratory evidence for the toxic effects of oxygen in pulmonary 
injury (1, 35-38), the majority of surveyed ICU physicians and nurses consider prolonged hyperoxic 
exposure to be associated with an increased risk for lung injury, although a lower risk than high tidal 
volumes and inspiratory pressures. In contrast, in actual clinical practice, the majority of PaO
2
 values 
recorded in ICU patients are higher than recommended targets under comparable conditions and 
are generally accepted by ICU physicians and nurses without adjustment of ventilator settings.
Compared with previous studies from other countries, more respondents identified oxygen 
toxicity as a major threat to lung injury in ICU patients (59% compared with 26% and 51% in studies 
from Australia and Canada, respectively) (27, 28). Similar proportions of respondents considered 
high inspiratory oxygen concentrations a more important risk than high tidal volumes or inspiratory 
pressures, and a similar heterogeneity in self-reported attitudes regarding oxygen therapy was 
observed (27, 28, 39). The current results show generally higher minimum allowable SaO
2
 ranges 
than data from Canadian intensivists (28), which may indicate that clinicians’ beliefs have changed 
over the last decade or it may merely reflect geographical differences in oxygen therapy.
It appears that clinicians’ opinions regarding optimal oxygen therapy are more variable in 
case SaO
2
 is presented compared to PaO
2
 as marker of oxygenation. For PaO
2
, the vast majority 
of clinicians choose 7 to 10 kPa (52.5 to 75mmHg), whereas the preferred targets for saturation 
varied between 85% and 95%. Assuming that oxygenation targets should be in line with the best 
evidence in available guidelines, these preferred ranges may be triggered by recommendations and 
protocols providing comparable PaO
2
 targets (30, 40). However, caution is urged when interpreting 
pulse oximetry to differentiate between hyperoxemia and normoxia. Saturation levels above 95% 
require special attention, since the corresponding PaO
2
 levels usually cover a wide range and may 
substantially exceed target levels (24, 41).
According to the results from our questionnaire, the vast majority of respondents stated they 
would lower FiO
2
 levels if PaO
2
 was higher than 12 kPa (90 mmHg) or SaO
2
 was higher than 95% 
in ARDS patients. The proportion of respondents that would lower FiO
2
 is much lower if patients 
were presented with sepsis, cardiac and cerebral ischemia, or untreatable anemia. Unfortunately, 
we do not know whether respondents believe that oxygen is specifically harmful in patients with 
pre-existing acute lung injury or that higher oxygen levels are considered desirable in patients with 
ischemia or anemia. The latter hypothesis appears plausible, even though hyperoxemia has been 
reported to induce important vasoconstriction, which may lead to a paradoxical decrease in oxygen 
delivery (4, 42).




 than target levels appears to be in 
contrast with actual treatment of patients in the same three ICUs where the survey was conducted. 
Neither FiO
2
 nor PEEP was changed in the majority of cases when PaO
2 
was higher than 15 kPa (112.5 
mmHg) and FiO
2
 was 40% or lower. In cases when FiO
2
 was 40% to 100%, ventilator settings were 
adjusted more often, but even in these circumstances, hyperoxemia was accepted in approximately 
20%. Considering the absence of definitive guidelines and robust controlled clinical evidence, this 





















towards oxygen therapy on the one hand and actual treatment by the same healthcare workers on 
the other hand is striking.
The findings about oxygenation in ICU patients are consistent with previous findings from 
single center studies, showing that hyperoxemia was frequently present in mechanically ventilated 
patients and seldom led to adjustment of ventilator settings (31, 32). Clinicians may have specific 
reasons not to adjust ventilator settings when PaO
2 
levels are higher than the target range. 
Indeed, we identified a considerable number of cases in which a presumed inadequate adjustment 
ultimately proved reasonable in the subsequent ABG sample (e.g., high PaO
2
 followed by an 
increase in FiO
2
, but resulting in a lower PaO
2
). These cases may reflect scenarios in which clinicians 
anticipate deterioration in oxygenation or otherwise consider PaO
2
 values as erroneous (e.g., 
arguably high PaO
2
 – see Table 4, row PaO
2
 > 30) or not representative for the current situation of 
a patient. Alternatively, it may be argued that hypoxemia harbors greater inherent hazards than 
 hyperoxemia (3). 
The differences between self-reported attitudes and actual treatment of patients should be 
interpreted with caution. First, the cases presented to the respondents included only limited details 





 categorized in ranges that were arbitrarily chosen. This may have influenced interpretation 
of the hypothetical cases. Second, ICU clinicians may have given more favorable responses in 
the online questionnaire due to social desirability and attention bias, although this is less likely as 
anonymous evaluation was secured. Third, the respondents were asked for the minimum allowable 
range in a specific ARDS case vignette, which may not reflect their beliefs regarding oxygen therapy 
in general. In the analysis of actually achieved oxygenation, we studied all patients independent 
of admission diagnosis. Also, response rates for the survey were relatively modest. However, 
the profession distribution in the group of respondents closely reflects a typical staff constitution in 
a general ICU in the Netherlands, which reduces the chance of sampling bias. In the Dutch clinical 
setting where respiratory therapists are not available, it is often the bedside nurse that responds 
first to changes in oxygenation. Therefore, the opinions of ICU nurses about oxygen therapy are 
important in the actual care of critically ill patients (39). Finally, some ABG samples, taken shortly 
after ICU arrival, may reflect oxygen therapy initiated on the operating room and influenced by 
anesthesiological ventilation strategies. However, successive ventilator adjustments were all 
recorded on the ICU and were supervised by critical care physicians. Therefore, high PaO
2
 values in 
the direct postoperative period are not a plausible explanation for the low proportion of hyperoxic 
ABG samples not followed by adaptation of the ventilator settings.
Strengths of this study include the large sample of questionnaire responses and the extensive 
set of ABG data, derived from the same ICUs where the questionnaire was conducted. This facilitated 
a comprehensive comparison between self-reported attitudes and actual practices of oxygen 
therapy for both physicians and nurses. Further, the design of the present questionnaire closely 
resembles previous surveys from Canada and Australia, thereby exploring geographical patterns 
and trends in time concerning oxygen therapy. Our study extends these data as we have assessed 

























allows further estimation of the effects of recorded FiO
2
 adjustments in comparison with previous 
data (32).
C O N C L U S I O N S
This study shows that most clinicians acknowledge the potential adverse effects of prolonged 
exposure to hyperoxia, in accordance with emerging evidence for pulmonary toxicity and increased 
risk of poor outcome in both humans and animals caused by excessive oxygenation (2, 4, 6, 8, 16, 18, 
20, 35, 44). However, objective data also suggest that clinicians did not consistently accommodate 
this conception in actual clinical practice and a large proportion of patients was exposed to 
arterial oxygen levels higher than self-reported as acceptable by nurses and physicians. Additional 
education, feedback, and implementation strategies, aimed at careful titration of oxygen, may 
therefore be an effective approach for strict adherence to oxygenation targets (45). Studies on 
the effects of different target ranges for PaO
2
 on clinically relevant endpoints are needed to guide 
ICU professionals on how much oxygen should be administered to their patients.
L I S T  O F  A B B R E V I AT I O N S
ABG, arterial blood gas; FiO
2
, fractions of inspired oxygen; ICU, intensive care unit; PaO
2
, partial 
arterial oxygen pressure; PDMS, patient data management system; PEEP, positive end-expiratory 
pressure; SaO
2
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A B S T R AC T
Objective
Conservative oxygen therapy is aimed at the prevention of harm by iatrogenic hyperoxia while 
preserving adequate tissue oxygenation. Our aim was to study the effectiveness and clinical 
outcomes of a two-step implementation of conservative oxygenation targets in the ICU.
Design
This was a before and after stepwise implementation study of conservative oxygenation targets, 
between July 2011 and July 2014. The primary endpoint was the proportion of PaO
2
 values within 
the target range. Secondary outcomes included ventilator-free days (VFDs) at day 28, length of stay 
(LOS), and mortality.
Setting
Three closed-format ICUs in the Netherlands.
Patients
We analysed data on 15,045 eligible admissions.
Interventions 
The first implementation phase consisted of providing training and feedback on new guidelines 
instructing for explicit targets for arterial oxygen tension (PaO
2
 55–86 mmHg) and oxyhemoglobin 
saturation (SpO
2
 92–95%). In the second phase, bedside clinicians were additionally assisted in 
guideline adherence by a computerized decision-support system.
Measurements and Main Results
The proportion of PaO
2
 in the target range increased from 47% at baseline to 63% in phase 1 and to 
68% in phase 2 (P<0.0001). Episodes of hyperoxia decreased (P<0.0001), whereas hypoxic episodes 
remained unchanged (P=0.06) during the study. Mechanical ventilation time was significantly lower 
(P<0.01) during both study phases. After adjustment for potential confounders, VFDs in phase 1 and 
phase 2 were higher than baseline: adjusted mean difference 0.55 [95% CI 0.25, 0.84] and 0.48 [0.11, 
0.86], respectively. Adjusted ICU mortality and intensive care unit free-days did not significantly 
differ between study phases. Hospital mortality decreased in reference to baseline: adjusted OR 
0.84 [95% CI 0.74, 0.96] for phase 1 and 0.82 [95% CI 0.69, 0.96] for phase 2.
Conclusions
Stepwise implementation of conservative oxygenation targets was feasible, effective, and appeared 
safe in critically ill patients. The implementation was associated with several changes in clinical 
outcomes, but the causal impact of conservative oxygenation is still to be determined. 



















I N T R O D U C T I O N
The application of oxygen has always been of undisputed importance in emergency and critical 
care medicine. It is a highly effective therapy in preventing or compensating hypoxic injury and has 
life-saving properties. However, the risks of excessive oxygenation have recently placed the liberal 
use of oxygen in a new perspective. Oxygen is essential for cell metabolism and organ function, 
but triggers free radical formation and induces hemodynamic and inflammatory changes in higher 
doses (1-4). Furthermore, hyperoxia may promote lung injury during mechanical ventilation and 
has been linked to poor outcome in various subgroups (5-10). A considerable proportion of patients 
in the intensive care unit (ICU) is exposed to hyperoxia (11, 12), but preventive strategies may be 
hampered by a lack of clinical trials. Guidelines are available for a limited number of subgroups and 
are not easily extrapolated to universal recommendations for critically ill patients. 
Conservative oxygen therapy is aimed at the prevention of iatrogenic hyperoxia while preserving 
adequate tissue oxygenation through careful oxygen titration (13, 14). This pragmatic strategy is 
increasingly advocated but its feasibility and effects on important clinical parameters are still to be 
assessed (15, 16). We hypothesized that a stricter adherence to conservative oxygenation guidelines 
may improve patient-centered outcomes by preventing derangements and inherent harm. Our aim 
was to study the effectiveness and clinical outcomes of a two-step implementation of conservative 
oxygenation targets in the ICU.
M AT E R I A L S  A N D  M E T H O D S
Study Design
This was a before and after stepwise implementation study of conservative oxygenation targets in 
the ICUs of three participating hospitals, including two academic and one large teaching hospital 
in the Netherlands. The participating ICUs are mixed medical and surgical, tertiary care units, with 
20–30 beds, where full responsibility for the patient and treatment is transferred to the critical 
care physician.
The study was registered with the Netherlands Trial Register, number NTR3424. Ethical approval 
was granted by the Medical Ethical Committee of the Leiden University Medical Center. The need 
for informed consent was waived under Dutch National law for the type of study and in view of 
the retrospective and anonymous data collection.
Data Collection
Arterial blood gas (ABG) analyses, concurrent ventilator settings, and hourly pulse oximetry data 
recorded between July 1, 2011 and July 1, 2014 were extracted from the patient data management 
system (PDMS) databases (MetaVision, iMDsoft, Tel Aviv, Israel) of participating ICUs. Data were 
supplemented with anonymous demographic patient data, admission and discharge data, and data 
to quantify severity of illness from the Dutch National Intensive Care Evaluation (NICE) registry, 
a high quality database, which is subject to multiple quality checks and local audits in accordance 



















All ABG data were used when analyzing the effects on oxygenation. For clinical endpoints, 
data were summarized per patient admission and in case of readmissions only the first admission 
was included. Analyses were conducted on data from all ICU patients with subgroup analyses on 
mechanically ventilated patients. Patients on extracorporeal membrane oxygenation were excluded 
from the study. Retrospective baseline analyses were performed over a 12-months period prior to 
the implementation and details have been described previously (11).
Procedures
At baseline, oxygen therapy was approached liberally and targets for the partial pressure of arterial 
oxygen (PaO
2
) only specified a lower limit of 75 mmHg with liberal oxyhemoglobin saturation by 
pulse oximetry (SpO
2
), in the participating hospitals. Local guidelines instructed for a fraction 
of inspired oxygen (FiO
2
) and positive end-expiratory pressure (PEEP) depending on individual 
oxygenation measures and generally avoiding FiO
2
 levels higher than 0.6 by increasing PEEP levels, 
instituting inverse-ratio ventilation, or prone positioning.
The first implementation phase of this study started at July 2012 and consisted of providing 
a written guideline, instructing to supply as little oxygen as possible with clear recommendations 
how to adapt oxygen administration and ventilator settings depending on ABG analyses. Guidelines 





 targets were set between 55 and 86 mmHg, and 92–95%, respectively, and were 
chosen since they were considered safe, feasible, and consistent with previously suggested 
targets (18, 19). In patients with severe cardiac ischemia, cerebral ischemia, or untreatable anemia, 
higher target levels up to 105 mmHg were allowed. Repeated passive and interactive education on 
the rationale of conservative oxygenation targets and a clear description of preferred PEEP/FiO
2
 
combinations were provided to all ICU clinicians in the participating hospitals. Baseline strategies 
for protective ventilation remained unchanged and during all study phases guidelines instructed for 
tidal volumes between 6–8 ml/kg ideal body weight, PEEP levels between 5–24 cm H
2
O, respiratory 
rate between 8–35 per minute and pH higher than 7.2. During the first study phase feedback was 
provided by statistical process control (SPC) and involvement of local leadership to promote 
a culture that supports guideline compliance. SPC was provided through newsletters and posters 
showing a summary of the guideline and the results of the previous time period including plots 








In the second and last phase of this study, from December 2013 till July 2014, a computerized 
decision-support system (CDSS) was introduced in the active, critiquing mode, meaning that it will 
automatically give decision-support, but only if the actual situation is not according to the guideline 
provided in phase 1 (20, 21). Raw data of all registered measurements were used for CDSS and 
filtered on data quality. A pop-up window appeared in the PDMS for bedside clinicians if either 
PaO
2
 in ABG analysis was higher than the upper level or SpO
2
 measurements were continuously 
higher than or equal to 97% for at least 30 minutes. The event was only triggered if the FiO
2
 or 



















the previous notification was more than three hours ago. The notification window suggested to 
adjust oxygen administration and/or ventilator settings for a maximum of two times per shift and 
not within the first three hours of ICU admission. Measures from the first phase of implementation 
were also continued using repeated training and feedback. The implemented guidelines and CDSS 
were introduced with an intention-to-treat approach. Actual decisions to change the settings or 
targets were left to the discretion of the attending physicians and nurses in the ICU.
Outcomes
The primary endpoint was a priori defined as the proportion of PaO
2
 values within the targeted 
study range. Secondary outcomes included ventilator-free days at day 28 after admission, duration 
of mechanical ventilation, length of stay (LOS), and mortality. PaO
2
 according to study protocol was 
defined as 1) any PaO
2
 in target range; 2) any PaO
2
 higher than target range with concurrent FiO
2
 
at 0.21 and PEEP at 5 or followed by a decrease in FiO
2
 or PEEP; 3) any PaO
2
 lower than target range 
with concurrent FiO
2
 at 1.0 and PEEP at 24 or followed by an increase in FiO
2
 or PEEP. Hyperoxia was 
defined as any PaO
2
 higher than 120 mmHg (22, 23) and hypoxia as any PaO
2
 lower than 45 mmHg.
Mechanical ventilation time was calculated as the sum of all mechanically ventilated episodes 
during the same admission. The ventilator-free days (VFDs) were calculated as the number of 
ventilator-free days and alive, 28 days after ICU admission according to a previously described 
definition (24). Accordingly, the intensive care unit-free days (ICUFDs) were calculated as 





 ratio multiplied by the concurrent mean airway pressure. The standardized mortality 
ratio (SMR) was calculated using the APACHE IV predicted mortality.
Statistical Analysis
The study was designed to detect a 5% difference in the primary endpoint with 98% power, assuming 
5000 ICU admissions in the participating hospitals per year. 
Every set of ABG data and ventilator settings could be compared with the following set, as 
described previously (11, 25). Means with standard deviations and medians with interquartile ranges 
are provided according to the underlying distribution. In some cases, both means and medians are 
provided in order to comprehensively summarize the data. Differences between study phases were 
tested with ANOVA or Kruskal Wallis as appropriate. Multivariate analyses were performed using 
generalized linear regression models for ventilator-free and ICU-free days and logistic regression 
for mortality while adjusting for confounding covariates. Confounding variables were stepwise 
selected using the 10% change-in-estimate method (26). Propensity scores were included in 
the multivariate models in order to adjust for each patient’s propensity to be admitted during either 
study phase. Variables included in the propensity score model were age, sex, hospital, APACHE III 
score, admission type, admission source, planned admission, co-morbidities, vaso-active drugs 
in the first 24 hours of admission and confirmed infection within 24 hours of admission. Mixed-
effects models with random intercepts were performed to account for random effects within 



















multicollinearity in the multivariate models. All analyses were conducted using R version 3.1.3 (R 
Foundation for Statistical Computing, Vienna, Austria) and RStudio version 0.98.1103 (RStudio Inc, 
Boston, MA).
R E S U LT S
In total, 295,701 ABG analyses were obtained over the baseline and implementation period. After 
excluding readmissions, 15,045 patients were included (Table 1). Eligible patients were predominantly 
male (64.2%), with a median age of 65 years. The majority of patients were mechanically ventilated 
at any time (81.8%) during admission and 17.3% was ventilated for more than 48 hours. Patient 
characteristics were comparable across study phases in terms of age, sex, body mass index, planned 
admission rate, illness severity, and several co-morbidities. The percentage of medical admissions 
increased from 33.7% at baseline to 36.8% in phase 1 and 38.1% in phase 2.
During the study, median levels of arterial oxygen pressures (PaO
2
), oxyhemoglobin saturation 
(SpO
2
) and central venous oxygen saturation (ScvO
2
) decreased significantly (Table 1). Lactate was 
slightly higher during phase 2, but not during phase 1.
Arterial oxygenation
The proportion of ABG analyses with a PaO
2
 in the targeted study range was markedly higher after 
implementation and increased from 47% during baseline to 63% in the first implementation phase 
and 68% during the second implementation phase (Table 2).
The mean difference between baseline and phase 1 was 16.1 [95% CI 15.8, 16.5] and 21.0 [95% CI 
20.5, 21.5] between baseline and phase 2. The compliance showed a gradual increase during the 12 
months of phase 1, but in comparison to the end of phase 1 no further improvement was found after 
implementation of the CDSS  in phase 2 (Fig. 1).
The proportion of PaO
2
 in range per patient admission, increased from 38% at baseline to 53% 
in phase 1 and 57% in phase 2. PaO
2
 within target range as well as PaO
2
 outside target range but 
promptly followed by adequate adjustments of oxygen administration or ventilator settings (PaO
2
 
according to study protocol) increased from 72% to 86% and 90%, respectively. The proportion of 
SpO
2
 measurements in the target range increased from 16% to 25% and 27%, respectively. PaO
2
 levels 
showed a rapid and persistent decline after the study start (supplemental figures, Supplemental 
Digital Content 1). The incidence of hyperoxia decreased from 15.3% during baseline to 9.0% and 
7.6% in phase 1 and phase 2, respectively. The incidence of hypoxic episodes (<45 mmHg) did not 
essentially change (0.4% during baseline, 0.5% during both implementation phases).
In mechanically ventilated patients, the oxygenation index and FiO
2
 levels decreased significantly 




 ratio (Table 1). PEEP levels increased marginally 
in phase 2, and were adjusted less frequently than FiO
2
 levels in all study phases. Mean airway 
pressures remained unchanged. Oxygenation higher than the upper study limit was less commonly 
observed after implementation and FiO
2
 and PEEP levels were more frequently lowered in these 
cases (Table 2). Likewise, these ventilator settings were more frequently increased when PaO
2
 levels 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1. Percentage of arterial blood gas analyses in targeted oxygenation range during baseline and 
study phases. 
Blue scatters are weekly means of primary outcome with weighted regression lines (95% CI) per study phase. 
Red horizontal lines are study phase means with SD
Table 2. Measures of implementation and oxygenation during all study phases
Total
Study phase
Baseline Phase 1 Phase 2 P-value
PaO
2
 in target range, % 57.9 46.7 62.8 67.7 <0.0001
SpO
2
 in target range, % 22.2 16.0 24.6 26.6 <0.0001
PaO
2
 in target range per patient, % 48.6 38.0 52.5 56.8 <0.0001
PaO
2
 according to study protocol, % 81.8 72.2 85.9 89.5 <0.0001
PaO
2
 > upper study limit, % 39.4 51.3 34.1 29.0 <0.0001
 of which followed by decrease in FiO
2
 or PEEP, %a 45.7 39.6 50.3 55.9 <0.0001
PaO
2
 < lower study limit, % 2.8 2.0 3.2 3.3 <0.0001
 of which followed by increase in FiO
2
 or PEEP, %a 56.4 52.4 55.0 66.6 <0.0001
PaO
2
 > 120 mmHg, % 11.0 15.3 9.0 7.6 <0.0001
PaO
2
 < 45 mmHg, % 0.4 0.4 0.5 0.5 0.06
ABG per patient, n 7 (4-16) 7 (4-17) 6 (4-16) 6 (4-15) <0.0001
ABG per 24 hours, n 5 (4-6) 5 (4-7) 5 (4-6) 4 (3-6) <0.0001
Abbreviations: ABG, arterial blood gas; PaO
2
, partial pressure of arterial oxygen; FiO
2
, fraction of inspired oxygen; 
PEEP, positive end-expiratory pressure; SpO
2
, oxyhemoglobin saturation by pulse oximetry. 
aData in italics are subanalyses on mechanically ventilated patients of which PaO
2
 was higher than the upper limit or 



















Table 3. Crude clinical outcomes during all study phases
Total
Study phase
Baseline Phase 1 Phase 2 P-value
All patients, n 15045 4890 7148 3007 -
 ICU LOS
  Mean, days 3.4 (6.5) 3.4 (6.8) 3.5 (6.5) 3.4 (5.9) 0.72
  Median, days 1.4 (0.8-3.1) 1.1 (0.8-3.0) 1.5 (0.8-3.2) 1.7 (0.9-3.6) <0.0001
 Hospital LOS
  Mean, days 14.3 (17.1) 14.7 (18.0) 14.2 (17.1) 13.8 (15.5) 0.04
  Median, days 9 (6-16) 9 (6-16) 9 (6-16) 8 (5-16) 0.22
 ICUFDs, days 21.6 (9.2) 21.5 (9.5) 21.7 (9.1) 21.6 (8.9) 0.63
 ICU mortality, n 1487 (9.9%) 475 (9.7%) 709 (9.9%) 303 (10.1%) 0.86
 Hospital mortality, n 2063 (13.7%) 723 (14.8%) 942 (13.2%) 398 (13.2%) 0.03
 SMR [95% CI] 0.78 [0.75, 0.82] 0.84 [0.77, 0.90] 0.75 [0.70, 0.80] 0.76 [0.69, 0.84] 0.01
Mechanically ventilated at 
any time, n
12206 (81.1%) 4043 (82.7%) 5789 (81.0%) 2374 (78.9%) 0.0003
 Mechanical ventilation time
  Mean, hours 46.9 (111.4) 50.7 (129.8) 46.0 (103.9) 42.5 (93.7) 0.01
  Median, hours 10.8 (5.2-39.0) 11.4 (6.0-40.3) 10.8 (5.0-38.8) 9.4 (4.6-36.4) <0.0001
 ICU LOS
  Mean, days 3.8 (7.1) 3.8 (7.4) 3.9 (7.1) 3.8 (6.5) 0.63
  Median, days 1.7 (0.9-3.8) 1.3 (0.8-3.6) 1.7 (0.9-3.8) 1.8 (0.9-4.0) <0.0001
 Hospital LOS, days
  Mean, days 14.3 (17.2) 14.7 (18) 14.3 (17.3) 13.7 (15.7) 0.09
  Median, days 9 (6-16) 9 (6-16) 9 (6-16) 8 (6-15) 0.22
 VFDs, days 22.3 (9.4) 22.1 (9.6) 22.5 (9.3) 22.5 (9.3) 0.10
 ICUFDs, days 21.1 (9.6) 21.0 (9.8) 21.1 (9.5) 21.0 (9.4) 0.78
 ICU mortality, n 1393 (11.4%) 452 (11.2%) 663 (11.5%) 278 (11.7%) 0.80
 Hospital mortality, n 1802 (14.8%) 634 (15.7%) 824 (14.2%) 344 (14.5%) 0.13
 SMR [95% CI] 0.80 [0.76, 0.84] 0.85 [0.78, 0.91] 0.77 [0.71, 0.82] 0.80 [0.71, 0.88] 0.01
Data are means (standard deviation), or medians (interquartile range) according to distribution, unless stated 
otherwise. Abbreviations: ICU, intensive care unit; LOS, length of stay; ICUFDs, intensive care unit-free days 
and alive at day 28; VFDs, ventilator-free days and alive at day 28; SMR, standardized mortality ratio according to 
APACHE IV model.
Secondary end points
Secondary outcome measures are listed in Table 3 and depicted in the supplemental figures. 
ICU mortality and ICUFDs did not differ between study phases. The median ICU LOS was longer 
in phase 2 compared to phase 1 and baseline, whereas the mean ICU LOS remained unchanged. 
Median hospital LOS did not change and hospital mortality decreased from 14.8% during baseline to 
13.2% during both implementation phases. Standardized mortality ratios and Kaplan-Meier curves 
for survival and mechanical ventilation time are shown in more detail in the supplemental figures. 
For patients requiring mechanical ventilation at any time (n=12,206), median mechanical 



















Mortality rates showed no statistically significant change in this subgroup. The VFDs increased from 
22.1 to 22.5 days after implementation. For the smaller cohort of patients who were ventilated for 
more than 48 hours (n=2,609), no significant differences for major outcome measures between 
study phases were observed (Supplemental Tables, Supplemental Digital Content 2). For surviving 
patients, mechanical ventilation time decreased, ICU LOS increased, whereas hospital LOS remained 
unchanged over the study time (Supplemental Tables, Supplemental Digital Content 2).
Separate analyses for the effect of the implementation in the individual participating ICUs are 
shown in the supplemental tables. Similar improvements in PaO
2
 in target range were found in each 
ICU. In one of the units, the proportion of medical admissions increased markedly in phase 1 and 
phase 2, and potentially related to this, a concurrent increase in ICU LOS was found. The effect sizes 
of other outcome measures were in the same order of magnitude for all three ICUs.
Multivariate analyses
When the model for the proportion of PaO
2
 samples in the target range was reanalysed in mixed-
effects models, the associations were virtually unchanged (data not shown). The crude and adjusted 
estimates were calculated as mean differences or odds ratios per study phase in reference to 
baseline and were adjusted for identified confounders and propensity scores (Table 4). No increase 
in ICUFDs was found in either the unadjusted or adjusted analyses. After adjustment, the increase 
in VFDs was stronger. There were no statistically significant differences in ICU mortality, whereas 
the odds ratios for hospital mortality were lower in both implementation phases, after adjustment 
for confounders.
Table 4. Clinical outcomes with adjustment for confounders
Study phase 1 Study phase 2
Unadjusted Adjusted Unadjusted Adjusted
Mean difference [95% CI]
 VFDsa 0.38 [0, 0.76] 0.55 [0.25, 0.84]* 0.39 [-0.08, 0.87] 0.48 [0.11, 0.86]*
 ICUFDsb 0.16 [-0.17, 0.50] 0.16 [-0.11, 0.42] 0.08 [-0.34, 0.50] 0.10 [-0.23, 0.43]
Odds ratio [95% CI]
 ICU mortalityc 1.02 [0.91, 1.16] 1.09 [0.93, 1.27] 1.04 [0.89, 1.21] 1.09 [0.90, 1.32]
 Hospital mortalityc 0.87 [0.79, 0.97]* 0.84 [0.74, 0.96]* 0.88 [0.77, 1.00] 0.82 [0.69, 0.96]*
Multivariate models were adjusted for admission type, APACHE III score and propensity score (for admission during 
either phase 1 or phase 2). Abbreviations: ICUFDs, intensive care unit-free days and alive at day 28; VFDs, ventilator-
free days and alive at day 28. a Mean difference in ventilator-free days in reference to baseline for subgroup of 
mechanically ventilated patients. b Mean difference in intensive care unit-free days in reference to baseline for all 



















D I S C U S S I O N
Key findings
In this multicenter clinical trial, stepwise implementation of a strategy targeting conservative 
oxygenation levels through education, feedback, and decision support was shown to be feasible 
and effective in critically ill patients. Targeting PaO
2
 levels of 55–86 mmHg and SpO
2
 levels of 92–95% 
resulted in lower but safe oxygenation levels of arterial blood. Taking the before after design in 
consideration, this study was limited in the ability to address the clinical impact of our strategy. In 
adjusted analyses, implementation of the study protocol was associated with a slight improvement 
in ventilator-free days and hospital mortality. However, ICU-free days and ICU mortality were 
unaffected over the study time.
Interpretation
The proportion of PaO
2
 samples in the target range (primary outcome) increased strongly in 
the first study phase in which traditional implementation strategies were applied. These strategies 
consisted of education for all ICU nurses and physicians, providing written guidelines on targets and 
ventilator settings, and frequent feedback using statistical process control. In contrast, the CDSS, 
which was offered in phase 2, had no additional effect on the primary outcome and may even have 
been somewhat counterproductive. However, phase 2 was shorter than phase 1 and trends could 
therefore be assessed with less precision. A ceiling effect of modifiable oxygenation should also 
be considered as ventilator settings are often initiated outside the ICU (e.g. during anesthesia or at 
the emergency room) and first ABG samples, taken shortly after ICU arrival, were responsible for an 
important part of these out-of-range samples. Other reasons for a ceiling effect can be postulated 
in terms of knowledge barriers, attitude barriers, and behavioral barriers (27). Barriers include 
reluctance of clinicians to adhere to new guidelines, resistance to change, and reluctance to replace 
pre-existing guidelines (28-30). Guideline implementation strategies were previously shown to 
be successful when strategies were multifaceted and actively engaged clinicians throughout 
the process (31). Although CDSS is usually beneficial (32), its effects in a multifaceted approach 
may be less (cost-)effective (33-35). An alternative explanation for the apparently paradoxical 
course of compliance in phase 2, is that traditional implementation was so successful that no 
additional benefit could be achieved by a decision support module. However, we cannot rule out 
that prolonged CDSS, different algorithms, more frequent reminders, or more specific suggestions 
to change ventilator settings, could have been more effective. During phase 2, the proportion of 
PaO
2
 values within range was even somewhat lower than at the end of phase 1. Although this may 
be normal fluctuation by chance, decision support may alternatively induce passive behavior of 
bedside clinicians leading to slower adjustments of ventilator settings. Even after implementation 
of conservative oxygenation targets, approximately 30% of PaO
2
 and 70% of SpO
2
 measurements 
was higher than the target range. The latter marker of oxygenation is indeed less reliable and more 
variable, albeit the percentage of registered values increased significantly with implementation. 
The proportion of samples according to protocol, also including PaO
2
 outside the limits followed by 



















at the end of the study. In this respect, phase 2 was superior to phase 1, in line with other clinical 
outcome measures in multivariate analyses. Controlled evidence is warranted to further evaluate 
CDSS in comparison to traditional training and feedback (21).
Strengths and Limitations
The following potential limitations of this study should be considered. First, the non-randomized 
intervention in this clinical trial hampers causal inferences, especially regarding effects on 
relevant clinical patient outcomes. Differences in case-mix between the baseline period and both 
implementation phases may have been responsible for differences in outcomes such as length of 
stay, mechanical ventilation time, or hospital mortality. However, demographic characteristics 
and illness severity scores were very similar across the study periods and multivariate analyses 
were adjusted for confounders and propensity scores. The longitudinal design of this study yields 
potential bias as outcomes of ICU patients may improve over time due to factors other than 
oxygenation targets. Hypothesizing that attentive monitoring of oxygenation and ventilation 
improves outcome, study awareness may elicit attention bias. Indeed, we could not fully control 
for secular trends and potential changes in clinician behavior and ventilation management during 
the study. Interestingly, improvement of clinical outcomes was observed in all three ICUs during 
the first implementation phase, but without a further improvement after adding CDSS. Also, during 
the 12 months baseline period, no significant trends to improved survival, LOS, or mechanical 
ventilation time were found. 
General oxygenation strategies were specified as much as possible, but specific and individual 
oxygenation strategies were left to the discretion of the participating centers and responsible 
clinicians. In this context, individual cases with amended target ranges including patients with 
severe anemia or ischemia were not specifically registered in the database. Hospital related 
differences in case-mix, patient care, and guideline adherence may accordingly influence 
the overall-effects, although there was a consistent signal for end points in the sensitivity analyses, 
even when wider PaO
2
 target levels up to 105 mmHg were used for analysis. The only exception was 
ICU LOS which increased only in the ICU where an increase in the proportion of medical admissions 
was found. The finding that median ICU LOS increased during the study should therefore be 
interpreted with caution. Accordingly, in the multivariate analysis, also adjusting for admission type, 
no association between ICUFDs and implementation was found. Finally, our findings may not be 
directly generalizable to other ICUs although we believe that the inclusion of patients from three 
participating hospitals during two years can robustly represent a general ICU population. At least it 
shows the feasibility of conservative oxygen therapy with strict adherence to oxygenation targets. 
Strengths of this study include the multicenter trial participation, the large patient cohort, 
the quality of the database, and the possibility to control for many covariates. Further, our findings 
are consistent with a previous single-center pilot study reporting compliance with targeted 
saturation in a small sample of mechanically ventilated patients (13). In this study, conservative 
oxygen therapy was shown to be free of adverse biochemical, physiological, and clinical outcomes. 























In mechanically ventilated patients, we could not demonstrate an improvement in mortality rates 
and LOS, yet mechanical ventilation time decreased in a significant manner. Potential mechanisms 
underlying the observed effects in clinical outcomes are multifarious. Precise control of arterial 
oxygenation avoids significant variation from the target range and may successfully reduce 
the harms associated with unnecessary extremes (15). In addition, conservative oxygen therapy 
may contribute to acclimatization and cellular adaptation to mild hypoxia, which may result in 
improved efficiency of ATP production and protection of mitochondria (15). Reducing the exposure 
to hyperoxia may decrease mechanical ventilation time by preventing absorption atelectasis, 
pulmonary inflammation, and other histopathological changes in the lung (1, 4, 9). Patient-centered 
outcomes are also likely to be impacted by reactive oxygen species, oxygen-induced cardiovascular 
alterations (2), oxidative DNA damage (36) and mediators of oxygenation. Interestingly, hospital 
mortality decreased during the study whereas ICU mortality remained unchanged. This observation 
is in agreement with results from pooled cohort studies, showing that arterial hyperoxia was 
associated with hospital mortality but not specifically with ICU mortality (10). Clinical improvements 
may alternatively be attributed to behavioral changes in clinical practice and precise control of 
oxygenation, rather than to the prevention of hyperoxia per se (37).
The oxygenation ranges used in this study were chosen based on previous recommendations 
(18, 19). In accordance, this range was within the standard of care and no reasonably foreseeable 
risks of the actually achieved oxygenation were anticipated. Although other target ranges for 
conservative oxygen therapy may well be as good as or even better than the range we studied (14), 
our approach was safe in terms of major clinical end points. Also, the incidence of severe hypoxia 
was rare and did not increase over time. In comparison to baseline, tissue oxygenation represented 
by arterial lactate or oxygenation index did neither deteriorate. Moreover, the higher percentiles 
of lactate levels remained virtually unchanged (data not shown). In prospective evaluation of 
conservative oxygenation, a randomized intervention, alternative mediators and the effects on 
specific parameters including hemodynamics and the microcirculation are still to be assessed.
C O N C L U S I O N S
Stepwise implementation of conservative oxygenation was feasible and showed a rapidly established 
high compliance to targeted arterial oxygen and saturation levels. The gradual improvement in 
guideline adherence was accompanied by a slight improvement in several clinical outcomes, but 
this should be interpreted with caution in view of the study design. Future randomized controlled 
studies should further clarify the causal effects of oxygenation targets on clinical outcomes for 
ICU patients.
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In a recent issue of Critical Care Medicine, Helmerhorst et al. (1) made two important points. 
First, hyperoxia is associated with significant morbidity and mortality. Second, an intervention 
with minimal cost, involving training and provider feedback, decreased improper use of oxygen 
by 25% (p < 0.0001), ensuring that 63% of patients received appropriate therapy (SpO
2
 , 92–95%). 
This modest intervention resulted in a significant decrease in hospital mortality and mechanical 
ventilation time. However, in low-income nations, undertreatment of hypoxemia, as opposed to 
the “more is better” scenario addressed by Helmerhorst et al. (1), is still a problem. A single study 
found that the point prevalence of undiagnosed hypoxemia was 9% among 109 inpatient adults in 
Zambia (2). In 2015, the Lancet Commission on Global Surgery found that 24% of developing country 
hospitals lack oxygen, and 70% of operating theaters do not have pulse oximeters (3). Our group 
sought to determine the occurrence rate of hypoxemia and associated mortality among all inpatient 
adults in a low-income setting. We conducted a prospective single-center observational study in 
one of Rwanda’s two public tertiary care hospitals, with 12,000 annual admissions (4). We screened 
all adult inpatients (age > 15yr) every day for 4 weeks in 2014 with an Acare/Lifebox oximeter (Acare 
Technology Co., Ltd., Taipei, Taiwan). Hypoxemia was defined as oxygen saturation less than 90% 
or receiving oxygen supplementation. During the 4 weeks of the study, 1,046 adult patients were 
admitted to the hospital (4). One hundred twenty-six patients (12.0%) were hypoxemic on one or 
more days with an inpatient mortality rate of 49.2%. Median age was 49 years (interquartile range 
(IQR), 34–65 yr). Mortality was worse with worsening hypoxemia. As hypoxemia increased from 





 ratio between 200 and 300; 100–200; < 100), respectively. While 111 patients 
(88.1%) received adequate oxygen at least 1 day, 76 (60.3%) of hypoxemic patients either received 
no oxygen therapy or inadequate oxygen therapy on at least 1 day (SpO
2
 < 90%). Median time 
from admission to hypoxemia was 1 day (IQR, 1–3 d). Oxygen has been listed as one of the World 
Health Organization’s Essential Medicines since the first online edition was published in 2002 (5); 
however, very little research exists on hypoxemia in adult populations. In our study of inpatient 
adults, hypoxemia occurred at epidemic proportions. Although 85.7% of hypoxemic patients were 
in hospital wards outside the ICU, their 49.2% mortality rate was almost identical to the mortality 
of our ICU patients (47.1%) (4). It is possible that hypoxemia is simply a marker of severe disease; 
however, our data raise the question of whether consistent oxygen therapy at all levels of the health 
system could make an impact on mortality. While Helmerhorst et al. (1) study rightly emphasizes 
that more oxygen is not always better, “some” oxygen to address hypoxemia is almost certainly 
beneficial. Helmerhorst et al. (1) trial indicates that simple, low cost educational and behavioral 
interventions are capable of improving oxygen use where oxygen is available and hyperoxia 
a common occurrence. For much of the world, making oxygen consistently available and educating 
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We thank Sutherland et al. (1) for their interest and thoughtful comments regarding our work. They 
have raised an important issue that regional differences play a key role in oxygen management and 
that insufficient availability may contribute to higher mortality rates as shown by Riviello et al. (2). 
Despite the potential risks of excessive oxygenation, it is extremely important to realize that oxygen 
has life-saving properties in many critical conditions. This accounts for all patients worldwide, but 
Sutherland et al. (1) duly emphasize that its availability is not self-evident in all countries. Especially 
in low-income nations, meeting the basic needs of oxygen should receive first priority as long as 
hypoxemia imposes a major threat to public health. Indeed, sufficient oxygen therapy is vital for all 
levels of the health system, and adequate training and education on the accessibility, use, and misuse 
of oxygen remain crucial. This makes it even more pertinent that our study showed that clinicians’ 
behavior regarding oxygen management can be (permanently) changed by simple and universal 
measures such as education, feedback, and training (3). We also showed that, with increased focus 
on conservative oxygen therapy, hypoxemic events were more adequately acted upon during our 
study period. Computerized decision support may be of added value in this context but should be 
further studied and may not be universally available in all health institutions.
A second issue that Sutherland et al. (1) address is adequate recognition and treatment 
of hypoxemia. Early diagnosis by pulse-oximeters and point-of-care blood gas analyzers are 
prerequisites for optimal oxygen therapy, avoiding both hypoxemia and hyperoxia. Furthermore, 
tailored oxygen administration through nasal cannulas, masks, or ventilators and appropriate 
titration of the dose determine the success of the intervention. These assets are essential for 
patient-centered outcome and are impacted by the (financial) resources and focus of the institution 
and caregivers. 
We believe that our study yielded hopeful results for further implementation of targeted 
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P L E A D I N G S
This thesis addresses the clinical challenge of providing the right amount of oxygen to critically 
ill patients. 
In the first part we reviewed the literature for the experimental and clinical effects of inspired 
and arterial hyperoxia (chapter 2). Sufficient oxygen supply is essential for human survival and 
administering high levels of inspired oxygen is therefore a powerful and efficient tool to prevent 
the life-threatening effects of hypoxia in critically ill patients. However, excessive oxygenation also 
has deleterious properties in various pathophysiological processes. The effects of supplemental 
oxygen prove to be diverse and reactive oxygen species play an important role in hyperoxia-
mediated tissue injury and oxidative stress, characterized by cell damage, cell death and 
inflammation. When human lungs are continuously exposed to hyperoxia, symptoms start locally 
with tracheobronchitis, atelectasis, pulmonary edema, and eventually respiratory failure. Symptoms 
may also spread to the central nervous system, as evidenced by nausea, dizziness, headache, 
visual disturbances, neuropathies and convulsions. Vascular effects originate rapidly and include 
vasoconstriction in most vascular beds. The increase in systemic vascular resistance may prove 
useful in counteracting unfavourable vasodilation during shock or anesthesia, but may also impair 
cardiac output and organ perfusion. We concluded that oxygen remains of life-saving importance 
in critical care, but can also be toxic in higher doses and after prolonged exposure. We must further 
stress that evidence from experimental models that are clinically relevant to the critical care setting 
were scarce and the effects of hyperoxic exposure on critically ill patients requires further research 
due to the lack of robust evidence from clinical studies. 
As a proof of principle, we further investigated which effects prolonged hyperoxia has 
in a preclinical context (chapter 3). By exposing mice to increasing levels of inspired oxygen 
during mechanical ventilation, we found that hyperoxia has a time- and dose dependent effect. 
We demonstrated a severe vascular leakage and a pro-inflammatory pulmonary response in 
mechanically ventilated mice, which was enhanced by hyperoxia and longer duration of mechanical 
ventilation. Prolonged ventilation with high oxygen concentrations induced a time-dependent 
immune response characterized by elevated levels of neutrophils, cytokines and chemokines in 
the pulmonary compartment, which was not directly translated into extensive lung injury. This was 
in line with previous findings even though remarkable differences in cytokine levels were noted 
and lung injury scores were comparable between the study groups. The complex kinetics and 
dynamics of the immune response make it very difficult to characterize the exact mechanisms, 
interpret the effects and attribute these to a specific part of the combined exposure to anesthesia, 
mechanical ventilation and hyperoxia. Moreover, translation of these study results to the clinical 
situation remains cumbersome as healthy mice are not identical to critically ill patients. Our 
experimental model may be a useful representation of the intensive care setting and may aid to 
determine optimal ventilator strategies in critically ill patients but needs further modification and 
validation to test new hypotheses, acquire more insight in save oxygen management and generate 




















In the second part of this thesis, we focused on the clinical effects of hyperoxia and the associated 
outcomes in critical illness. Concentrating on the vascular effects of clinical implementation, we 
experimentally introduced a brief hyperoxic interval in the postoperative period of mechanically 
ventilated patients in the ICU after coronary artery bypass grafting surgery (chapter 4). We 
evaluated the acute hemodynamic changes and aimed to comprehensively describe alterations of 
the circulation by measuring cardiac output, mean systemic filling pressure, resistance to venous 
return, cerebral blood flow velocity and markers of the microcirculation. During a 15-minute 
exposure to hyperoxia, we observed significant alterations in systemic circulation mainly by 
vasoconstriction of both the venous and arterial circulation and an increase of mean systemic filling 
pressure. Effects on cardiac output, cerebral blood flow and the microcirculation were relatively 
small and may be clinically insignificant in hemodynamically stable subjects. However, the increase 
in systemic resistance, stressed volume and systemic filling pressure by hyperoxia resembled 
the effects of norepinephrine and associated changes in central circulatory variables may have 
clinically important consequences in critically ill patients when hemodynamic changes are vital. 
These findings underscore the potential benefit of inducing hyperoxia during vasodilatory shock, 
but may also explain why patients with acute cardiac ischemia have a greater myocardial infarct 
size after supplemental oxygen therapy in the ambulance and during cardiac catheterization. 
Furthermore, these results shine light on associations found between arterial hyperoxia and in-
hospital mortality among patients admitted to the ICU following resuscitation from cardiac arrest.
In order to further appraise this relationship, we examined the separate and combined effects 
of the partial pressures of both arterial carbon dioxide and arterial oxygen in a multicenter cohort 
of patients admitted to Dutch intensive care units after cardiac arrest (chapter 5). We exhibited 




, revealed a U-shaped 
relationship with mortality for both parameters, and found that hypocapnia and hypoxia were 
independently associated with hospital mortality in post cardiac arrest patients. A synergistic 




 was not observed, but the close relationship 
between both parameters argues for a concurrent assessment of the effects and we concluded that 
accurate evaluation of target ranges is warranted.
With regards to arterial oxygenation, we systematically reviewed the literature for cohort 
studies comparing hyperoxia to normoxia in critically ill adults and performed a meta-analysis 
and meta-regression of the results (chapter 6). Nineteen studies were pooled and showed that 
arterial hyperoxia during admission decreases hospital survival. Functional outcome measures were 
diverse and generally showed a more favorable outcome for normoxia. Considering the substantial 
heterogeneity of included studies and the lack of a clinical definition, we interpreted that more 
evidence was needed to provide optimal oxygen targets to critical care physicians. 
We challenged this conclusion by evaluating previously used and newly constructed definitions 
of arterial hyperoxia (metrics) and systematically assess their association with clinical outcomes in 
different subgroups in the intensive care unit (chapter 7). Severe hyperoxia was associated with 
higher mortality rates and fewer days on the mechanical ventilator in comparison to both mild 
hyperoxia and normoxia for most metrics. Adjusted effect estimates for hospital mortality were 




















beyond the first 24 hours of ICU admission and was consistent for large subgroups. The largest 
point estimates were found for the exposure identified by measures of central tendency (average 
and median PaO
2
) and these estimates differed substantially between subsets. Time spent in 
hyperoxia showed a linear and positive relationship with hospital mortality. This led us to conclude 
that we should limit the PaO
2
 levels of critically ill patients within a safe range, as we do with other 
physiological variables. 
In the third part of this thesis, we studied current oxygen management and explored strategies 
to support guideline adherence regarding oxygen therapy. In order to pursue this, we identified 
common beliefs and self-reported attitudes of critical care physicians and nurses on oxygenation 
targets and compared this with actual treatment of patients in three tertiary care intensive care 
units in the Netherlands (chapter 8). Most ICU clinicians acknowledge the potential adverse effects 
of prolonged exposure to hyperoxia and report a low tolerance for high oxygen levels. However, in 
actual clinical practice, a large proportion of their patients was exposed to higher arterial oxygen 
levels than self-reported target ranges. 
Following these results, we subsequently studied the feasibility, effectiveness and clinical 
outcomes of a two-step implementation of conservative oxygenation targets in the same three 
intensive care units (chapter 9). With education, feedback and a computerized decision support 
system, we recognized that stepwise implementation of conservative oxygenation targets was 
feasible and showed a rapidly established high compliance to targeted arterial oxygen and 
saturation levels. Targeting PaO
2
 levels of 55-86 mmHg and SpO
2
 levels of 92–95% resulted in lower 
but safe oxygenation levels of arterial blood. The gradual improvement in guideline adherence was 
accompanied by a decrease in mechanical ventilation time and hospital mortality, but this should 
be interpreted with caution in view of the before-after design of this study. Future randomized 
controlled studies should further clarify the causal effects of oxygenation targets on clinical 
outcomes for ICU patients.
W I T N E S S  A N D  J U RY
The side-effects of hyperoxia can be roughly subdivided in cell damage, inflammation, pulmonary 
complications, neurological symptoms and vascular effects. These major features are responsible 
for the large majority of the unfavourable effects and increased risk for morbidity and mortality 
following (prolonged) exposure to hyperoxia.
As a result of oxygen free radicals (reactive oxygen species) and damage associated molecular 
patterns (DAMPs), DNA and cell damage may manifest as apoptosis and necrosis leading to tissue 
injury and local organ-specific complications. DNA damage has been suggested to underlie 
the worse outcomes of cancer patients exposed to high FiO
2
 levels during oncological surgery (1, 2). 
Pathways of cell damage and oxidative stress contribute to a pro-inflammatory state in which tissue 
injury is exaggerated and the innate immune system may be impaired. Neurological symptoms can 
be transient or severe but are usually less pertinent and difficult to diagnose in sedated critically 
ill patients. Pulmonary complications, however, are more frequently encountered as atelectasis 
and pulmonary edema can have major influence on oxygenation and ventilation parameters. 




















organ perfusion. Likewise, increased mortality and morbidity have been observed with hyperoxia 
during events such as ischemic heart disease (3), cardiac arrest (4, 5), stroke (6, 7), traumatic brain 
injury and mechanical ventilation.
Interestingly, it has long been suggested that hyperoxia may have anti-bacterial properties 
and can reduce surgical site infections or infectious complications, but in recent meta-analyses 
this effect appeared to be marginal or even absent (8, 9). Pursuing prolonged periods of 
supraphysiological oxygenation may thus not have any beneficial effect compared to normoxia. As 
the risk of adverse events may be increased by a FiO
2
 of 60% or higher, and as robust evidence is 
lacking for a beneficial effect, evidence is still insufficient to support the routine use of hyperoxia 
during anesthesia, surgery and mechanical ventilation of non-injured lungs (10). 
In the ICU setting, clinical practice guidelines generally target oxygen levels in arterial blood 
comparable with healthy adults at sea level (11-13). Recently published trials comparing conservative 
with conventional or maximal oxygen therapy (14, 15) show potential benefits for conservative 
oxygenation which is in keeping with the results of the Oxytar trial (16), but contrasts with results of 
a pilot randomized controlled trial (RCT) that demonstrated the feasibility and safety of conservative 
oxygen administration (17). 
R U L I N G  A N D  V E R D I C T 
From this thesis, we conclude that careful oxygen titration and monitoring is the best therapeutic 
strategy aimed at the prevention of potentially dangerous hyperoxia while preserving adequate 
tissue oxygenation. In this context, conservative oxygenation in the intensive care unit is a promising 
strategy to achieve better clinical outcomes for critically ill patients. Importantly, the beneficial 
effects of sufficient oxygen supply should not be undervalued in attempts to prevent hyperoxia and 
pursue conservative oxygenation. In critical situations, administering oxygen remains essential to 
prolong the window of opportunity and provide as much oxygen as necessary in anticipation of (e.g. 
pre-oxygenation), or during arterial hypoxia (e.g. respiratory failure, carbon monoxide intoxication, 
gas embolism, decompression sickness), and to rapidly establish pulmonary vasodilation (e.g. in 
right-sided heart failure) or systemic vasoconstriction (e.g. in vasodilatory shock), when other 
measures are inadequate or fail. At the same time, clinicians should be well aware of the side-effects 
that are induced by supplying high levels of oxygen, as hyperoxia is also frequently encountered in 
critically ill patients.
Given the risk of bias in the available evidence, definitive recommendations in providing the right 
dose of supplemental oxygen are not yet obtainable and further RCTs from robust methodological 
quality are warranted. Some RCTs have provided further leads for patients in specific subsets and 
several more trials have recently been initiated. In selected patients, targeting the lower ranges 
of normoxia (55-80 mmHg) can be safely pursued. In expectation of compelling evidence from 
future clinical trials, targeting relative normoxia (80-150 mmHg) by avoiding exposure to both 
subphysiological as well as supraphysiological oxygenation should be considered the most rational 
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N E D E R L A N D S E  S A M E N VAT T I N G
Bij een aanzienlijk deel van patiënten op de intensive care (IC) afdeling wordt het ademen 
ondersteund met een beademingsmachine. Zuurstoftoediening kan hierbij van levensreddend 
belang zijn om het lichaam van voldoende zuurstofrijk bloed te voorzien tijdens een kritieke 
ziekteperiode. Ondanks het grote belang van deze behandeling zijn er aanwijzingen dat beademing 
met hoge zuurstofconcentraties de kans op complicaties en zelfs overlijden op de IC vergroot. Er 
wordt dus vermoed dat overdaad schaadt. De mechanismes die leiden tot complicaties zijn echter 
nog onvoldoende opgehelderd maar zijn van essentieel belang in de behandeling en preventie van 
zuurstofschade bij beademde patiënten. 
Dit proefschrift gaat in op de klinische uitdaging voor zorgverleners om de juiste hoeveelheid 
zuurstof toe te dienen aan kritisch zieke patiënten. In het eerste deel van dit proefschrift wordt 
de huidige stand van zaken beschreven op het gebied van de fysiologische, (dier)experimentele en 
klinische effecten van hoge concentraties zuurstof (hyperoxie) in de ingeademde lucht en in het 
slagaderlijke bloed.
In hoofdstuk 2 beschrijven we dat voldoende zuurstofvoorziening essentieel is voor het 
menselijk bestaan en dat de toediening van een hoge dosis zuurstof een krachtig en efficiënt 
middel is om een levensbedreigend zuurstoftekort bij kritisch zieke patiënten te voorkomen. 
Teveel zuurstof heeft echter ook nadelige gevolgen in een aantal ziekteprocessen. De effecten van 
zuurstoftoediening zijn divers en zuurstofradicalen spelen een belangrijke rol bij de weefselschade 
door celschade, celdood en ontstekingsreacties (de zogenaamde ‘oxidatieve stress’). Op het 
moment dat onze longen continu blootgesteld worden aan hyperoxie, beginnen de symptomen 
van zuurstofvergiftiging vaak met een lokale ontstekingsreactie, het samenvallen van longblaasjes 
(atelectase), een toename van longvocht (longoedeem), en op den duur kan de ademhaling zelfs 
volledig falen. De symptomen kunnen zich verspreiden naar het centrale zenuwstelsel, waarbij er 
misselijkheid, duizeligheid, hoofdpijn, visusklachten, gevoelsstoornissen en convulsies kunnen 
ontstaan. De effecten op de bloedvaten kunnen zich heel snel manifesteren, waarbij de bloedvaten 
vrijwel overal in het lichaam, met uitzondering van de longen, samenknijpen (vasoconstrictie). 
Hierdoor ontstaat een toename in de systemische vaatweerstand en bloeddruk. Dit kan gunstig zijn 
in het geval van een lage bloeddruk met vaatverwijding (vasodilatatie) bij shock of na het geven van 
narcosemiddelen (anesthetica), maar kan ook het hartminuutvolume en de weefseldoorbloeding 
verminderen. Op basis van deze bevindingen concluderen we dat zuurstof van levensreddend 
belang blijft in spoedeisende situaties en op de IC, maar dat zuurstof ook toxisch kan zijn in hogere 
doses en na langdurige blootstelling. Bovendien moeten we benadrukken dat het bewijs voor 
zuurstoftoxiciteit uit experimentele studies, die klinisch relevant zijn voor de IC setting, mager 
en onvoldoende is. Doordat er gelijktijdig een gebrek is aan goed uitgevoerde, klinische studies, 
behoeft het effect van hyperoxie bij kritisch zieke patiënten zonder twijfel meer onderzoek. 
Om meer inzicht te krijgen in de effecten van langdurige hyperoxie in een preklinische context 
hebben wij in hoofdstuk 3 gebruik gemaakt van een experimenteel beademingsmodel. Door muizen 
bloot te stellen aan oplopende hoeveelheden zuurstof met een beademingsmachine, hebben 
we laten zien dat hyperoxie een tijds- en dosis-afhankelijk effect heeft. We hebben aangetoond 







dat door de beademing de longvaten kunnen gaan lekken en dat er een ontstekingsreactie 
in de longen van muizen ontstaat. De beademingsduur en de mate van hyperoxie zijn hierbij 
belangrijke determinanten voor de longschade en -ontsteking. Langdurige beademing met 
hoge concentraties zuurstof veroorzaakte een tijdsafhankelijke reactie die gepaard gaat met 
verhoogde waardes van witte bloedcellen en andere ontstekingsmediatoren in longvocht. Dit 
komt overeen met resultaten uit voorgaande studies maar er zijn ook opvallende verschillen in 
de concentratie van de ontstekingswaarden. Bovendien zijn de scores voor longschade 
vergelijkbaar in de verschillende zuurstof-studiegroepen. Dit kan verklaard worden door 
de complexiteit van de immuunreactie waarbij het ingewikkeld is om de verschillende waarden 
specifiek toe te schrijven aan de verschillende onderdelen van de gelijktijdige blootstelling 
aan narcose, mechanische beademing en hyperoxie. Daarnaast blijft het complex om 
de experimentele resultaten eenduidig naar de klinische praktijk te vertalen. Ondanks dat 
gezonde muizen niet identiek zijn aan kritisch zieke mensen, kan ons experiment een bruikbaar 
model zijn voor de intensive care setting. Het kan bijdragen aan de zoektocht naar optimale 
beademingsstrategieën, maar het model behoeft validatie en verdere aanpassingen om 
nieuwe hypotheses te testen, meer inzicht te geven in veilige omgang met zuurstof en nieuwe 
aanknopingspunten te genereren voor de klinische toepasbaarheid.
In het tweede gedeelte van dit proefschrift ligt de focus op de klinische gevolgen van hyperoxie 
en de gerelateerde uitkomsten in kritieke fases van ziekte. In hoofdstuk 4 hebben we ons 
geconcentreerd op de effecten van hyperoxie op de bloedvaten. Daartoe hebben we beademde 
patiënten een korte periode blootgesteld aan hoge fracties zuurstof in de inademingslucht, terwijl 
zij op de intensive care waren opgenomen nadat ze een bypass van de kransslagaders van het 
hart hadden ondergaan. Tijdens deze periode hebben we de veranderingen in de hemodynamiek 
(circulatie en drukken van het hart- en vaatsysteem) van de patiënten geëvalueerd. Daarbij 
zijn ook de veranderingen in de hersendoorbloeding en doorbloeding van de kleine haarvaten 
(microcirculatie) in acht genomen. Tijdens een 15-minuten-durende blootstelling aan hyperoxie 
hebben we waargenomen dat er significante veranderingen optraden in de bloedcirculatie. Deze 
veranderingen worden voornamelijk veroorzaakt door het samenknijpen van de bloedvaten in 
zowel het slagaderlijke (arteriële) als aderlijke (veneuze) systeem. We hebben hierbij opgemerkt 
dat de bloeddruk stijgt ten gevolge van de blootstelling aan hoge fracties zuurstof. Ook de druk 
die overblijft tijdens een hypothetische stilstand van de bloedsomloop (bijvoorbeeld tijdens een 
hartstilstand) kon worden nagebootst in een model en liet een belangrijke toename zien tijdens 
hyperoxie. De effecten op de output van het hart, de hersendoorbloeding en de microcirculatie 
zijn relatief klein en kunnen van ondergeschikt belang zijn in stabiele gezonde patiënten. 
De toename in de vaatweerstand door hyperoxie blijkt daarentegen goed overeen te komen met 
eerder aangetoonde effecten van het vaak toegediende hormoon noradrenaline als medicament. 
De daarmee gepaard gaande veranderingen in de hemodynamiek kunnen klinisch van groot belang 
zijn bij kritisch zieke IC patiënten. Deze bevindingen benadrukken het potentiële nut dat hyperoxie 
kan hebben als een patiënt zich in een kritieke fase van shock bevindt met een bijkomende lage 
bloeddruk. Het laat echter ook zien hoe patiënten met een acute vernauwing of verstopping van 







de ambulance of tijdens de hartkatheterisatie. De resultaten kunnen ook een recent aangetoond 
verband verklaren tussen hyperoxie en ziekenhuissterfte bij patiënten die na een hartstilstand en 
reanimatie op de intensive care worden opgenomen.
Om dit verband nader in kaart te brengen onderzochten we de onafhankelijke 
en gecombineerde effecten die de waarden van zuurstof (PaO
2
) en koolstofdioxide (PaCO
2
) in 
het slagaderlijke bloed hebben in patiënten die na een hartstilstand opgenomen zijn geweest op 
Nederlandse intensive care units (hoofdstuk 5). Daarbij hebben we laten zien dat zowel lage als 




 de overlevingskans negatief beïnvloeden (U-vormige 
curve). Hypocapnie (verlaagd PaCO
2
) en hypoxie (verlaagd PaO
2
) zijn voor deze patiënten 
onafhankelijke voorspellers van toegenomen sterfte. We zien hierbij geen versterkt (synergistisch) 




, maar de nauwe verwantschap tussen 
zuurstof en koolstofdioxide rechtvaardigt een gelijktijdige beoordeling van de effecten. We 
concluderen dat nauwkeurige evaluatie van deze streefwaarden derhalve essentieel is.
Ten aanzien van de slagaderlijke zuurstofwaarden, hebben we in de literatuur gezocht naar 
cohortstudies die hyperoxie vergelijken met normoxie (zuurstof binnen de normaalwaarden) bij 
kritisch zieke patiënten. Deze studies hebben we systematisch beoordeeld en opgenomen in een 
meta-analyse (hoofdstuk 6). We hebben negentien studies gevonden die aan de inclusiecriteria 
voldeden. Door de resultaten van deze studies te combineren hebben we aangetoond dat hyperoxie 
in het slagaderlijke bloed gedurende de IC-opname sterk geassocieerd is met een verhoogde kans 
op ziekenhuissterfte. Voor functionele uitkomstmaten zijn de resultaten van de verschillende 
studies divers, maar over het algemeen laten dezen een gunstigere uitkomst zien voor patiënten 
met zuurstof binnen de normaalwaarden. De geïncludeerde studies zijn sterk uiteenlopend en met 
het oog op het gebrek aan een duidelijke klinische definitie van hyperoxie hebben we geconstateerd 
dat er meer bewijs nodig is om optimale zuurstofstreefwaarden vast te stellen. 
Deze conclusie hebben we vervolgens getest door de klinische uitkomsten, gebaseerd 
op nieuwe en bestaande definities van hyperoxie, in verschillende IC patiëntengroepen te 
onderzoeken (hoofdstuk 7). Ernstige hyperoxie blijkt geassocieerd met een hoger sterfterisico en 
minder beademingsvrije dagen op de IC in vergelijking met zowel milde hyperoxie als normoxie 
(licht verhoogde of normale zuurstofwaarden). Deze associatie gaat op voor de meest gebruikte 
definities van hyperoxie bij verschillende grote subgroepen en blijft bovendien bestaan als we 
corrigeren voor mogelijk verstorende factoren. De hoogste risicocijfers worden gevonden 
voor de definities van hyperoxie gebaseerd op gemiddelde of mediane zuurstofwaarden berekend 
over de opnameduur. Daarnaast hebben we aangetoond dat de kans op ziekenhuissterfte lineair 
toeneemt met de tijdsduur waarbij er sprake is van hyperoxie bij een IC patiënt. Dit brengt ons 
tot de conclusie dat zorgverleners de zuurstofwaarden van kritisch zieke patiënten binnen veilige 
marges moeten houden, zoals we dat ook al voor veel andere variabelen nastreven.
In het derde en laatste deel van dit proefschrift hebben we onderzoek gedaan naar de huidige 
omgangsvormen met zuurstoftherapie en naar strategieën om de naleving van richtlijnen te 
bevorderen. Daartoe hebben we zelf-gerapporteerde ideeën en standpunten van IC artsen 
en verpleegkundigen ten aanzien van zuurstoftherapie en –streefwaarden in kaart gebracht 







care units in Nederland (hoofdstuk 8). De meeste IC zorgverleners erkennen het potentiële 
gevaar van langdurige blootstelling aan hyperoxie en rapporteren een lage tolerantie voor hoge 
zuurstofwaarden. In de klinische praktijk blijkt echter dat een groot gedeelte van de door hen 
behandelde patiënten bloot gesteld wordt aan hogere zuurstofwaarden in het slagaderlijke bloed 
dan de streefwaarden die de zorgverleners zelf hebben benoemd. 
Als vervolg op deze observaties, hebben we de haalbaarheid, effectiviteit en klinische 
uitkomsten bestudeerd van implementatie van nieuwe zuurstofstreefwaarden (hoofdstuk 9). 
Op de drie betrokken Nederlandse IC afdelingen werd hiervoor een richtlijn geïmplementeerd 
waarbij conservatieve oxygenatie werd nagestreefd met een streefwaarde van 55-86 mmHg 
(7.3-11.5 kPa) voor arteriële zuurstofspanning (PaO
2
) en 92-95% voor de zuurstofsaturatie van het 
bloed. In het eerste jaar bestond de implementatie uit het geven van onderwijs en verspreiden 
van zakkaartjes en posters. In de tweede fase werd een geautomatiseerd behandeladvies 
gegeven wanneer de zuurstofwaarde van de patiënt buiten de streefwaarden viel. Beide 
fases werden vergeleken met de periode voorafgaand aan de implementatie. Het blijkt goed 
haalbaar om dit beleid te implementeren en te handhaven op de afdelingen. Er wordt snel effect 
gezien van het onderwijs en de trainingen op de behaalde zuurstofwaarden in het bloed van 
de patiënten in de deelnemende centra. Een conservatief zuurstofbeleid voor IC patiënten blijkt op 
basis van deze studie haalbaar en veilig, maar voor het aantonen van effect op klinische uitkomsten 
is de opzet van deze studie niet afdoende en zullen nieuwe gerandomiseerde studies nodig zijn. 
De behandelparadigma’s ‘treat first what kills first’ en ‘the more, the merrier’ leiden vaak tot 
ruimhartige zuurstoftoediening om een tekort aan zuurstof (hypoxie) te vermijden, maar er zal bij 
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